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The design of artificial catalysts to hydrolyse phosphate diesters under mild conditions 
remains extremely challenging. In particular, dissecting and quantifying the interactions that 
lead to efficient catalysis has yet to be achieved fully to allow the complete understanding of 
current catalysts. Furthermore, the use of weak, supramolecular interactions to influence and 
control the activity of these catalysts remains a challenge, despite the central role that these 
interactions play in natural systems. 
This work focuses on catalysing the hydrolysis of DNA- and RNA-like substrates with 
mono- and dinuclear zinc complexes. Particular attention is given to quantifying the effect of 
varying structural features on kinetic activity and to study the impact of organic groups that 
affect the microenvironment and potential assembly of these complexes. 
The activity of a series of dinuclear zinc complexes is separated into ground and 
transition state effects to understand the impact of changing peripheral ligand substituents in 
cleaving RNA-like substrates. The presence of amino functionalities (NH2 and NHMe) in the 
vicinity of the metal ions resulted in a 30-fold increase in ground state binding and 40 to 130-
fold increase in transition state stabilisation compared to the parent complex. The role of 
headgroup is explored, and an unexpected sensitivity to reversible inhibition by carbon 
dioxide discovered. 
To introduce aggregation of mononuclear complexes through non-covalent interactions, 
ligands with hydrophobic anchors were synthesised so that they could be embedded into 
vesicles. No evidence for an increase in activity through aggregation was observed, but a 
medium effect in cationic vesicles enhanced the activity of the catalytic centre by more than 
an order of magnitude (3.6 ± 0.4 M-1 s-1) relative to the reactivity in more polar aqueous 
environment (0.16 ± 0.01 M-1 s-1). 
More specific structural organisation of the same zinc complex was attempted through 
the conjugation of peptides that were designed to assemble into dimers, but the observed 
activity reflected that of the monomeric species. Structural characterisation suggested that 
although the peptides did form the anticipated secondary structure, intermolecular association 
did not occur to an appreciable extent. 
Finally, the effect of varying the structures of alcohol and oxime nucleophiles 
covalently incorporated into zinc complexes was explored. The introduction of methyl groups 
close to the nucleophilic centre led to significant changes in solution properties, but 
approximately 3-fold lower reactivity towards DNA-like substrates. 
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Chapter 1  - Introduction  
 
1.1 - Phosphates in nature 
 
Phosphates are prolific in nature, and used in a variety of biochemical processes and 
structures ranging from the cell membranes (phospholipids), cell signaling and protein 
regulation through phosphorylation to chemical energy molecules (adenosine triphosphate, 
ATP), see Figure 1.1. These molecules are of great importance in living organisms although 
one could argue that the most vital task performed by phosphates is the storage of genetic 
information in the biopolymers of DNA and RNA.  
 
Figure 1.1. The structure of mono-, di- and triesters as well as ATP. R1, R2 and R3 represent various 
substituents. 
The DNA and RNA backbone consists of a polyanionic phosphate diester polymer 
linked through the 3’- and 5’-OH of nucleosides, see Figure 1.2. 
 
Figure 1.2. An illustrative structure of a nucleoside. 
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The reason for the prevalence of phosphates in nature has been at the core of decades of 
research into the chemistry of these molecules.[1,2] It has been argued by Westheimer that 
other functionalities (carboxyl ester, amides etc.) could be used for the same task of forming 
the RNA/DNA backbone but that the phosphate possesses superior qualities.  
A potential functionality that can be used as a genetic information bearer is required to 
be divalent, for connectivity, to allow the formation of single stranded biopolymer as well as 
maintaining a charge at neutral pH. The ionisable functionality should have a pKa that is lower 
than 4 or higher than 10 to ensure that the moiety is essentially fully protonated or 
deprotonated under neutral conditions (phosphate diester pKa ≈ 2).  
The charge of the phosphates is believed to play an important role in keeping the 
phosphate biopolymers within the cell. It has been hypothesised that the earliest forms of life 
began to appear from the primordial mixture of compounds only when molecules became 
adsorbed on surfaces or compartmentalised in cell-like structures.[3–5] This would allow for 
sufficiently high concentrations of biomolecules to accumulate for complex chemical 
reactions to become feasible. These structures would most likely have been primitive 
analogues of the lipophilic cell membranes found in all living organisms today.The 
compartmentalisation of charged moieties within lipophilic structures is heavily reliant on the 
charge-lipophile repulsion.[6] The lack of charge or polar character would allow for relatively 
easy diffusion across the lipophilic barrier and therefore reduces the capacity to concentrate 
complex species.  
The trivalent linker molecule citrate seems to fulfill these requirements but it is far less 
stable to hydrolysis than the phosphate diester. The stability of the phosphate diester to 
nucleophilic attack has been associated with the negative charge that is in close proximity to 
the electrophilic phosphorous center. The neutralisation of the charge on phosphate diester, 
illustrated by a triester, leads to a significant increase in reactivity (typically 4 to 5 orders of 
magnitude in water), consistent with this explanation. It has been suggested that molecules 
that feature negatively charged moieties in the vicinity of the hydrolysable bond could be 
stabilised by a similar mechanism. The hydrolysis of phosphates (and esters/amides) proceeds 
through a mechanism involving a nucleophilic attack on the electrophilic carbonyl/phosphate. 
The charged species must be held in close enough proximity to the vulnerable electrophilic 





Figure 1.3. The structures of phosphate and citrate diesters show the difference in the proximity of the 
anionic species to the electrophilic centers (phosphorous or carbonyl). R1 and R2 represent various 
substituents. 
The hydrolysis of phosphates is particularly disfavored due to the high local charge 
concentration at the phosphorous center. The negatively charged moiety in citrate is relatively 
distant from the hydrolysable bond, see Figure 1.3, so the electrostatic repulsion of the 
incoming nucleophile is likely to be less effective. 
The main conclusion that is to be taken from this comparison of potential chemical 
functionalities for DNA/RNA is that the phosphate diester moiety is better suited to perform 
the tasks for which it has been employed than any other functionality. 
 
1.1.1 - DNA and its model compounds 
 
Deoxyribonucleic acid (DNA) is a biopolymer linked through phosphate diesters that 
are very stable to hydrolysis at the P-O bond, see Figure 1.4. The stability of the phosphate 
diester bond to spontaneous hydrolysis at neutral pH and 25 °C makes monitoring the reaction 
under these conditions impossible, which has prompted the use of elevated temperatures     
(up to 250 °C) in order to accelerate the reaction.This stability is a desirable property to 
preserve the genetic information but there are other bonds in DNA that cause strand 
breakage/degradation that are more labile.  
Common degradations seen in DNA are the deamination of nucleobases or the 
depurination/depyrimidination processes,[7] see Figure 1.5, and are counteracted by repair 
mechanisms in vivo. These reactions occur under physiological conditions but become even 
more prevalent at high temperatures. 
The dinucleoside monophosphate TpT has been reported to have rate constants for the 
decomposition that exceed the rate constants for the hydrolysis of phosphate diesters by          




Figure 1.4. The hydrolysis of the phosphate backbone of DNA. 
5 orders of magnitude.[8] This renders DNA unsuitable as a candidate for the study of 
phosphate diester hydrolysis when uncatalysed. The cleavage and formation of the phosphate 
diester bond is an essential biochemical process for the transcription and repair of DNA and 
RNA. The repair process for DNA would have to involve breaking of the phosphate ester 
bond followed by insertion of a new nucleoside which would be unfeasible if left uncatalysed. 
The phosphates diesters are subject to enzymatic catalysis that efficiently accelerates the 
hydrolysis. 
 
Figure 1.5. The depyrination and depyrimidination process for DNA. 
The lack of reactivity of the phosphate diester bond is efficiently counterbalanced by the 
remarkable rate accelerations (1017-fold) reducing the half-life under physiological conditions 
from millions of years to milliseconds.[8,9] These remarkable rate accelerations (provided by 
for example staphylococcal nuclease[9]) are not uncommon for enzymes.[8] This makes the 
hydrolysis of phosphate diesters an excellent reaction to study, not just to understand the 
chemistry of phosphates but more generally, to understand the structures and interactions that 


































The rate of spontaneous hydrolysis of DNA under neutral conditions and at 25 °C was 
extrapolated from high temperature experiments using the model compound dimethyl 
phosphate (DMP) that eliminates the problems associated with the deoxyribose nucleobases. 
The main mechanism involved in the hydrolysis was the C-O bond breakage (> 99 %) as 
opposed to the targeted P-O bond (< 1 %), see Figure 1.6. The reported half-life was 1.3 × 105  
years for the C-O bond breakage[10] which indicates that the upper limit for the half-life of the 
P-O bond breakage is 2.2 × 106 years. 
 
Figure 1.6. The hydrolysis of DMP through competing mechanisms of C-O (red) and P-O (blue) bond 
breakage. 
More appropriate model compounds that sterically preclude C-O bond breakage, see 
Figure 1.7, were used by Williams et al. to study phosphate diester hydrolysis at high 
temperatures.[8,11] The reported first-order rate constant for the hydrolysis of these substrates 
at neutral pH and 25 °C was estimated to be 7 × 10-16 s-1, which equates to a half-life of       
3.1 × 107 years.  
 
Figure 1.7. The phosphate diesters used for the measurement of P-O bond breakage. 
The difference in the rates of spontaneous hydrolysis between the neutral and negatively 


























Figure 1.8. The observed rates at 250 °C versus pH (measured at 25 °C) for Np2P (squares) and Np*2P 
(circle).[8] Reproduced with permission from Schroeder, G. K., Lad, C., Wyman, P., Williams, N. H. & 
Wolfenden, R. The time required for water attack at the phosphorus atom of simple phosphodiesters and 
of DNA. Proc. Natl. Acad. Sci. U. S. A. 103, 4052–5 (2006). Copyright (2006) National Academy of Sciences, 
U.S.A. 
The source of the phosphate diester stability to nucleophilic attack is the negative 
charge on the phosphate backbone which forms on the non-bridging oxygen under neutral and 
basic conditions. In order to mimic the neutral form of the substrate Np*2P a methylated 
triester equivalent Np*2MeP was used, see Figure 1.9. 
 
Figure 1.9. The triester Np*2MeP was used as a more appropriate model for the neutral form of 
Np*2MeP. 
Comparing second-order rate constants for the base-catalysed hydrolysis of Np*2P    
(1.4 × 10-15 M-1 s-1) and Np*2MeP (1 × 10-6 M-1 s-1) show a remarkable 109-fold increase in 
reactivity simply due to the removal of the electrostatic repulsion. The use of a triester as an 
analogue for the neutral diester hydrolysis could be subject to criticism since the neutral 
diester (unlike the triester) could participate in proton transfer processes which would render 




experimental results for the triester model have been confirmed more recently using 
computational investigation.[12] 
Interestingly the observed pH-rate profile in Figure 1.8 for the hydrolysis of the DNA 
analogues indicates acid-catalysed (pH < 6), pH-independent (6 < pH < 13) and base-
catalysed (pH > 13) hydrolysis.  
Given the possible pathways by which the DNA can be degraded, why do we focus on 
the hydrolysis of the phosphate diester bond which is so difficult? The answer to this lies in 
the fact that this stable bond is hydrolysed with relative ease by enzymes which indicates that 
there is a lot of knowledge about catalysis to be gained from studying these reactions. 
The stability of the DNA phosphate diester bond makes it a very challenging target for 
small synthetic molecular complexes that aim to mimic the natural nucleases (see subsequent 
chapters). The reactivity of these small complexes is insufficient to achieve measurable 
reactivity over a reasonable time period. The alternative lies in the use of more activated 
substrates that allows for relatively rapid hydrolysis with small artificial complexes. The most 
commonly used DNA analogue is bis-(4-nitrophenyl) phosphate (BNPP) which releases       
4-nitrophenol (PNP) upon cleavage, see Figure 1.10.  
 
Figure 1.10. The hydrolysis of BNPP. 
The PNP allows for easy UV-visible monitoring of the reaction progress at 400 nm 
which does not overlap with the absorbance maximum of many other molecules used in the 
kinetic experiments. The increased reactivity of BNPP is due to the relatively acidic PNP  
(pKa ≈ 7) which arguably cannot be directly correlated to the alkyl leaving groups of DNA. 
The BNPP model compound therefore serves as a crude indicator of the activity of nuclease 
mimics although nuclease-like rates of hydrolysis are yet to be observed for small molecular 
catalysts. BNPP is widely used as an intermediate solution to the final goal of achieving 
enough catalytic activity to hydrolyse DNA efficiently. The rate of spontaneous hydrolysis of 




diesters with various leaving groups[15,16] have been reported in literature as DNA analogues 
but BNPP provides a large amount of accumulated data in the literature for comparison. 
 
1.1.2 - RNA and its model compounds 
 
The study of ribonucleic acid (RNA) and its hydrolysis has been ongoing for over half a 
century with the earliest studies involving alkaline hydrolysis reported nearly a century 
ago.[17] 
The first detailed investigations regarding the hydrolysis products of RNA indicated the 
formation of pairs of 2’- and 3’-phosphorylated ribonucleosides.[18–20] This caused confusion 
as to whether the structure of the native RNA was 2’- or 3’-phosphorylated.                              
The 3’-phosphorylated isomer was later found to be the substrate for enzymes in subsequent 
reactions which indicated that the native RNA must have been 3’-linked, see Figure 1.11.  
 
Figure 1.11. The formation of 2’- and 3’-phosphorylated product reported in literature. 
The isomers pointed to the existence of a cyclic intermediate in the RNA hydrolysis that 
could subsequently be hydrolysed to form the two isomers. This revealed the source of the 
increased alkaline lability of RNA compared to DNA. The 2’-OH acts as an intramolecular 
nucleophile, see Figure 1.12, which is generally more effective than an intermolecular 
nucleophile.[21] This means that the hydrolysis of RNA is in fact a transesterification where 
the nucleophile is an intramolecular alkoxy functionality. The half-life for the phosphate 
diester bond in RNA at 25 °C and neutral pH has been reported to be in the order of 100 
years.[22] The study of RNA and DNA provides a measure for the effectiveness of having an 











Figure 1.12. The cleavage of RNA by the intramolecular 2’-nucleophile. 
105-fold although the difference is larger for the base-catalysed than the spontaneous reaction 
(RNA transesterification has a small pH-independent region at pH ≈ 5). 
The mechanism of RNA cleavage was proposed by Westheimer[23] in 1968 where he 
introduced the notion of pseudo-rotation in pentacoordinate phosphorane intermediates. The 
mechanism of the RNA cleavage has been extensively studied and reviewed over the 
years.[24,25] 
The departure of the leaving group in RNA cleavage is preceded by the formation of a 
pentacoordinate phosphorane intermediate. The intermediate adopts the form of a trigonal 
bipyramid with two longer apical bonds and three shorter equatorial bonds to the phosphorous 
center, see Figure 1.13. The substituents in the trigonal bipyramid prefer either the apical or 
equatorial position depending on their inherent chemical properties. Electronegative 
substituents prefer the apical position (longer P-O bond) and electropositive substituents 
prefer the equatorial (shorter P-O bond). This implies that the attack by the nucleophile and 
leaving group departure can only occur through the apical positions. If the intermediate is 
stable enough the process of pseudo-rotation takes place and isomerisation can occur if the 
substituents on the phosphorane are of similar acidity. The pseudo-rotation involves the 
interchange between apical and equatorial substituent which results in a change of 
configuration, see Figure 1.14  
This process is required for the isomerisation of the RNA i.e. the formation of a phosphorane 
containing a five-membered ring (2’,3’-cyclisation) where the 3’-OH of the ribose is initially 
equatorial and the 2’-OH apical (diapical and diequatorial structures are energetically 
disfavored). Upon pseudo-rotation the 2’-OH becomes equatorial and 3’-OH apical which 




Figure 1.13. The formation of the phosphorane intermediate in phosphate hydrolysis. 
 
Figure 1.14. The mechanism of pseudo-rotation for the phosphorane intermediate. The substituents are 
coloured according to their initial position, the apical position (red) and the equatorial position (blue). 
The cleavage of the RNA analogue 3’,5’-UpU, see Figure 1.15, revealed that the 
cleavage reaction is acid (pH < 4) and base (pH > 6) catalysed with a small pH-independent 
region at pH 5. The corresponding isomerisation reaction between 2’,5’- and 3’,5’-UpU was 
acid catalysed below and pH-independent above pH 4. Interestingly the isomerisation 
surpasses the rate of cleavage between pH 3-6 and is 25-fold faster than the corresponding 
cleavage in the pH-independent region (pH 5).[24,25] 
The intramolecular transesterification is proposed to occur through a water-mediated 
deprotonation of the 2’-OH coupled with a nucleophilic attack by the developing oxyanion on 
the phosphorous center. It was initially believed that small molecular catalysts generally do 
not provide enough stabilisation to achieve the interconversion between the two isomeric 
products (2’- or 3’-phos-phorylated) of the cyclic phosphate.[26]  
More recent results[27,28] have proven that a small dinuclear Zn(II) complexes are able to 
both cleave and isomerise RNA model compounds. Using a phosphonate that precludes the 
possibility of in-line displacement of a leaving group the observed isomerisation proves that 
the complex stabilises the pentacoordinate phosphate intermediate sufficiently for this to 
occur. The stabilising effects of similar dinuclear complexes through Lewis acidic interactions 
and potential hydrogen bonding will be discussed in subsequent chapters. 






Figure 1.15. The mechanism of the pH-independent transesterification of RNA where the positions of the 
substituents in the phosphorane are indicated by a (apical) and e (equatorial). R1 represents various 
substituents. 
An RNA analogue, see Figure 1.16, that is commonly used with artificial complexes is 
2-hydroxypropyl-(4-nitrophenyl) phosphate, HPNPP, that is 100-fold more reactive than UpU 
to base catalysed cleavage. HPNPP is subject to the same criticism as BNPP due to the 
presence of the very good leaving group (PNP). The native RNA (and DNA) lacks good 
leaving groups that can be conveniently detected (nucleoside) by UV-vis compared to HPNPP 
(4-nitrophenol).  
The extent of the P-O bond fission in the rate limiting transition state varies depending 
on the leaving group which is confirmed by the Brønsted parameter (βLG) that has been 
estimated for alkyl (-1.28) and aryl 3’-phosphates (-0.59). The pentacoordinate alkyl 
phosphorane has a finite life time and the rate limiting step (RLS) is the departure of the 
leaving group whereas the RLS for the pentacoordinate aryl phosphorane is the formation of 
the phosphorane. Interestingly, studying the reaction of HPNPP transesterification using 
kinetic isotope effects (KIE, Chapter 1.4.2) measured at the nucleophilic atom and in the 
leaving group revealed that the uncatalysed reaction proceeds through a single transition state 
with little bond fission between the leaving group and phosphorous center.[29] The KIE for the 
nucleophile indicated that the bond formation to the phosphorous center was the RLS. In the 













































































and greater nucleophile bond formation to the phosphorous with the KIE indicating that the 
leaving group departure had become the RLS.The nucleophilic 2’-OH of HPNPP is more 
flexible and has a higher pKa than the corresponding ribose OH in RNA. The advantages of 
HPNPP paradoxically are also its flaws since it becomes more dissimilar to the native RNA 
for which the study is intended. 
 
Figure 1.16. The intramolecular transesterification of HPNPP. 
A HPNPP analogue that can be used when still greater reactivity is convenient is 
HPNPPi. The substrate HPNPPi, see Figure 1.17, is a more reactive isomer of HPNPP which 
contains a primary alcohol as the intramolecular nucleophile. This substrate is approximately 
10-fold more reactive than HPNPP and is usually used in conjunction with less efficient 
catalysts. 
 
Figure 1.17. The structures and the mechanism for the transesterification of HPNPPi and HPNPP are 
very similar. 
A more RNA like alternative that has been used in literature is UpPNP, see Figure 1.18, 
that still uses the PNP leaving group but with a ribonucleic 2’-OH nucleophile.[30] The 
substrate UpU and its equivalent dinucleoside monophosphates offer the advantage of being 
essentially a dimeric RNA unit and is mainly used with highly reactive complexes.[27] The 
poorer leaving group in UpU (nucleoside) compared to HPNPP results in the RLS for the 


































Figure 1.18. The UpPNP and UpU that are commonly used as RNA analogues (U = Uracil). 
 
1.2 - Role of metal ions 
 
Metal ions play an important role[31,32] in the catalytic processes in the active site of 
many enzymes and are therefore central to the mechanistic investigation and design of 
artificial catalysts. Although most metal ions do not display remarkable reactivity unless 
bound to one or multiple ligands, the activity of some metal ions is substantial even in the 
absence of ligands (e.g. Ce (III)).  
 






























































Among the most reactive metal ions for the catalysis of phosphate diester bond 
hydrolysis are lanthanides (La(III), Ce(III/IV), Th(IV) etc).[33] The DNA and RNA hydrolysis 
mechanisms with free lanthanide ions in solution has been proposed to involve metal 
hydroxide gel structures, see Figure 1.19. Lanthanides are known to form multi-nuclear 
clusters in solution under physiological conditions even in the absence of ligands. Although 
lanthanides have proven to be highly effective in promoting the hydrolysis of DNA and 
RNA[34,35] they are not biologically relevant. Many natural enzymes achieve remarkably high 
rates using metal cofactors that are moderately reactive in solution or in artificial complexes 
(Zn(II), Fe(II/III), Mg(II) etc). This demonstrates the inability of the artificial complexes to 
mimic the interactions in enzyme active sites and ultimately highlights the limited knowledge 
of these processes. 
Many first-row transition metals can be found in the active sites of metalloenzymes that 
utilise one, two or more metal cofactors (Zn, Cu, Fe etc).[36] The metal nuclei can be seen 
interplaying cooperatively to achieve the overall catalytic effect: activating the substrate 
through Lewis acidic interaction with the metal ions, stabilising the transition state structure, 
lowering the pKa of the nucleophilic moiety in the reaction (intramolecular hydroxyl or metal 
bound water) and aiding in the departure of the leaving group, see Figure 1.20.  
 
Figure 1.20. The different potential roles of metal ions (M) in catalysis from left to right: Lewis activation, 
transition state stabilisation, nucleophile activation, leaving group coordination and leaving group 
protonation. 
Magnesium-dependent nucleases are common in nature[37] but Mg(II) itself is a weak 



















































solution,[38] although it has been reported that a Cl--bridged Mg(II) catalyst was able to cleave 
DNA.[39]  
Zinc has been identified in hundreds of metalloenzymes and several grams of it can be 
found in the human body. Due to the versatility of Zn(II) and its appearance in many enzymes 
it has been the focus of many synthetic complexes.[40] It is commonly found in a mononuclear 
tetrahedral coordination geometry in the active site of enzymes.[41,42] The tetrahedral 
coordination sphere for Zn(II) in enzymes exhibit a striking preservation of the ligand 
structural arrangement between different enzyme families. 
The three amino acid residues that form the base of the tetrahedron are positioned in a 
distinct pattern along the sequence. The ligands (L1, L2 and L3) are arranged so that L1 and L2 
are spaced by 1-3 amino acids and thus form the initial bidentate coordination to the Zn(II). 
The L3 ligand is positioned 20-120 amino acids further along the sequence and provides the 
third coordination to the Zn(II) with some margin for flexibility.[43] One example of this 
arrangement can be found in carbonic anhydrase II (CAII) that coordinates to Zn(II), see 
Figure 1.21, by means of His94, His96 and His119. There are several examples of this in 
enzymatic active sites that employ Zn(II) cofactors but also iron and copper.[44] 
 
Figure 1.21. The anti parallel β-sheet around the Zn(II) core in the carbonic anhydrase. The sequence 
displayed here includes Tyr88 to Asn124 and the ligands are His94, His96 and His119 (PDB code: 2CBA).[45]  
The prevailing coordination geometry in enzymes with a single metal ion cofactor is the 
tetrahedral arrangement involving three backbone amino acids (usually histidine, cysteine, 
glutamic acid or aspartic acid) and a fourth coordinated water molecule. Some enzymes, for 
example prometalloproteinase, have a tetrahedral coordination to 4 amino acids (L1, L2, L3 
and Lx) and need to be activated[46,47] in order for water to coordinate, see Figure 1.22.  
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The metal-bound water is essential for the catalytic activity of many enzymes since 
Lewis acidic Zn(II) is able to reduce the pKa of the water to near 7, making the nucleophilic 
hydroxyl species available at significantly lower pH than would otherwise be possible. Metal 
ions in catalytic structures have generally been considered to contribute to the hydrolysis rates 
by providing a general base (hydroxide) near neutral pH. 
 
Figure 1.22. The activation of Zn(II) through displacement of the non-aqua ligand LX followed by various 
interactions with the Zn(II) bound water. 
Interestingly, the increased acidity of the metal bound water has been reported to 
potentially lead to acid catalysis, as has been reported for Co(III) complexes.[48] Base 
catalysed transesterification of RNA leads to a dianionic transition state and the release of an 
alkoxide (βLG = - 1.28) whereas the acid catalysed reaction leads to an alcohol leaving group 
(βLG = - 0.12). The mechanism of RNA transesterification in the presence of a metal ion is 
similar to base catalysed transesterification since no intermediate has been observed but the 
leaving group has been found to depart as an alcohol (βLG = - 0.32). The use of Zn(II) appears 
to enhance the protonation of the leaving group compared to the buffered pH-independent 
reaction. The behavior of Zn(II) therefore bears characteristics of both the acid and base 
catalysed reaction, see Figure 1.23. The potential dual catalytic role of the Zn(II) begs the 
question of the possibility of simultaneous interaction with multiple metal ions. 
The mechanism for the pH-independent spontaneous RNA cleavage, see Figure 1.15, 
has been suggested as the most appropriate model for the transesterification involving small 










Figure 1.23. The proposed mechanisms for the Zn(II) catalysed transesterification of RNA. The general 
base catalysis (left) and general acid catalysis (right). 
complexes do not use a mechanism involving acid/base catalysis.[30] The small molecular 
complexes used for the cleavage of RNA or DNA model compounds will be introduced in the 
subsequent chapters.  
Many enzymes have dinuclear arrangements in the active site to allow for cooperative 
activation and stabilisation of the substrate. The cooperativity between metal ions is central to 
the roles of many enzymes where multiple metal cofactors interact to achieve the desired 
catalytic activity. The cooperative role of the metal ions and amino acid residue in enzyme 
active sites have been reviewed[49,50] and suggests their important role in transition state 
stabilisation, leaving group activation and nucleophile activation. 
The importance of correct positioning of the substrate in the active site prior to the 
catalysis is essential and might account for some of the discrepancy in reactivity between 
enzymes and artificial catalysts.  
 
Figure 1.24. The proposed coordination mode of the transition state analogue 4-nitrophenyl phosphate to 





























In an artificial dinuclear catalyst for the hydrolysis of phosphate diesters the binding of 
the substrate is suggested to be through the non-bridging oxygens of the phosphate, see  
Figure 1.24, leaving very little room for a nucleophile to be activated by the Lewis acidic 
nuclei.[51] In the case of dinuclear enzyme active sites the substrate is bound in an alternate 
arrangement that allows for simultaneous nucleophile and leaving group activation. This is 
illustrated by the structure of a transition state analogue (vanadate, VO43-), see Figure 1.25, in 
the active site of the naturally occurring enzyme phosphodiesterase X. axonopodis nucleotide 
pyrophosphates/phosphodiesterase (NPP).[37,52,53] 
 
Figure 1.25. The structure of the metal coordination site in enzyme X. axonopodis NPP with bound 
vandate illustrates the possible interactions in the active site between the dinuclear structure and a 
phosphate diester in the transition state. Threonine (Thr90) represents the nucleophile which held in close 
proximity of both the Zn(II) and vanadate (PDB code: 2GSO).[45]  
Since no artificial catalyst has been successful in achieving all the interactions or rate 
enhancements seen in enzymes it is clear that there is still a gap in our knowledge of how to 
replicate the function of these catalysts. 
The key to understanding the catalytic rate enhancement provided by enzymes is to 
study the interactions in their active sites and identify the structural requirements for efficient 
catalysis.  
 
1.3 - Enzyme catalysis  
 
Enzymes are large biopolymers that function as highly efficient catalysts for most 
biochemical reactions.[54] The ratio of the size of the enzyme to the size of the active site for 
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most enzymes reveals that the bulk of the structure is not directly involved in the catalysis, see 
Figure 1.26. The enzyme structure is not efficient with respect to total enzyme residues versus 
active catalytic residues but the large structure is necessary for other recognition/regulation 
processes in vivo.  
The structure of the enzyme functions as a macromolecular scaffold for the appropriate 
positioning of interacting residues around the active site. The residues involved in the active 
site are usually widely spaced in the linear protein sequence but become well organised in the 
active site due to the enzymes secondary and tertiary structure. 
The catalytic rates observed in enzymes are due to the well defined structure of the 
active site that allows for multiple specific interactions with the substrates.  
The maximum catalytic efficiencies (kcat/KM) for most enzymes are relatively similar 
regardless of the reaction in question since there is an upper limit to the reaction rate. This 
upper limit is the rate of enzyme-substrate collisions in a solution and depends on the 
bimolecular diffusion rates of the components (diffusion controlled kinetics). There are many 
enzymes that reach this limit[54–56] but most enzymes work within a few orders of magnitude 
of it.  
 
Figure 1.26. The structure of the enzyme X. axonopodis NPP illustrates that the size of the active site is 
relatively small compared to the overall enzyme structure. The metal coordinated residues (blue) and 




The catalytic efficiency of enzymes will only become as large as is required for a given 
biological process thus there is no need for diffusion controlled rates for all reactions.[57] For 
most biological processes the reactions that occur on a milli- to microsecond time scale are 
sufficiently fast. The effective contribution of an enzyme to the rate of a given reaction can 
only be appreciated when compared to the rate of the corresponding uncatalysed reaction. 
The rates for uncatalysed reactions (kuncat) can differ by many orders of magnitude. The 
catalytic proficiency ((kcat/KM)/kuncat) differs significantly for enzyme catalysed reactions since 
it takes into account the rate for the uncatalysed reaction which provides a more suitable 
comparison for the work performed by the enzymes.[56] The catalytic proficiency also gives a 
measure of the formal affinity of the catalyst for the transition state of the substrate which can 
be compared with transition state analogues.[58] These comparative ratios have revealed a rate 
acceleration for the enzyme alkaline phosphatase of 1027-fold.[16,53] 
The efficiency of an enzyme is characterised by its ability to stabilise the transition state 
structure of the substrate relative to the ground state and can be related to the dissociation 
constant of the transition state KTS, see Figure 1.27. The catalyst (C), substrate (S) and 
catalyst-substrate complex (CS) are in a dynamic equilibrium with KM representing the 
dissociation constant. kuncat represents the rate at which the unbound substrate (S) reaches the 
transition state (S*) while kcat represents the same process for the catalyst-bound substrate 
(CS). The product (P) and the catalyst-product complex (CP) are not considered in this 
transition state approach. Since kcat > kuncat, the tightness of substrate binding should 
correspondingly be ground state < transition state (KM > KTS). 
 












The relationship between the parameters can be described as seen in Equation 1.1. An 
alternative approach is to treat the catalytic proficiency (kcat/KM)/kuncat as the inverse of KTS. 
 =	 	
	     (Equation 1.1) 
The desired properties of a catalyst are to stabilise the transition state better than the 
ground state since the free energy of activation would otherwise remain unchanged, see 
Figure 1.28. The differential between the ground state and the transition state equals the free 
energy of activation (∆Gθ).  
 
Figure 1.28. The free energy diagrams of the non-catalysed reaction (red) compared to the catalyst-
substrate reaction with no differential binding between the ground and transition state (blue). The 
differential binding between the ground and transition state represents the action of a catalyst (green). 
If the binding is identical for the ground state and transition state the there will be no 
overall reduction in the transition state energy (∆G‡uncat = ∆G‡cat). In the case of active 
catalysis there is a difference in binding between the ground state and transition state binding 
(∆G‡uncat > ∆G‡cat).  
The difference between the uncatalysed reactions in solution and the catalysed reactions 
in the active site of enzymes are the additional interactions provided by the well defined 
structure of the cavity. For phosphoryl transfer, upon progression from the ground state to the 
transition state there is a change from tetrahedral to a trigonal bipyramidal configuration 
which necessitates relocation of the non-bridging oxygens. The electrostatic interactions in 
the cavity provide efficient stabilisation of the transition state, see Figure 1.29. 
The mechanistic path along which the reaction proceeds is determined by studying the 



















species (life time generally don’t exceed 10-13 - 10-14 s) it is not possible to study directly but 
it is rather inferred using mechanistic investigation.  
 
Figure 1.29. A schematic representation of a phosphate monoester binding to an active site in the ground 
state, transition state and product state. The dotted blue lines represent interactions with positively 
charged active site residues (or potentially H-bonding). 
 
1.4 - Studying the transition state 
 
The single most important structure in the investigation of mechanisms is that of the rate 
limiting transition state. The use of stable compounds that mimic the transition state structure 
should efficiently inhibit a catalysed reaction.[59,60] The problem is that the use of transition 
state analogues is a limited approach since it is difficult to strictly control the distances 
between the leaving group and nucleophile relative to the phosphorous center. The differences 
between a loose and a concerted transition state in terms of bond lengths between the entering 
and leaving group could be as little as 0.5 Å.[38] It is also worth noting that the transition state 
analogue would most likely adapt the most energetically favorable binding mode which does 
not necessarily translate into the same mode as the reacting substrate. Additionally, the use of 
transition state analogue inhibitors would not be useful for elucidation of the mechanism of 
the non-catalysed reaction in solution. 
It is important to note that the Boltzmann distribution of structures of the transition state 
varies for different substrates depending on the nature of its intrinsic components and on its 
environment. A poor leaving group is likely to depart in a transition state that has progressed 
farther along the reaction coordinate (late transition state) compared to a good leaving group. 
The extent of bond fission and formation in the transition state will vary depending on 




unfeasible in solution. The different transition states that can form are distinguished by the 
extent to which a bond is broken or a new bond is formed to the phosphorous center. The 
transition states are referred to as tight, synchronous or loose depending on the extent of the 
bond breakage/formation to the phosphorous center.  
 
Figure 1.30. The schematic hydrolysis of a phosphate diester using a nucleophile (Nuc) through a tight, 
synchronous or loose transition state. R1 and R2 represent various substituents. 
The hydrolysis or transesterification of phosphate diesters proceeds through a 
pentacoordinate phosphorane that decomposes into the product. The schematic representation 
in Figure 1.30 illustrates the nucleophilic attack on the phosphorus center of a diester where 
OR1 is a better leaving group than OR2. These potential transition states can be characterised 
through carefully devised experiments that have been developed for the mechanistic 
investigation of reactions. 
 
1.4.1 - Linear Free Energy Relationships 
 
A tool commonly used for characterising transition states involves the linear free energy 
relationships (LFER). The concept of free energy relationships is based on the notion that a 
bond breakage or formation represents a change in the electron density in the transition state 






















































donating or withdrawing group (EDG/EWG) on either of the moieties around the bond will 
affect the electron density. The charge development in the transition state of a given reaction 
provides a potential for charge stabilising interactions that can enhance the rate of the 
reaction. A carefully selected EDG or EWG that is incorporated into the structure of the 
substrate in order to interact with the developing charge can provide a deeper understanding 
of the reaction pathway.  
A simple and well established example[61] of this stereoelectronic effect is the increased 
acidity observed for phenol upon the introduction of an electron-withdrawing NO2-group in 
the 4-position, see Figure 1.31.  
 
Figure 1.31. The difference in the acidity constant for the phenol and 4-nitrophenol. 
The effect of the substituent R1 in Figure 1.32 on the overall rate constant can be 
determined by measuring the rate constant of the reaction using different leaving groups with 
varying pKa.  
 
Figure 1.32. The partial negative charge (δ-) on the leaving group develops over the transition state and is 
fully formed in the product. R1 represents various substituents. 
The logarithm of the rate constant (log k) plotted versus pKa (for the leaving group or 
nucleophile) provides a linear fit for which the slope is βLG and βNUC, respectively. The βLG-
values are generally negative since reducing the acidity of leaving groups leads to lower 
reaction rates. The magnitude of βLG indicates the extent of bond breaking to the leaving 
group in the transition state. The βNUC-values are generally positive and indicate the extent of 
the bond formation to the starting material since the increase in basicity translates into 
increase nucleophilicity.  
In loose transition states the bond to the leaving group is extensively broken and 
significant charge has developed. A leaving group with lower pKa would in this case cause a 
R1 = H pKa ~ 10









more dramatic increase in rate than for a tight transition state where not much charge has 
developed on the leaving group. The βLG is a good indicator for the mechanism of the reaction 
although some catalysed reactions have displayed large βLG-values despite the presumed 
associative nature of their mechanism.[38] It is therefore important to evaluate the participation 
of the nucleophile through the βNUC in order to accurately determine the transition state. 
The relationship between the logarithm of the equilibrium constant (log KEQ) and the 
pKa gives the gradient βEQ which can be used to normalise the βLG and βNUC-values. The 
normalisation indicates how similar the charge development in the transition state is to the 
final reaction product. The ratios X= │βLG/ βEQ│ and Y=│βNUC/ βEQ│ can be plotted in a 
More O’Ferrall-Jencks diagram, see Figure 1.33, which quantitatively presents the 
experimentally determined nature of the transition state. These ratios correspond to the slope 
of (log k) versus (log KEQ) which reveals the extent to which the phosphorous-leaving group 
bond (P-LG) has broken and the extent to which the phosphorous-nucleophile bond (P-NUC) 
has formed. The scales on the axes in the More O’Ferrall-Jencks diagram range from 0-1 and 
are sometimes referred to as the bond order. These values correspond to the similitude 
between the transition state and the product with respect to the P-LG and P-NUC bonds.  
Any given reaction can pass through a continuum of different paths from the bottom left 
corner to the top right corner of the diagram in Figure 1.33. The loose transition state is used 
to describe any transition state that has a dissociative character (elimination-addition) and 
passes below the diagonal usually denoted as DN+AN. The tight transition state indicating an 
associative mechanism (addition-elimination) and passing above the diagonal is usually 
denoted as AN+DN. It is important to note that each of these paths can contain more or less of 
the dissociative or associative characteristics. The synchronous transition state is an SN2-like 
(concerted, ANDN) mechanism that passes along the diagonal and signifies proportional bond 
breaking and bond formation.  
The nature of a compound determines the structure of the transition state for the 
uncatalysed reaction. It has been suggested in early studies that the hydrolysis of phosphate 
monoesters proceeds though a metaphosphate intermediate although a substantial amount of 
evidence has been suggesting a metaphosphate intermediate it has been challenged by more 
recent findings.[16] These studies suggest that the mechanism is a concerted process which 
passes through a metaphosphate-like, loose transition state. 




Figure 1.33. The two dimensional More O’Ferrall-Jencks diagram illustrating the mechanistic paths for 
the respective transition states. R1 and R2 represent various substituents. 
phosphate triesters proceed through a tighter phosphorane-like transition state. An illustrative 
example for the use of LFER can be found in literature for the hydrolysis of phosphorylated 
pyridines, see Figure 1.34, using nucleophiles of substituted pyridines and morpholine.[62,63] 
 
Figure 1.34. The nucleophilic attack of various nitrogen nucleophiles on phosphorylated pyridines as 
reported in literature.[62,63] The partial charge (δ- or δ+) is displayed next to relevant atoms. 
The data for the mechanistic analyses provides the parameters βLG (-0.95) and βNUC 
(0.16) which were obtained using the linear fits to the data shown in Figure 1.35, and βEQ has 
been reported as 1.05 in literature.[63] The linear relationship plotted between the pKa for the 

















Brønsted plot. The normalisation of the obtained β-values with βEQ yields                              
X = │βLG/ βEQ│ = 0.90 and Y =│βNUC/ βEQ│ = 0.15.These values indicate extensive breaking 
of the P-LG bond and little bond formation for P-NUC as can be seen in the bottom right 
corner in the Figure 1.33. This corresponds to a loose transition state where the mechanism is 
dissociative and the transition state is therefore metaphosphate-like. 
  
Figure 1.35. The β-values for the leaving group (LG) and nucleophile (NUC) determined from literature 
data.[62,63] 
 
1.4.2 - Kinetic Isotope Effect 
 
Another widely used tool for investigating the transition state and mechanistic paths is 
the kinetic isotope effect (KIE). The concept entails the use of an isotope in or near the bond 
that is broken/formed. The KIE is based on the principle of the zero-point energy of the bonds 
that are involved in the reaction. Using a heavier isotope reduces the vibrational energy 
relative to the lighter isotope which results in a larger activation energy (Ea) upon progression 
to the transition state, see Figure 1.36.  
The remote label method involves changing an atom that is not directly involved in the 
bond formation/fission and which is paired with an isotopic substitution near the site of 
cleavage. The 4-nitrophenol leaving group can be studied with the primary isotope effect 
using 16O/18O or with the secondary isotope effect where the 14N of the nitro functionality can 

















































Figure 1.36. The illustration of the KIE where the difference in energy for the light (L) and heavy (H) 
isotope is exaggerated to indicate the observed ratio of reaction rates.  The figure is illustrates the 
commonly observed klight > kheavy which is associated with the reversed relationship of Ea (L) < Ea (H). 
The observed ratio of the rate constants when using the isotopes (klight/kheavy) indicates 
the extent of the bond fission in the transition state since the difference in vibrational energy 
becomes less pronounced as the bond length is increased. This method can be used for both 
catalysed and uncatalysed reactions. When studying the catalysed reaction it is obviously 
more difficult to vary the nucleophile in enzymes compared to the reaction in solution and 
normal LFER are therefore abandoned in favor of KIE.  
The incorporation of an isotope into the substrate is not very invasive in the sense that 
the structure of the substrate remains unchanged and it is therefore reasonable to assume that 
the overall properties of the compound are retained. The main disadvantages of isotope 
chemistry are the high-precision instrumentation required for the analysis, the limited 
dynamic range of the potential effects, and the dependence on theory to interpret the data in 
structural terms. Despite this the KIE still remains a powerful tool for mechanistic 
investigation. 
 
1.5 - General Aims 
 
The overall aim of this project is to study the behavior of catalytic Zn(II) complexes and 
develop an understanding of the interactions that are important for catalytic activity. The 




Ea (L) Ea (H) 
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synthetically modified to study the effects of specific interactions (hydrogen bonding, nuclear 
Lewis acidity, internuclear distance etc.). 
The initial studies focus on the reactivity of dinuclear Zn(II) complexes. The use of the 
dinuclear arrangements in small molecular catalysts[64] stems from the extensive precedence 
of multinuclear configurations in the active site of many enzymes.[36] 
Although mononuclear complexes have proven to be reactive towards phosphate 
diesters[14] it is clear that internuclear association is important for highly reactive systems 
since the dinuclear arrangement can offer cooperatively interacting nuclei.[51,65–67]The 
dinuclear complexes presented herein incorporate a bridging functionality that encourages the 
cooperation of the Zn(II) nuclei. These complexes have been reported to be among the most 
reactive complexes to date.[51] 
A further aim of this project is to study the interactions between mononuclear Zn(II) 
complexes in different association-promoting environments and its effect on the rate of 
HPNPP transesterification. The reactivities of these systems are generally less impressive than 
the covalently linked dinuclear complexes. There have been reports of mononuclear 
complexes and dinuclear complexes lacking cooperative internuclear bridges that surpass the 
reactitivity of bridged dinuclear complexes although these activities have been attributed to 
medium effects.[68,69] The effects of incorporating mononuclear complexes in membranes and 
peptides will be discussed herein and compared to the dinuclear complexes. 
Lastly, the use of nucleophilic species in mononuclear complexes for the hydrolysis of 
the DNA model compound BNPP will be discussed as well as their potential incorporation 


































Chapter 2 - Dinuclear complexes 
 
2.1 - Introduction 
 
The stability to hydrolysis of the phosphate diester bond was described in the previous 
chapter, along with the fact that this reaction is very efficiently catalysed by enzymes. A 
major challenge is to achieve similar catalytic efficiency using small molecular catalysts and 
significant effort has been made over the years to study and develop these catalysts.[22,40,70–72]  
It has been described in the previous chapter that metal ions can assist in the 
deprotonation of the intramolecular 2’-OH nucleophile as well as aid in leaving group 
departure through general acid-base catalysis. This has also been suggested to be the case for 
dinuclear metal complexes based on the observations by Morrow et al.[66] where the lack of 
coordinated H2O/OH in Cu(II), see Figure 2.1, due to the five-coordinate nature of the metal 
ions has been proposed to be the reason for its lack of reactivity towards HPNPP. The Zn(II) 
nuclei on the other hand can adapt a 6-coordinate geometry which allows for metal bound 
nucleophiles to exist simultaneously with a bound substrate.  
 
Figure 2.1. The different coordination geometries of Zn(II) and Cu(II) in a dinuclear complex has been 
proposed to affects their reactivity towards HPNPP. 
However, more recently it has been reported that these assumptions are not 
substantiated by experimental observations. The dinuclear Zn(II) complex indicated no 
solvent kinetic isotope effect (SKIE) for either mononuclear[73] or dinuclear Zn(II) 
complexes[30] and normal equilibrium solvent isotope effects were observed for the pKa of 
metal-bound water which excludes the involvement of Brønsted acid-base catalysis.[30]  





general acid catalysis for phosphate hydrolysis.[74] These results suggest that the main 
contribution of the dinuclear complexes towards the transesterification of HPNPP is the 
electrostatic stabilisation of the transition state through the dinuclear cationic core. 
This chapter focuses on the dinuclear Zn(II) complex catalysed transesterification of 
HPNPP and builds on previous studies[51] with suggestions for potential future modifications 
of the catalyst structure. 
 
2.1.1 - Zn(II) ions in complexes 
 
Mononuclear metal complexes are molecular entities in which one metal ion is 
coordinated to one or more molecular ligands that alter its coordination geometry and/or 
Lewis acidity. The chemical properties of the metal ion are central to the activity of the 
complex as a whole and can be tailored by various coordinating functionalities. The Lewis 
acidity of a metal ion indicates its ability to activate a substrate or nucleophile towards a 
specific chemical reaction.  
Zn(II) has been reported to catalyse the cleavage of RNA[48] in solution but the catalysis 
is limited by the solubility of the metal ion which decreases with increasing pH due to the 
formation of poorly soluble zinc hydroxides. Coordinating Zn(II) to a ligand helps avoid 
precipitation. The pKa of water bound to the metal ion, which indicates its Lewis acidity, 
increases with increasing tightness of binding to the ligand (the reported pKa for [Zn(H2O)6]2+ 
is 8.96).[75] It has been reported by Kimura et al.[76] in their study of carbonic anhydrase 
mimics that a small structural change in the ligand results in tighter metal binding and reduced 
Lewis acidity of the Zn(II), see Figure 2.2. Thus, complex stability and one of the parameters 
correlated with activity are in conflict with each other.  
The ability of the metal ion to polarise a substrate is an important property as the 
increased acidity of the metal-bound water will increase the concentration of nucleophile 
available at low pH. It has generally been considered desirable to obtain highly acidic metal 
complexes since this is indicative of a highly Lewis acidic Zn(II). Many enzymes contain 
relatively acidic metal bound species (e.g. bovine carbonic anhydrase pKa 7.5) which lends 
further support to this reasoning. However, it is important to remember that enzymes operate 




Figure 2.2. The pKa of the metal bound water increases with increasing tightness of binding between metal 
and ligand. 
sufficient amounts of nucleophile. Reducing the pKa of the metal bound water leads to larger 
amounts of the active nucleophile being present at low pH but concomitantly reduces its 
nucleophilicity. 
A series of complexes, see Figure 2.3, were investigated by Bonfá et al. and showed 
that the acidity of the metal-bound water in Zn(II) complexes is highly dependent on the 
ligand structure and coordination geometry.[73] 
 
Figure 2.3. The structure of the ligands used in literature with Zn(II) where the reactivity of the complexes 
increases with basicity. The pKa reported for the compounds in the figure are for the corresponding Zn(II) 
complexes. 
The HPNPP transesterification was studied with these mononuclear Zn(II) complexes 
and the Brønsted plot yielded a steep slope (βNUC = 0.75) which displays a strong correlation 
between basicity of the metal bound hydroxide and the observed activity. The coordination 
environment was also found to determine the reactivity of the catalyst since the metal ion is 
required to have free binding sites for the substrate.  
The tridentate ligands are more reactive than the tetradentate ones due to the different 









reactivity despite having Zn(II) ions of similar Lewis acidity. The reason the discrepancy is 
that the ligands which can form a facial coordination environment around the metal ions can 
bind the substrate more efficiently than ligands that are unable to provide such a coordination 
geometry.[73] 
The activity of mononuclear complexes is usually limited to highly reactive substrates. 
Given that many enzymes utilise two or more nuclei in the active site, it is reasonable to 
investigate the effects of combining multiple mononuclear complexes to encourage 
cooperative interaction.[39,71] It is has been shown that ligands containing two metal 
coordinating sites form dinuclear complexes that are more reactive than their mononuclear 
equivalents if cooperative interaction is encouraged.[51,65] In small multinuclear complexes the 
bridging interaction is often achieved using a covalently bound functionality (e.g. alkoxy, 
phenoxy[40,64,77] etc). 
Among the most studied artificial catalysts for phosphate diester hydrolysis are the 
1,4,7-triazacyclononane (TACN) based complexes that have been studied both in a 
mononuclear and dinuclear arrangement.[66,67,78–81] The complexes in Figure 2.4 were used for 
HPNPP transesterification by Iranzo et al. and provide a good benchmark for comparing the 
effects on reactivity of having two covalently linked mononuclear complexes in close 
proximity.[66,67] 
The dinuclear complexes were all found to form stable complexes with Zn(II) but the 
large differences in rate constants between the alkoxy-bridged complex and the non-bridged 
ones is symptomatic of the inability of the non-alkoxy-bridged complexes to form cooperative 
interactions between the nuclei. A 2-fold rate increase for a dinuclear complex over its 
mononuclear equivalent is consistent with the additive reactivity of non-interactive subunits 
whereas a larger increase indicates internuclear cooperativity.  
The desired structural feature of a catalyst for the hydrolysis of phosphate diesters is to 
provide a high local positive charge density that can stabilise the developing negative charge 
in the transition state. The relative rates presented in Figure 2.4 can be seen in light of the 
increasing internuclear association. A tether containing a negatively charged bridge will 
shield the cationic repulsion between the Zn(II) and deliver two mononuclear complexes in 
relatively close proximity to each other. Likewise, the alkoxy-bridged dinuclear complex 
provides two closely associated mononuclear complexes resulting in cooperative (120-fold) 




Figure 2.4. The relative rates for HPNPP transesterification at pH 7.6 for the TACN based complexes 
indicate cooperative interactions between the Zn(II) nuclei. 
complex which only accounts for one twentieth of the observed rate increase. The 
introduction of an alkoxide appendage into the mononuclear complex led to a reduction of 
reactivity at pH 7.6[67] and an increase of the pKa to 9.5 (8.1 for TACN)[73] which indicates 
that the alkoxide reduced the Lewis acidity of the Zn(II). It appears that the internuclear 
bridge is important for efficient cooperativity in dinuclear complexes but it raises questions 
about the potential interference of the oxyanion due to electrostatic effects.  
The logical arguments against the anionic bridging are based on the potential 
electrostatic repulsion with the anionic substrate and the reduction of the Lewis acidity of the 
metal nuclei. Despite this apparent loss of favorable charge interactions with the substrate, 
there is an overall beneficial cationic charge density from the Zn(II) ions that stabilises the 
developing net negative charge in the transition state.The effect of the alkoxy-bridge has been 
studied in non-aqueous media (MeOH) following the enormous rate acceleration[69] seen for 
the dinuclear complex in Figure 2.5.  
 
Figure 2.5. The dinuclear complex studied by Brown et al. for the transesterification of HPNPP in 
MeOH.[69] 











system the results were compared to methanol experiments internally between relevant 
complexes, see Figure 2.6. The conclusion is that the permanent anionic bridge is not required 
to achieve strong cooperativity between the nuclei in methanol but rather it seems to have a 
detrimental effect on the activity. This effect is consistent with the proposed reduction of 
Lewis acidity and change in the coordination geometry upon binding the alkoxide. Despite 
these results in methanol it is clear that the reactivity in aqueous media is dependent on a 
bridging functionality in order to achieve internuclear cooperativity. It would be interesting to 
compare the effects of the alkoxy-bridge with less nucleophilic bridging functionalities in the 
dinucleating environment and this will be discussed in later sections. 
 
Figure 2.6. The relative rates for the transesterification of HPNPP in MeOH using bridged and non-
bridged complexes. 
 
2.1.2 - Internuclear association 
 
The distance between the nuclei in dinuclear complexes is likely to be important for the 
activity of the complex given the expected bidentate interaction with the substrate. The 
importance of the internuclear distance has been highlighted in the literature and further 
encourages the investigation of the impact of flexibility between the Zn(II) centers. The effect 
of the internuclear distance on reactivity has been reported by Kawahara et al.[82] for the 
transesterification of UpU with complexes having different spacing between di-2-








many enzymes with either a homonuclear or a heteronuclear pair of metal ions. In the alkaline 
phosphatase superfamily the internuclear distance varies from one enzyme to another.[37] The 
effect of internuclear distance has also been indicated by the study of 2,6-
diaminomethylpyridine Zn(II)/Cu(II) complexes functionalised on the upper rim of 
calix[4]arenes, see Figure 2.7.[83,84] The flexibility of the structure due to the low 
conformational energy barriers which permits close association of the nuclei is proposed to 
promote enzyme-like dynamic binding. This assumption has been further supported by 
comparing the flexible structures with structurally rigid equivalents where the lower rim of 
the calix[4]arenes is covalently bridged. The rates for HPNPP transesterification is 60-fold 
faster for the flexible structure compared to the rigid linker which points to the importance of 
having a suitable internuclear distance in complexes. 
Multinuclear arrangements have also been reported using allosterically controlled 
structures to encourage association of the mononuclear subunits and the formation of active 
complexes.[85–87] 
 
Figure 2.7. The structural difference between the flexible and rigid calix[4]arenes. 
 
2.1.3 - Interactions in the nuclear microenvironment 
 
The binding of phosphates to enzymes is usually attributed to the interactions between 
the metal ion nuclei and the non-bridging oxygens of the phosphate although there are other 
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determined by the hydrogen bonding and lipophilic interaction in the active site pocket. Given 
these interactions it is sensible to alter the microenvironment of artificial catalysts to achieve 
similar interactions.[88] Charge stabilisation is very important in the transition state and 
interactions with charged moieties of the catalyst therefore make more of an impact on the 
activity compared to lipophilic interaction.  
There have been many attempts made to synthesise mimics of enzyme active sites by 
including the functionalities that are present in the enzyme’s coordination sphere around the 
metal nuclei. The resulting complexes have not been nearly as efficient as the native enzyme 
which indicates that either additional interactions are present in the active site, or the 
utilisation of these components are difficult to optimise using small complexes.[64]  
The ammonium functionality in the second coordination sphere in enzymes (provided 
by the amino acid lysine) is usually involved in hydrogen bonding in the active site. Artificial 
analogues can be found in the form of methylated amines used in conjunction with bipyridyl 
Zn(II)[89] and Cu(II)[90] complexes. Crystallographic studies show that the Zn nucleus adapts a 
more tetrahedral-like geometry whereas the Cu adapts a square planar (2,2’-bipyridine) or a 
square pyramidal (with either of the ammonium ligands) geometry, see Figure 2.8.[91] The 
expected geometries for Zn(II), i.e. trigonal-bipyramid and octahedral, are disfavored due to 
steric interactions with the alkyne moieties. The square pyramidal Cu(II) geometry would 
allow for an in-plane interaction with the metal-bound hydroxide and ammonium 
functionality.  
The proposed mechanism of hydrolysis indicates the role of the hydrogen bonding 
interaction with the substrate. The addition of the ammonium functionality leads to an 
increase of more than 3 orders of magnitude in the rate constant for BNPP hydrolysis 
compared to the rate constant observed for 2,2’-bipyridine Cu(II) complex. The pKa for the di- 
and trimethylated ammonium ligands were estimated to be approximately 6.8 which indicates 
that the difference in reactivity is not due to the acidity of the metal bound hydroxide. The 
reactivity of the dimethylated ligand decreases by an order of magnitude when the water 
content is increased to 15% which indicates that the low polarity of the medium plays a role in 
promoting the interaction between substrate and complex. This is not unexpected given that 
water can disrupt the hydrogen bond and electrostatic interaction between the phosphate and 
the NHMe2+ as seen in Figure 2.8. These electrostatic interactions with methylated amines 




Figure 2.8. The structures of the Cu(II) complexes used by Krämer et al. to evaluate the effects of 
hydrogen bonding interactions on reactivity.[91] 
The reactivity of the complexes, both relative and absolute, can seem somewhat 
capricious in light of the discussed observations in the experiments. The problems 
encountered range from Cu(II)-Cu(I) reduction, precipitation and some cases of poor 
reproducibility. Despite this there is no denying that substantial rate increase was achieved for 
the hydrolysis of BNPP of 4 × 107 fold. 
With regard to Zn(II) complexes studied for the transesterification of HPNPP,       
Brown et al. reported the effect of various functionalities in the vicinity of the metal ions in 
methanol.[93] The greatest effects were observed with amine or amide functionalities. 
 























































It has also been shown by Feng et al. that the introduction of a hydrogen bonding amino 
functionality in the 2-pyridine position of a mononuclear complex, see Figure 2.9, resulted in 
a 750-fold rate increase relative to the unsubstituted ligand.[58] The effect of hydrogen 
bonding of the amino functionality in the 2-pyridine position was also compared to a 
dinuclear complex, see Figure 2.10, for which the reactivities were virtually identical. This 
demonstrated that the effect of the amino functionality in the mononuclear complex can have 
the same effect as an additional metal nucleus.[65] 
 
Figure 2.10. Complex M2-3 is the mononuclear equivalent of complex 2-3. The mononuclear (M2-3) and 
dinuclear complex (2-1) are equally reactive although the substrate binding is tighter in the latter.[65] 
Cooperativity between metal ions in the dinuclear complex is suggested to be additive 
with respect to the amino functionality in the 2-pyridine position. These results have been 
combined in the development of the most reactive dinuclear Zn(II) complex to date, see 
Figure 2.11, which has been reported to have a second-order rate constant of 53 M-1 s-1 for the 
transesterification of HPNPP.[51]  
 
Figure 2.11. The most reactive dinuclear Zn(II) complex to date for the transesterification of HPNPP. 
The work presented herein is based on this complex (Figure 2.11) and addresses the 






2.2 - Aims 
 
The aim of this study of dinuclear Zn(II) complexes is to evaluate the effect of 
incorporating two Lewis acidic centers in close proximity to provide double Lewis activation 
of the RNA-like substrate HPNPP. Additionally, the nuclear microenvironment is studied by 
altering the functional groups around the metal ions in an attempt to simulate and understand 
the interactions, for example hydrogen bonding, in the secondary coordination sphere of the 
active site in enzymes. Finally, the possibility to circumvent the use of a structurally 
important but electrostatically problematic bridging functionality is evaluated.  
 
2.3 - Synthetic procedure 
 
 
Figure 2.12. The dinuclear alkoxy-bridged complexes used for the binding and hydrolysis of phosphate 
diesters. 
The dinuclear complexes studied in this section are illustrated in Figure 2.12 and have 
been synthesised with different substituents on the 2-pyridine position which should offer a 
variation in microenvironment around the Zn(II) nuclei. Complex 2-1 is based on the parent 
pyridine ligand and serves as a benchmark for the effect of substitution at the 2-position. 
There will be a steric effect around the metal ions regardless of the functional group being 
introduced into the 2-pyridyl position and complex 2-2 serves as a gauge for the steric effects 
and potentially lipophilic interactions. Complex 2-3 provides a hydrogen bond donor in the 






























































of the hydrogen bond network found in many enzyme active sites. The final complex 2-4 was 
synthesised using a methylated amine in the 2-position which eliminated the byproduct 
formation that was encountered in the synthesis of 2-3, see Scheme 2.9. 
 
2.3.1 - Synthesis of the dinuclear complexes 
 
 
Scheme 2.1. The general procedure for the synthesis of the dinuclear ligands. 
The syntheses of the dinuclear ligands are virtually identical once the pyridyl precursors 
X1, X2, X3 and X4 have been obtained Scheme 2.1. The metal-free ligands are assigned the 
same designation as the corresponding complex with the addition of the prefix “L”,              
for example L2-1. The synthesis of L2-1 was repeatedly attempted starting from                         
2-pyridinemethanol. The formation of the mesyl ester followed by substitution with iodine has 
successfully been used for similar compounds, see precursors X2, X3 and X4 in Scheme 2.4, 
Scheme 2.6 and Scheme 2.13, but unfortunately did not yield the desired product in the case 
of 2-pyridinemethanol. The reaction with methanesulfonyl chloride, see step (i) in Scheme 
2.2, produced an intensely red compound that was not identified as the desired product. 
Although, it is interesting to note that the red compound was also seen when using another 
starting material, see Scheme 2.3  
An alternative synthetic route was devised using the commercially available precursor 
2-(bromomethyl)pyridine hydrobromide (X1). The ligand L2-1 was successfully synthesised 
in 25 % yield. Interestingly the precursor X1 turns a intense red color upon deprotonation 
R = Me (L2-2)
NH2 (L2-3)
NHMe (L2-4)




































Scheme 2.2. The unsuccessful synthesis of precursor for L2-1. (i) MsCl, Et3N, THF; (ii) LiI, THF. 
(after addition of DIPEA), see Scheme 2.3. It appears as if the compound X1 is stabilised in its 
acidic form but long-lived enough in its deprotonated form, in the presence of a primary 
amine, to allow for SN2 displacement of the bromide.  
 
Scheme 2.3. The synthetic procedure in which L2-1 was obtained in 25 % yield. 
Similarly the synthetic procedure for L2-2 was performed using the precursor               
2-(iodomethyl)-6-methyl-pyridine (X2) synthesised from (6-methylpyridin-2-yl)methanol, see 
Scheme 2.4. It is unclear why this reaction appears to work whereas the analogous reaction in 
Scheme 2.2 does not. 
 
Scheme 2.4. The synthesis of the precursor X2. (i) MsCl, Et3N, THF, 99 %; (ii) LiI, THF, 97 %. 
There are commercial equivalents of X2 available, although not at a convenient scale. 
The synthesis in Scheme 2.4 utilised the relatively inexpensive (6-methylpyridin-2-
yl)methanol and proceeded with approximately 96 % overall yield. The synthesis of L2-2, see 
Scheme 2.5, was performed using the standard procedure employed for SN2 reactions in this 
work which consists of the reactants and DIPEA dissolved in dry DMF and heated to 70 °C 












Scheme 2.5. The synthesis of L2-2. The reaction was performed at 70 °C for 12 h. 
The synthesis of the precursor tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (X3) 
for the ligand L2-3 was more laborious, see Scheme 2.6. The compound X3 required larger 
scale synthesis in order to produce feasible amounts since the overall yield was around         
10 - 20 %.  
 
Scheme 2.6. The synthetic route for the precursor X3. (i) Boc2O, Et3N, DMAP, DCM, 80 %; (ii) mCPBA, 
DCM, 97 %; (iii) Ac2O, 70 °C, 22%; (iv) NaOH, MeOH, 86 %; (v) MsCl, Et3N, THF, 94 %; (vi) LiI, THF, 
95 %. 
The synthetic procedure for coupling the precursor X3 to the 1,3-diamino-2-propanol 
was analogous to the previous methods used for L2-1 and L2-2. The final TFA treatment 
deprotects the amino functionality at the 2-pyridine position, see Scheme 2.7. 
The synthesis of L2-3 required relatively large amounts (10 - 50 g) of the starting 
material 2-amino-6-methylpyridine in order to yield sufficient amounts of the desired product. 


















































rarely exceeded 20 - 30 % and it was observed that large amounts of byproduct were formed 
which precipitated during the work up procedure.  
 
Scheme 2.7. The procedure used for the synthesis of L2-3. The yields were 31 % and 100 %, respectively. 
The synthetic route to X3, see Scheme 2.6, involved the introduction of an acetate 
functionality on the 6-methylpyridine position but acetylation was also observed at the 2-
aminopyridine position. This hints at the mechanism of the reaction that forms the byproduct 
in such substantial amounts (40 - 50%). The byproduct that was formed in step (iii) was 
characterised, see Scheme 2.8, and indicated a mechanism that involved the partitioning of an 
intermediate that was essential to the formation of the desired product.  
 
Scheme 2.8. The formation of byproduct from the N-oxide and acetic anhydride. 
The byproduct was isolated with relative ease since it was the only component that did 
not dissolve in EtOAc. The quantity of byproduct (40 - 50%) relative to the product posed a 
problem that needed to be addressed. First the starting material was refluxed in chloroform to 
rule out heat induced degradation. The proposed mechanism for the formation of the 
byproduct, see Scheme 2.9, is very similar to the mechanism for the formation of the desired 
product. The acetylation reaction yielded both a mono-, see Scheme 2.10, and diacetylated 















Scheme 2.9. The proposed mechanism for the formation of the byproduct in the acetylation reaction. 
The acetylation reaction will proceed as long as the N-oxide functionality is present and 
the intermediate (I1, Scheme 2.11) in the diacetylated product reaction is identical to the 
precursor for the undesired byproduct, see Scheme 2.9.  
 
Scheme 2.10. The mechanism for the formation of the monoacetylated product. 
Alternative synthetic routes that were designed using different activating agents to 
eliminate the formation of byproduct, see Scheme 2.12.  
 
Scheme 2.11. The proposed mechanism for the formation of the diacetylated product (main product of the 
reaction). The reaction proceeds with the acetylation of the carbamate followed by acetylation of the        





These reactions were unsuccessful and instead a different protecting group strategy 
(phthalimide) was considered, see Figure 2.13, but the acetylation of the N-oxide was difficult 
and the compound displayed low solubility and reactivity in acetic anhydride.  
 
Scheme 2.12. The proposed compounds that could minimise the formation of byproduct. The compounds 
were synthesis using tert-butyl N-(6-methyl-1-oxido-pyridin-1-ium-2-yl)carbamate under the following 
conditions (a) DCC, DMF; (b) MsCl, DMF. The acetylation was attempted through the subsequent 
addition of AcOH/Et3N to the same reaction vessel as the respective activations. 
After multiple attempts to circumvent the formation of the undesired byproduct it was 
found that methylation of the 2-aminopyridine position completely inhibited the formation of 
the byproduct (corroborating the involvement of the carbamate as a nucleophile in the 
proposed mechanism). This led to the synthesis of the precursor tert-butyl N-[6-(iodomethyl)-
2-pyridyl]-N-methyl-carbamate (X4), see Scheme 2.13. 
 
Figure 2.13. The phthalimide protected compound used for the acetylation reaction.  
The overall yield for X4 was estimated to be at least twice that for X3, despite the 
additional synthetic step, simply due to the introduction of a methyl group in the 2-
aminopyridine position. The synthesis of L2-4 starting from X4 was identical to that of L2-3 
apart from the differing starting material, see Scheme 2.14. 
Complex 2-3 was synthesised first, since it had been reported as the most reactive 
covalently bound dinuclear complex to date[51,71,84]for the transesterification of HPNPP. This 
was followed by the synthesis of 2-1 and 2-2 which served as controls. Complex 2-4 was the 





Scheme 2.13. The synthetic route used to obtain the precursor precursor X4. (i) Boc2O, Et3N, DMAP, 
DCM, 80 %; (ii) NaH, MeI, DMF, 100 %; (iii) mCPBA, DCM, 100 %; (iv) Ac2O, 70 °C, 93 %; (v) NaOH, 
MeOH, 80 %; (vi) MsCl, Et3N, THF, 91 %; (vii) LiI, THF, 90 %.  
compound but does provide some insight into the potential effects of methylation on 
reactivity. Despite the different synthetic problems related to each of the dinuclear ligands 
(L2-1, L2-2, L2-3 and L2-4) the difference in the final yields was not compelling. 
 








































2.3.2 - Synthesis of HPNPP 
 
The synthesis of 2-hydroxypropyl-(4-nitrophenyl) phosphate (HPNPP) was initially 
attempted using a modified literature procedure[29] using the tert-butyldimethylsilyl (tBDMS) 
instead of the tert-butyldiphenylsilyl (tBDPS) protecting group. The protected alcohol was 
synthesised, see Scheme 2.15, although very little product was obtained after the final 
purification step using fractional distillation. The compound could not be purified using flash 
chromatography due to the overlap of polarity of the components in the reaction mixture. 
 
Scheme 2.15. The synthesis of the protected alcohol used in the synthesis of HPNPP. The yields were 72 %, 
100% and 18%, respectively. 
A different procedure had been proposed in the same literature reference that reduced 
the number of synthetic steps and improved the overall yield, see Scheme 2.16. The reaction 
produced near quantitative yields in each step. The subsequent reaction steps were 
 



























straightforward, see Scheme 2.17, and sufficient amounts of HPNPP were obtained although 
the yields were not optimal.Interestingly, this reaction revealed some inherent stability issues 
with the tBDMS protecting group that did not cause any synthetic problems here but is 
nevertheless important to bear in mind, see Chapter 8.6. 
 
Scheme 2.17. The synthesis of HPNPP. The yield was 4 % over 3 steps. 
 
2.4 - Results and discussion 
 
2.4.1 - Kinetic results 
 
The initial kinetic examination of the complexes was performed at varying complex 
concentrations depending on the observed reactivity for the transesterification of HPNPP. 
Complexes 2-1 and 2-2 were both used at 2 mM concentration but the highly reactive 2-3 and 
2-4 only required a concentration of 0.2 mM to completely transesterify the substrate in less 
than 20 min. The pH-rate profile in Figure 2.14 shows the dependence of the observed rate 
constants on pH for the complexes, see Chapter 8.3, and a single ionisation model, Equation 
2.1, was fitted to the data. 
 =  	× 	 
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for 2-3 but also brought to light the instability of the complex in solution. It quickly became 
clear that 2-3 was more sensitive to the conditions in solution such as pH and apparently even 
gaseous exchange, as will be discussed later in this chapter.  
The reactivity of 2-4 was even higher than 2-3 but the solution stability of 2-4 also 
appeared to span an even smaller pH-range than 2-3. The complexes 2-1 and 2-2 proved to be 
less reactive but more stable over a wider pH range compared to 2-3 and 2-4. The lack of data 
points for 2-3 and 2-4 at higher pH as can be seen in Figure 2.14 is due to precipitation.  
 
Figure 2.14. The observed rate constant versus pH for 2 mM 2-1 (blue), 2 mM 2-2 (green), 0.2 mM 2-3 
(red) and 0.2 mM 2-4 (black) with 50 µM HPNPP and 50 mM HEPES or CHES with 0.1 M ionic strength 
(NaNO3). 
The concentration dependence of the reactivity of complexes 2-1 and 2-2 was studied 
using a 96 well plate reader and were carried out in triplicate at each pH. The rate constants 
were determined by the initial rate method, see Chapter 8.2, which only follows the initial    
10 % of the reaction progress and assumes a linear relationship for the appearance of product 
over time. The initial rate provides the second-order rate constant which is plotted versus pH, 
see Figure 2.15.  
A single ionisation model, Equation 2.2 which in essence is identical to Equation 2.1, 
was fitted to the data points. These equations only account for one deprotonation of the 
complex and the corresponding observed activity is obtained by multiplying the maximum 
rate with the percentage of available active complex. The equations take into account the 
























Figure 2.15. The second-order rate constants for 2-1 (blue) and 2-2 (green) versus pH. The data collected 
around pH 8 were intermittently unreliable due to occasional precipitation which is why some data points 
were omitted. The experiments performed in 50 mM HEPES or CHES at 0.1 M ionic strength (NaNO3). 
 =  	× 	 

[]   (Equation 2.2) 
of the complex. The second-order rate constants, k2max, and pKa were determined by the least 
square fits to be 5.6 (± 0.25) × 10-2 M-1 s-1 (pKa 6.83 ± 0.09) and 1.9 (± 0.06) × 10-2 M-1 s-1 
(pKa 7.26 ± 0.04) and for 2-1 and 2-2, respectively. The data for 2-1 is in good agreement with 
the existing literature 7.3 × 10-2 M-1 s-1 (pKa 6.4).[51,65] 
It should also be noted that the estimated limiting second-order rate constant for 2-1 is  
3 orders of magnitude lower than that for 2-3.[51] The increased rate for 2-3 can therefore be 
attributed to the amino functionality in the 2-pyridine position. 
The experimental rate constants indicate that complex 2-1 is 3-fold more reactive than 
complex 2-2 and that the methyl group in the 2-pyridine position has a detrimental effect on 
the apparent reactivity. Care needs to be taken when interpreting the second-order rate 
constants of the complexes since the observed increase in activity could be due to either 
tighter binding of the substrate or higher rates of reaction of the bound substrate. This will be 
addressed in the binding studies in the subsequent section, see Chapter 2.4.2. 
In the case of 2-3 and 2-4 the experimental setup used in the previous experiments 



















apparent influence of NaNO3 on the solubility of the complexes. The ionic strength of the 
solution was kept at 0.1 M using NaNO3 and this seemed to cause precipitation of the 
complex. This setback only manifested itself when the concentration of the complex was 
















1 * Clear 
2 * * Precipitate 
3 * * Clear 
4 * * Precipitate 
5 * * Precipitate 
 
Table 2.1. The solubility of 1 mM 2-3 at pH 6.9 in the presence of sodium nitrate, sodium chloride, sodium 
perchlorate and sodium triflate. 
A series of experiments, see Table 2.1, with various salts revealed that the only salt that 
did not cause precipitation was NaCl. This could possibly be explained by the oxygen atoms 
of the anionic counter ions of the salt binding to the Zn(II) nuclei in a bridging fashion. The 
fact that this was not observed in the case of complexes 2-1 and 2-2 indicates the possible 
influence of the 2-pyridine substituent on binding. The influence of the 2-pyridine substituent 
on binding will be presented in the following section: quantitatively by inhibition studies and 
qualitatively by indicator displacement assays. 
 
2.4.2 - Binding and reactivity 
 
The reactivity of the complexes towards phosphates in general and RNA analogues in 
particular can be dissected into two main components. These components are related to the 
binding of the substrate and the rate of conversion (turnover) into product. The overall 
reactivity represents the combined effect of both these factors. Two different catalysts may 
appear to be equivalent in overall reactivity but it might very well be so that one is more 
efficient at turning over the substrate and the other provides more efficient binding.  
A relevant example in literature is the kinetic comparison between the mononuclear and 
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dinuclear Zn(II) complexes, see Figure 2.10. The two complexes cover a range of parameters 
that can be investigated with carefully designed experiments. The complex M2-3 is the 
mononuclear equivalent of the dinuclear complex 2-3. Complex 2-1 illustrates the effect of 
having double Lewis activation and the mononuclear complex M2-3 can only offer single 
Lewis activation. The additional parameter that can affect the reactivity of M2-3 is the 
possible hydrogen bond donors in the vicinity of the metal ions. Interestingly the observed 
maximum second-order rate constants for these two complexes are virtually identical but the 
tightness of binding is stronger for complex 2-1. The tighter binding of the dinuclear complex 
(166-fold) compared to M2-3 is expected. The tight binding of the substrate simply translates 
into a greater portion of the substrate being bound to the complex and ready to react. This 
make product inhibition a problem that needs to be taken into account since both substrate and 
product are phosphate diesters. The reaction rates indicate that the hydrogen bond interaction 
in M2-3 provides a rate acceleration equivalent to having an additional Zn(II) nucleus. The 
high reactivity of M2-3 coupled with low substrate binding are highly desirable properties 
since they indicate that the complex provides very useful rate acceleration despite having less 
substrate bound. 
In light of the similar rates yet tighter substrate binding for 2-1 it can be concluded that 
the saturating rate for M2-3 will be higher. If interactions separate to the intrinsic binding 
properties of the catalytic centre (e.g. additional recognition factors) are introduced, M2-3 has 
the potential to generate a higher turnover rate. 
When studying possible ways to improve the reactivity of catalytic complexes in a 
particular reaction it is important to understand the contribution of each factor in order to 
tailor the interactions. When a catalyst binds a substrate the rate of the reaction increases due 
to the higher concentration of the catalyst-substrate species referred to as a Michaelis-Menten 
complex. The Michaelis-Menten equation, Equation 2.3, can be used to fit experimental data 
that measure the reactivity of catalysts versus the concentration of substrate.  
 
Scheme 2.18. The schematic representation of the catalytic reaction progression from substrate to 
product. The catalyst (C) and substrate (S) forms the reversible Michaelis-Menten complex [CS] with the 
rate constant k1. The complex breaks down into either the reactants with the rate k-1 or the product (P) 
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The parameters that can be obtained from the equation are kcat (s-1) and KM (M) that 
represent the catalytic turnover and tightness of binding to the substrate, respectively, see 
Scheme 2.18. In Equation 2.3 the rate of product [P] formation is related to the total 
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For the experiments presented here the substrate has been used at sub-saturating 
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The Equation 2.4 is a second-order rate equation and the k2 is the second-order rate 
constant (M-1 s-1) corresponding to KM / kcat. 
$ = %&	'()&      (Equation 2.5) 
The KM is referred to as the Michaelis constant and is defined as the two-directional 
decay of the catalyst-substrate complex as illustrated in Scheme 2.18, see Equation 2.5. In 
the case of most artificial catalysts k-1 >> kcat since their reactivity and binding of substrate are 
relatively limited which lead to Equation 2.6 where KM ≈ Kd. 
$ ≈	 %&& =	
[][]
[] = +    (Equation 2.6) 
Many highly efficient enzymes have high rates of turnover but relatively moderate 
substrate binding to allow for easy product release and limit the effect of product inhibition. 
Examples of this can be found in nature (e.g. carbonic anhydrase, chymotrypsin) where the 
KM is in the range of 10-3 M whereas the kcat ranges from 10-1 to 105 s-1 which equates to high 
second-order rate constants k2. These values are in good agreement with the expected values 
for the “average” enzyme.[57] 
For artificial catalyst the more challenging parameter to improve is kcat since the 




The overall rate for the transesterification of HPNPP was measure in the presence of the 
competitive inhibitor dimethyl phosphate (DMP).[51] DMP was used since it can be expected 
to bind to the complex in the same fashion as any other phosphate diesters but without being 
hydrolysed. Since the compound lacks both an internal nucleophile and an acidic leaving 
group the rate of spontaneous hydrolysis will be negligible (half-time 1.3 × 105 years)[56] and 
the compound does not interfere with UV measurements. 
 
Figure 2.16. The inhibition experiment illustrated by normalised rate k/k0 versus the concentration of 
DMP in mM at pH 6.9. The complex 2-1 (red) and 2-2 (blue), both used at 1 mM with 0.5 mM HPNPP at 
pH 6.9 in 50 mM HEPES and 0.1 M ionic strength (NaNO3). 
The kinetic analysis was performed using 2-1 and 2-2 at several DMP concentrations 
and monitoring the reduction in reactivity. The conclusions that can be drawn from these 
experiments rely on the premise that DMP binds to the complex in a similar fashion to the 
hydrolysable substrate. The graph in Figure 2.16 shows the normalised rate k/k0 where k0 
represents the rate constant with no inhibitor present.  
Equation 2.7 was used to fit the inhibition data for competitive inhibition[51] and 
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The difference in Ki can be seen in light of the previous data, see Figure 2.15, where the 














roughly a factor of 6 which can be compared to the 3-fold difference in the limiting second-
order rate constant in favor of 2-1. This translates into more substrate being bound to 2-1 
compared to 2-2. 
The decaying rate signifies the tightness of binding for the complex with respect to 
phosphate diesters and can be related to the observed overall activity to dissect it into its 
components. The DMP is similar to the substrate HPNPP in the sense that both are phosphate 
diesters and the binding of DMP simulates the binding of the substrate in the ground state. 
Other inhibitors (phenyl phosphate) that are dianionic have been used to estimate the 
transition state binding.[58] The Michaelis-Menten parameter KM is the substrate concentration 
at which the catalyst reaches half its maximum rate. The decaying curves for the DMP 
inhibition can be viewed as inverted Michaelis-Menten curves which means that the 
concentration at which the reactivity is halved, Ki, is equal to KM. The inhibition was also 
studied at pH 7.4, see Figure 2.17, which indicated a difference in observed inhibition, Ki.  
 
Figure 2.17. The inhibition experiment illustrated by normalised rate k/k0 versus the concentration of 
DMP in mM at pH 7.4. The complex 2-1 (red) and 2-2 (blue), both used at 1 mM with 0.5 mM HPNPP at 
pH 7.4 in 50 mM HEPES and 0.1 M ionic strength (NaNO3). 
At higher pH it is evident that the binding is reduced for both complexes since Ki equals 
1.0 (± 0.01) × 10-2 M and 6.2 (± 0.43) × 10-2 M for 2-1 and 2-2, respectively, although the 
ratio of Ki between the complexes remains 6-fold. 
As previously mentioned, the use of NaNO3 to adjust the ionic strength of the reaction 


















between all the complexes the inhibition studies for 2-1 and 2-2 were repeated using NaCl, 
see Figure 2.18. 
 
Figure 2.18. The DMP inhibition using 1 mM 2-1 (red) and 2-2 (blue) with 0.5 mM HPNPP in 50 mM 
HEPES at pH 6.9 and 0.1 M ionic strength (NaCl). 
Complex 2-2 displays similar binding (Ki = 3.2 (± 0.07) × 10-2 M) to previous 
measurements in NaNO3 containing solutions but binding for complex 2-1 differs by a factor 
of 3 (Ki = 1.6 (± 0.33) × 10-2 M). Although a difference might be expected, it is unusual that 
the binding remains virtually unaffected for one complex but changes for the other.  
 
Figure 2.19. The inhibition experiment illustrated by normalised rate k/k0 versus the concentration of 
DMP using 0.2 mM 2-3 (red) and 2-4 (blue) with 50 µM HPNPP in 50 mM HEPES at pH 6.9 and 0.1 M 

























The binding properties of 2-3 and 2-4 were kinetically analysed with DMP, see     
Figure 2.19, in the same fashion as 2-1 and 2-2 except that the concentration of the complexes 
was reduced to 0.2 mM. The binding of DMP (Ki) at pH 6.9 is virtually identical for the two 
at 6.0 (± 0.44) × 10-4 M (2-3) and 5.9 (± 0.33) × 10-4 M (2-4) which is around 25-fold less 
than 2-1 and 50-fold less than 2-2.  
Based on the data obtained for 2-3 at 0.2 mM, see Figure 2.14, the limiting second-order 
rate constant can be estimated using kobs at pH 7.4 divided by the concentration of complex 2-
3 (0.2 mM) to ≈ 23 M-1 s-1. With a KM of 6.0 (± 0.44) × 10-4 M, kcat can be estimated to be 
0.014 s-1. These kinetic parameters for 2-3 are in reasonable agreement with literature 
values[51] although the reported limiting second-order rate constant and Ki are                        
53 M-1 s-1 and 3.7 × 10-4 M, respectively, at pH 7.4.  
An experiment with 2-3, see Figure 2.20, had been performed at the highest pH at which 
the complex was stable in solution. This data serves as a crude indicator that the tightness of 
binding seems to decrease for 2-3 (Ki = 1.9 (± 0.08) × 10-3 M at pH 8.1) with increasing pH, 
as seen for 2-1 and 2-2, although some reservations are required as the influence of the 
NaNO3 is not fully understood.  
 
Figure 2.20. The inhibition experiment illustrated by normalised rate k/k0 versus the concentration of 
DMP using 0.2 mM 2-3 in 50 mM HEPES at pH 8.1 and 50 µM HPNPP and 0.1 M ionic strength (NaNO3). 
In this case NaNO3 had been used before the salt induced precipitation was discovered. 
A summary of the Ki-values is listed in Table 2.2 showing the results at various pH 















pH 6.9 pH 6.9 pH 7.4 pH 8.1 
Complex Ki (mM) NaNO3 Ki (mM) NaCl Ki (mM) NaNO3 Ki (mM) NaNO3 
2-1 4.98 (± 0.13) 16.23 (± 3.30) 9.76 (± 0.10) - 
2-2 31.09 (± 1.50) 32.54(± 0.70) 62.54 (± 4.30) - 
2-3 - 0.60 (± 0.044) - 1.94 (± 0.08) 
2-4 - 0.59 (± 0.033) - - 
 
Table 2.2. Ki for the dinuclear complexes at various pH. The experiments were all performed in 50 mM 
HEPES using either NaNO3 (red) or NaCl (green) to adjust the ionic strength to 0.1 M. Additionally, 0.5 
mM HPNPP with 1 mM complex was used for 2-1 and 2-2 and 0.2 mM complex with 50 µM HPNPP for 2-
3 and 2-4. 
The apparent second-order rates for the complexes at pH 6.9, measured at zero 
concentration DMP in the inhibition experiments, are listed in Table 2.3 and the difference in 
binding can be used to evaluate the contribution of binding to the overall reactivity. The 
apparent second-order rates were estimated from the initial rate or first-order fit of the data at 
pH 6.9 and normalised to the least reactive complex. The listed rates appear lower than the 













2-1 0.013 (± 4.17 × 10-5) 1.5 16.23 28 - 
2-2 0.0086 (± 2.40 × 10-5) 1 32.54 55 - 
2-3 15.03 (± 0.10) 1750 0.60 1 - 
2-4 47.79 (± 1.05) 5570 0.59 1 - 
HPNPP - - - - 5.16 × 10-9 
 
Table 2.3. The apparent second-order rate constant and the observed Ki at pH 6.9 for the dinuclear 
complexes. The data was collected at pH 6.9 in 50 mM HEPES at 0.1 M ionic strength (NaCl). The kuncat 
for HPNPP is given at pH 6.9 (k2 = 0.065 M-1 s-1).[65] 
The relative binding constants for 2-3 and 2-4 compared to 2-1 and 2-2 differ by an 
order of magnitude whereas the relative rates differ by over 3 orders of magnitude. This 
implies that the binding is stronger for the complexes a containing hydrogen bond donor in 
the 2-pyridine position. The main conclusion is that the improved reactivity is mainly due to 
higher catalytic turnover rather than tighter binding of the substrate.  
These effects can be determined quantitatively using the transition state theory where 
the contributions of binding and reactivity of a complex can be related to the free energy of 
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activation (∆Gθ) for the transition state. The interactions involved in the stabilisation of the 
transition state for the transesterification of HPNPP can be determined using the Eyring-
Polanyi equation, Equation 2.8, where the parameters k, kB, h, R and T are the rate constant, 
Boltzmann constant, Planck’s constant, gas constant and absolute temperature, respectively. 
The free energy of activation can estimated, Equation 2.9, using the obtained parameters 
(reaction rates or binding constants) of the reaction. 
 = 	.	 /01 2 3(
5Δ6‡ 89 )   (Equation 2.8) 
∆<‡ = 4.576	 × 	B[10.319	 + log/B 9 2] (Equation 2.9) 
The slowest rate of hydrolysis is expected to be the uncatalysed reaction which is 
reflected by the highest energy of activation, see Figure 2.21. The catalysed reaction, for any 
given complex, should display a lower energy of activation and represents the combination of 
the ground state and transition state stabilisation.  
The Gibbs free energy of activation (∆G‡) for the complex catalysed transesterification 
reaction of HPNPP can be calculated and compared to the uncatalysed reaction under similar 
conditions. 
 
Figure 2.21. A schematic energy diagram, where ∆G° represent the free energy for the ground state and 
∆G‡ represents the free energy for the transition state, showing the difference in free energy between 
catalysed (green) and uncatalysed (red) reactions. A complex that displays similar binding to the ground 

















The transition state stabilisation, ∆∆G‡cat, represents the difference between the energy 
of activation of the uncatalysed transesterification and the complex catalysed equivalent (∆G‡ 
(HPNPPuncat) - ∆G‡ (2-X)).  
The stabilising effect attributed to ground state binding ∆∆G°bind is estimated based on 
DMP inhibition experiments at pH 6.9 where the inhibitor is assumed to bind to the 
complexes similarly to the substrate. This indicates that the remainder of the ∆∆G‡cat is due to 
the interactions preceding the transition state. The ∆G‡stab and ∆G°stab, see Figure 2.22, 
represents the percentage of ∆∆G‡cat that can be attributed to the transition state and ground 
state interactions, respectively.  
The contribution of the ground state interaction increases with increasing reactivity with 
2-2 < 2-1 < 2-3 < 2-4. The overall increasing reactivity 2-2 < 2-1 < 2-3 < 2-4 and the 
contribution of kcat and KM is illustrated in Figure 2.22 and quantitatively summarised in  
Table 2.4.  
 
Figure 2.22. The free energy of activation illustrated as transition state interaction, ∆G‡stab (blue). and 
ground state interaction, ∆G°stab (red), for each complex. The upper limit of the combined (red and blue) 
bars corresponds to the free energy of activation for the uncatalysed transesterification of HPNPP and the 
lower limit corresponds to that of the catalysed reaction. 
The reactivities of the complexes increase in the order 2-2 < 2-1 < 2-3 < 2-4 which 


























The decrease in reactivity upon changing to a Me-functionality indicates a reduction in 
ground state binding but an increase in transition state stabilisation, i.e. less substrate is bound 
in the ground state but the reactivity is higher for 2-2 compared to 2-1. 
 
Complex k2 ratio (2-X/2-1) KM ratio (2-1/2-X) kcat ratio (2-1/2-X) 
2-1 1 1 1 
2-2 0.7 0.5 1.4 
2-3 1200 30 43 
2-4 3700 30 130 
 
Table 2.4. The KM and kcat ratios for the complexes indicate the contribution to the observed reactivity for 
each complex relative to 2-1. 
The effect of the NH2-functionality is an increased ground state binding (30-fold) as 
well as an increased transition state stabilisation (43-fold). The NHMe-functionality of 
complex 2-4 indicates similar ground state binding to the complex 2-3 but a greater transition 
state stabilisation (130-fold). 
 
2.4.3 - Indicator displacement assay 
 
The indicator displacement assays of the dinuclear complexes were motivated by 
reports in the literature.[94] Morgan et al. used various indicators with a phenoxy-bridged 
equivalent of complex 2-1, see Figure 2.23. The use of indicator displacement assay is a well 
established method for the detection of the binding of anions to metal complexes.[95] 
 
Figure 2.23. The dinuclear complex used in the literature to study the displacement of indicators. 
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The indicator pyrocatechol violet (PV), see Figure 2.24, was selected due to its large 
difference in absorbance maximum wavelength between free and bound indicator. This allows 
for both qualitative colorimetric and quantitative spectrophotometric determination of 
binding.  
The indicator PV is expected to bind to the complex though the catechol moiety which 
would have to compete with the negatively charged oxygens of the dianionic phosphate. The 
fact that dianionic substrates bind tighter to the electrophilic metal ions of dinuclear zinc 
complexes than their monoanionic analogues has been used to estimate the transition state 
binding of substrates.[58] The expected tight binding of complexes 2-3 and 2-4 should result in 
a much more obvious displacement of the indicator than for 2-1 and 2-2. 
 
Figure 2.24. Pyrocatechol violet (PV) indicator and the phosphate HPO42- used to displace the indicator. 
It is evident from the indicator displacement experiments, see Figure 2.25, that the two 
most reactive complexes (2-3 and 2-4) are displaying lower sensitivity towards the dianionic 
phosphate compared to the two least reactive ones (2-1 and 2-2). It is unexpected that this is 
the case given that the dianionic phosphate is supposedly more nucleophilic compared to the 
PV and should be expected to bind more tightly to the electrophilic dinuclear Zn(II) complex. 
The binding and displacement of PV was supposed to be used as an indicator for the behavior 
of the complexes towards phosphate but raised more questions than it answered. 
Since the interaction between the indicator and the complexes was not fully investigated 
there is little to justify any conclusion. The main observation from this is that the profiles of 
the indicator displacements show strong resemblance between 2-1 and 2-2 as well as between 
2-3 and 2-4, respectively. This seems to indicate that the less reactive complexes, 2-1 and 2-2, 




















Figure 2.25. The UV-vis profiles of the titrations of HPO42- into a 1:1 complex:PV (50 µM of each) in 50 
mM HEPES at pH 7.4 and 0.1 M ionic strength (NaNO3). Each complex was titrated up to 2 equivalents of 
HPO42- with 10 additions at 0.2 equivalents of PV each. The complex bound PV (blue trace), the titration 
curves representing the consecutive additions of phosphate (red trace) and the unbound PV (black trace) 
 
2.4.4 - Carbon dioxide effect on reactivity 
 
An issue that prompted an investigation was the apparent deterioration in reactivity for 
the dinuclear complex 2-3 over time. The first observations of this nature were made using 
complex 2-3 buffered at pH 7.4. 
The stock solutions of buffer were freshly prepared prior to the kinetic experiments and 




























































































pH 7.4, a clear reduction of reactivity was observed over time (approximately one third 
decrease over 12 hours). The reactivity was regained upon use of freshly prepared buffer 
solution. This seems to indicate that complex itself was not inherently unstable but rather 
some external factors that were being introduced over time affected the reactivity. The 
progression of this effect seemed to be inversely proportional to the volume of the buffer 
stock since buffer stored in smaller volumes lead to a reduction of activity at a faster rate. The 
size of the vials in which the buffer was being stored also seemed to affect the outcome since 
buffers stored in narrow vials maintained the activity for longer than wider ones. After 
repeated experiments in which the buffers were stored in different sized vials (glass or plastic) 
it was determined that the only thing that could come in contact with the buffer solutions was 
the ambient atmosphere and from the atmosphere only CO2 seemed to be the plausible culprit. 
In order to confirm this theory CO2 was passed through the buffer stock solution for 10 
seconds, where the pH was maintained at ≈ 7.4, which was subsequently used. A slight drop 
in pH (0.07 units) was observed after treatment with CO2 gas. Air was then passed through 
the same buffer stock solution for 20 min and the buffer was then used for an identical 
experiment. The results from the CO2 experiments are presented in Figure 2.26.  
 
Figure 2.26. The transesterification of 50 µM HPNPP catalysed by 0.2 mM 2-3 (green) and the effect of 
passing CO2 through the buffer for 10 seconds (red). The activity was regained after passing air through 
the CO2 treated buffer 20 minutes (blue). The experiments were performed in 50 mM HEPES at pH 7.4 
with 0.1 M ionic strength (NaNO3). 
CO2 seems to completely deprive the complex of activity although interestingly passing 




















physical bubbling of gas disfavors the retention of CO2 in solution and in effect becomes 
sparging.The spontaneous hydration of CO2 has a half-time of a few seconds[54] at neutral pH. 
It is likely that the carbonate that forms in aqueous solution from CO2 binds the dinuclear 
complex although the equilibrium lies towards CO2, see Figure 2.27, rather than carbonate.[96] 
There are data suggesting that some buffers may affect the activity of carbonic 
anhydrase from plants[97] under certain conditions (high concentrations of CO2) but despite 
the use of the same buffer (HEPES) it is unclear whether this can be related to the inhibition 
presented here. The binding mode for the mononuclear active site in carbonic anhydrase 
differs from that of the dinuclear complex. Once the carbonate is formed it is expected to bind 
to the metal ions in a bridging fashion[98] and act as an inhibitor at sufficiently high 
concentrations.  
 
Figure 2.27. The spontaneous hydration of CO2 at 25 °C (Keq = 2.6 × 10-3).[96] 
The inhibitory effect of CO2 was investigated using sodium carbonate in order to 
accurately estimate the concentration of carbonate in solution, see Figure 2.28.  
 
Figure 2.28. The Na2CO3 inhibition of 1 mM 2-1 (red) and 2-2 (blue) in 50 mM HEPES at pH 6.9 with 0.5 
mM HPNPP and 0.1 M ionic strength (NaNO3). 
The carbonate clearly inhibits the activity of the complex 2-1 and 2-2 more efficiently than 




















the dianionic nature of carbonate it is not unexpected that the compound binds to the 
complexes tightly. Although the carbonate is not the targeted compound it is likely 
bridgingthe Zn(II) nuclei, given its charge, similarly to a transition state analogue (phosphate 
monoester) as has been reported for 2-1.[98] 
Comparing the estimated Ki for the carbonate with the catalytic proficiency 
(kcat/KM)/kuncat where the kcat/KM (i.e. k2) was determined at pH 6.9 from the data in         
Figure 2.15 and kuncat at pH 6.9 (5.16 × 10-9 s-1)[65] yielding (0.39 µM and 0.58 µM, 
respectively) reveals a discrepancy of 6300-fold and 11200-fold for 2-1 and 2-2, respectively. 
These differences can be indicative of additional stabilising interactions in the transition state 
that are not fully accounted for by the Lewis acidic interactions with the Zn(II).[58] These 
conclusions are based on the assumption that the dianionic carbonate behaves similarly to the 
dianionic transition state in the phosphate diester hydrolysis which might not be entirely 
accurate. 
Carbonate inhibition was not studied with 2-3 and 2-4 but in light of the data obtained 
from the DMP inhibition it is reasonable to expect the binding to be even tighter and 
inhibition to be more effective.  
The observation that CO2 affects the Zn(II) metal complexes in such a manner was 
serendipitous and initially unexpected, although not surprising in light structure of the enzyme 
carbonic anhydrase[99] and research around artificial complexes for carbon capture in the 
literature.[100] 
 
Figure 2.29. The Zn(II) 1,4,7,10- tetraazacyclododecane and 1,5,9-triazacyclododecane that have been 
reported to display the highest rate of CO2 hydration for small metal complexes. 
Many carbonic anhydrase mimics have been studied[101–103] that bear strong structural 
resemblance to the hydrolytic catalysts studied here and some have displayed reactivity 
towards phosphate diesters. The most reactive small metal complexes, see Figure 2.29, for the 
81 
 
hydration of CO2[104] have also been used to study the hydrolysis of phosphate diesters which 
further consolidate the premise of this discussion. 
 
Figure 2.30. The trinuclear complex (left) based on [Zn(DPA)]2+ (right) used by Cao et al.[105] 
Most molecular mimics of CO2 binding enzymes use similar mononuclear arrangements 
although multinuclear Zn(II) structures have also been studied, see Figure 2.30.[81,105] DPA 
(di-(2-picolyl)amine) has commonly been used as a ligand in conjunction with Zn(II) for 
binding or catalytic purposes. The trinuclear complex has been found to bind both CO2 and 
phosphates. The monomeric [Zn(DPA)]2+ has an association constant of 1.43 × 107 M-1 at 
neutral pH[106] which indicates that it will be unstable in the presence of CO32- (ZnCO3 has a 
solubility product of 1.46 × 10-10).[105] Despite this apparent limitation of the DPA ligand the 
multinuclear complex seems to resist demetallation by carbonate.[105] 
This result can be extended for the dinuclear complexes 2-1, 2-2, 2-3 and 2-4 since they 
either remain relatively active in presence of carbonate or regain activity after treatment with 
CO2. The apparent reversible binding of CO2 poses an inconvenience that is readily solved by 



























2.4.5 - Oxazole-bridged dinuclear complexes 
 
The structural change that is of interest to study would be the removal of the bridging 
hydroxyl group. The role of the bridging hydroxyl group is to promote the association of the 
two mononuclear moieties through binding of the two Zn ions to the central alkoxy. The 
potential drawbacks of having an anionic oxygen between two electrophilic metal ions 
become apparent when the function of the complex is taken into account. The incoming 
substrate that the complex is meant to target is a negatively charged phosphate diester that 
will experience electrostatic repulsion from the alkoxy-bridge. The activation and interaction 
that is central in the catalytic role of the complex is dependent on the Lewis acidity of the 
metal nuclei which depends on the binding geometry and character of the metal coordinating 
ligands. It is therefore reasonable to assume that the electron-rich negatively charged alkoxy-
bridge reduces the Lewis acidity of the positively charged Zn(II). 
The reactivity of bridged dinuclear complexes is significantly higher than their 
mononuclear equivalents. The effects are cooperative rather than additive since the difference 
can be several orders of magnitude.[14,51,65] 
A potential neutral alternative to the polar alkoxy group is required to encourage 
association of the nuclei and a viable option is pyrazole, which has been reported in 
literature.[75]  
A series of compounds linked by an oxazole group, see Figure 2.31, was kindly 
supplied by Dr. Guoqiang Feng at Wuhan University. These ligands were complexed with 
Zn(II) and screened for activity under similar conditions to the alkoxy-bridged complexes  
Equation 2.1 was fitted to the observed rate constants measured at various 
concentrations, see Figure 2.32, although a successful fit was not possible for 2-6 due to 
insufficient data points.  
The observed rates indicated that the amino functionality in the 2-pyridine position gave 
the most reactive complex as had previously been established for 2-3 and that the complexes 
2-5 and 2-7 were equally reactive. Complex 2-6 appeared even less stable in solution than 2-3 
and the data point pH 7.4 is unreliable due to the appearance of precipitate during the 
reaction. The activity of L2-6 was studied using Co(II) to determine whether changing metal 




Figure 2.31. The oxazole-bridged dinuclear complexes. 
 
Figure 2.32. The observed rate versus pH for complexes 2-5 (red), 2-6 (blue) and 2-7 (green) at 0.4 mM 
complex concentration and 50 µM HPNPP. The solutions were buffered using 50 mM HEPES or CHES 
with 0.1 M ionic strength (NaNO3). 
There are numerous examples of Co(III) being used in the context of hydrolytic 
catalysis[13,107] although there have not been as many examples in literature of small metal 
complexes using Co(II) compared to Co(III) despite the fact that the former can replace Zn(II) 
in many enzyme active sites. The investigation of Co(II) for both catalytic and binding 
applications in catalytic biopolymers has been reported[36,50,108,109] as well as small di- and 
























Figure 2.33. The use of equimolar amounts of Co(II) with 0.4 mM L2-6 (black) proved more fruitful and 
lead to the a more reasonable solution stability of the complex. The red (2-5) and green (2-7) plots are the 
same as in the previous figure. The solutions were buffered using 50 mM HEPES or CHES with 0.1 M 
ionic strength (NaNO3). 
The reactivity of 2-3 has been reported to quadruple upon changing the metal ions from 
Zn(II) to Co(II) for the transesterification of UpU.[111] The reactivity of L2-6-Co(II) does not 
seem to surpass that observed for 2-6 (data point at pH 6.9) but did yield an improved solution 
stability. These results allowed direct comparison between 2-1 and 2-5 as well as between 2-3 
and 2-6 (compared at pH 6.9). The apparent second-order rates for the alkoxy and oxazole-
bridged complexes are listed in Table 2.5. 
Complex Apparent k2 (M-1s-1) 
2-1 0.056 (± 0.003) 
2-3 23.33 (± 2.23) 
2-5 0.13 (± 0.11) 
2-6 0.40 (± 0.001) 
L2-6-Co(II) 0.34 (± 0.007) 
 
Table 2.5. The apparent second-order rate constant k2 determined for 2-1 (Figure 2.15) and 2-3 (Figure 
2.14) compared to the relevant oxazole complexes. 
Despite the apparent 2-fold rate increase the conclusion is that the reactivity of the 
complex 2-5 is approximately the same as for 2-1. A more significant difference is observed 





















The overall result seems to be that the oxazole-bridged complexes are not more reactive 
than their alkoxy-bridged equivalents. 
The effect of CO2 on reactivity was qualitatively investigated for complex 2-6 which is 
the oxazole-bridged equivalent of complex 2-3. The reactivity of 2-6 before and after CO2 
treatment, see Figure 2.34, displayed similar behavior as seen for 2-3. The reactivity of 2-6 
was completely lost due to the exposure to CO2 although passing N2 through the solution did 
not restore activity in this case.  
Complex L2-6-Co(II) was also studied with CO2 at pH 7.32 (pH 7.08 after CO2) and 
yielded similar results to 2-6. This apparent difference in reactivity and irreversible CO2 
interaction for the oxazole complexes could possibly be explained by the less tightly 
coordinated metal ions and larger internuclear distance. The reduced tightness of binding to 
the metal by the neutral bridging group should yield more Lewis acidic metal nuclei that bind 
the CO2 tighter. The CO2 could possibly displace the oxazole and bind to the resulting 
tricoordinated metal ion in a facial bidentate way.[101] 
 
Figure 2.34. The activity of 0.4 mM 2-6 with 50 µM HPNPP before (red) and after treatment with CO2 
(blue) displayed similar behavior to 2-3 but the complex was not reactivated upon bubbling N2 gas 
through the solution. The solution conditions were 50 mM HEPES with 0.1 M ionic strength (NaNO3) at 
pH 7.4 before and pH 6.9 after CO2 treatment. 
Pyrazole complexes with Zn(II) have been reported in literature as β–lactamase 




































Figure 2.35. The structure of the pyrazole-bridged ligand affect the interaction between the Zn(II) nuclei. 
The linkers lead to the formation of the structure due to the Zn(II) being forced apart. 
The Zn2OH (µ-hydroxo) structure has been reported to be less reactive than the Zn2.H2O.HO 
structure. Given the length of the linkers in the complexes studied herein it is likely that 
Zn2.H2O.HO structure is more relevant. This would further validate the assumption that the 
greater internuclear distance reduces the possibility for double Lewis activation of the 
phosphate. 
 
2.5 - Conclusion 
 
The dinuclear complexes presented here have successfully been used for the 
transesterification of HPNPP and have highlighted the effects of different substituents in the 
2-pyridine position. The native dinuclear complex 2-1 containing no functionality in the 2-
pyridine position (2-H) was more reactive than the complex 2-2 containing a methyl 
functionality (2-Me). This seems to be mainly due to tighter ground state binding for 2-1. The 
amino functionalised complexes 2-3 and 2-4 display improved ground state binding over 2-1 
but also significant additional transition state stabilisation. The amino functionalities could 
potentially provide hydrogen bonding to the substrate which leads to the higher rates of 
transesterification. The increased reactivity of 2-3 and 2-4 comes at the cost of their stability 
in solution since both complexes are sensitive to pH changes. Additionally, the complexes 
were discovered to be sensitive to carbonate after the observation that exposure to ambient 
atmosphere reduced their reactivity. 
The kinetic study of complexes containing a neutral bridging group (oxazole) revealed 




potentially be attributed to the larger internuclear distance in the oxazole complexes that leads 
to poorer interaction with substrate. These results confirm what has previously been reported 
for dinuclear complexes in aqueous media, i.e. that the presence of an appropriate bridging 
group is important for the catalytic activity. 
Subsequent chapters will introduce the concept of the association of mononuclear 
complexes without a covalent bridging unit to produce similar reactivities to those observed 
for dinuclear complexes.  
 
2.6 - Future work 
 
The concept of removing the bridging group will be the basis of subsequent chapters but 
the changing of the bridging group is a potential future study of covalently bound dinuclear 
complexes. The effects in the case involving the oxazole bridging unit were modest from a 
reactivity perspective but there are other neutral moieties that can serve as potential bridging 
groups. Triazole based bridging groups have been considered in the course of this work and 
although it was not used here the starting materials, see Figure 2.36, for this were synthesised 
for other applications, see Chapter 4. 
 
Figure 2.36. The azide compound used for peptide coupling and triazole synthesis (left) and the triazole 
linker in a potential dinuclear ligand (right). 
Another compound that was considered due to the simplicity of the suggested synthesis 
was the keto-bridged equivalent of 2-2, see Scheme 2.19. The attempted synthesis yielded a 
mixture of products that were difficult to separate. The resulting reaction mixture was similar 
to that of other attempts to oxidise alcohols with potentially acidic α-protons (see Chapter 5, 
L5-8). The reaction mixture turned increasingly green with time and was dark green in the 
work up. This unidentified green colour was not observed for other (successful) oxidations 





Scheme 2.19. The attempted oxidation of 2-2 using Dess-Martin Periodinane. 
Despite not being as easy to synthesise as initially envisioned the keto-bridged complex 
would still be interesting to study due to the less anionic nature of the carbonyl oxygen 
compared to the alkoxy oxygen. 
An alternative synthetic route lies in the preparation of the starting material, in           
this case the 1,3-diamino-2-propanol. The oxidised analogue of the starting material                          
1,3-diaminoacetone dihydrochloride is commercially available although it quickly became 
evident that upon deprotonation of the amines the formation of imine polymers would 
strongly interfere with the SN2 displacement of iodine. 
 
Scheme 2.20. The formation of the protected starting material using triethyl orthoformate and 
concentrated H2SO4 in EtOH. 
The other option was to convert 1,3-diaminoacetone dihydrochloride into a protected 
ketone in the form of a ketal. This was attempted using an acidic procedure, see Scheme 2.20, 
in order to avoid deprotonation of the amines. 
 

























The procedure was successful and the starting material was obtained. The amino ketal 
was used in the synthesis with precursor X2 although the reaction was unsuccessful.  
It might be questionable as to whether the target compound itself will resist the 
eliminations that has plagued its predecessors but it is still an alluring molecule to study 
which leads the quest on. If the keto-bridged complex can be synthesised it would be 
interesting to investigate the possibility to convert the ketone into an oxime, see Scheme 2.21.  
 
Figure 2.37. The proposed structure of a dinuclear oxime complex. 
Since the oxime functionality will most likely only bind to one Zn(II) it will not bridge 
the two nuclei but rather have a non-coordinated nucleus as an appendage, see Figure 2.37. 




































Chapter 3 - Membrane based complexes 
 
3.1 - Introduction 
 
The concept of organisation at the interface of membranes can be traced back to features 
derived from nature. The cell membrane is a prime example of an organised structure that is 
of utmost importance for the compartmentalisation of cellular components as well as 
intercellular communication. The formation of the membrane structure in solution is driven by 
the disfavored interaction between the lipophilic structure of the surfactant tail and the 
solvent.  
On a cellular level there are a multitude of different molecules of varying sizes that are 
encouraged to associate by the macromolecular structure that is the membrane of the cell.[113] 
Mimicking these features is a valid approach to investigating the structural interactions that 
are of relevance for reactivity given that many binding processes are known to occur on 
membrane surfaces. Biological membranes consist of various surfactants that are of the 
general phospholipid structures seen in Figure 3.1. The self-assembled structures that are 
spontaneously formed by these phospholipids in aqueous solution are similar to cell 
membranes and serve as appropriate models for it.[114] 
 
Figure 3.1. The general structure of the phospholipid membrane component where R1=aliphatic chain and 
R2 = charged species. 
The interactions at the membrane interface has been studied using Cu(II) binding 
receptors.[115] The binding interactions displayed cooperativity and were substantially 
enhanced in the interface compared to the solution which has been suggested to be due to the 
lower polarity of the environment as well as a local concentration effect when the receptors 
are localised to the surface.  
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An example of the local concentration effect is the hydrolysis of lipophilic esters and 
amides in the membrane interface by carboxyl functionalised lipids.[116] The experiments 
consisted of simply mixing various long alkyl chains with polar head groups that are known to 
form micelles in solution with an alkyl ester (S1) and amide (S2), see Figure 3.2. Of these 
surfactants the carboxyl functionalised hexadecanoate (Cat 1) was found to efficiently 
hydrolyse ester and amide substrates. 
 
Figure 3.2. The structures of various substrates used to study the reactivity of Cat 1 at the membrane 
interface. 
The rate of reaction was measured under different conditions and the estimated half-
lives of the uncatalysed, acetate-catalysed and Cat 1 catalysed hydrolysis of S2 were 1 year, 
2.5 weeks and 3 min, respectively. The Cat 1 accelerated hydrolysis is approximately 8 orders 
of magnitude faster than the acetate-catalysed reaction assuming a linear dependence on the 
concentrations of the catalysts (which were 20 µM and 200 mM, respectively). The reaction is 
stochiometric which indicates that the hydrolysis of the mixed anhydride that is formed is rate 
determining for the turn-over, see Figure 3.3. The interesting point to note is the structural 
constraints for the hydrolysis achieved. The presence of three methylene groups (S3) is 
enough to cause a complete loss of activity which indicates the importance of proximal 
interaction (carboxylate-ammonium) to the targeted functionality. 
 














The mechanism of action is arguably similar to that of Carboxypeptidase A (CPA) 
where the glutamic acid anion functions as a nucleophile[91] and it has tentatively been 
proposed that the random search through lipophilic aggregates could prove surprisingly 
rewarding in terms of catalytic activity. 
In light of these membrane induced effects it is chemically sound to study the effects of 
introducing metal complexes into these environments.[117–120] The effect of introducing a 
1,4,7,10-tetraazacyclododecane derivative, see Figure 3.4, was reported[121] for the hydrolysis 
of fluorescein diacetate (FDA) which revealed a 25-fold rate increase when embedded in a 
membrane structure compared to solution. The rate increase was found to depend on the 
fluidity of the membrane structures where a more flexible membrane allowed for more 
pronounced cooperativity. 
 
Figure 3.4. The structure of the lipophilic metal complex using a dinuclear arrangement of 1,4,7,10- 
tetraazacyclododecane monomers. 
Similar complexes have been used to study vesicle-based phosphate diester 
hydrolysis[122] and have been reported to result in substantial rate accelerations compared to 
the equivalent solution-based structures, see Figure 3.5. The mononuclear solution-based 
catalyst was reported to provide 3 orders of magnitude rate acceleration when covalently 
bound in a dinuclear fashion as can be seen illustrated by the middle structure in Figure 3.5. 
When the mononuclear complex was embedded into a vesicle the acceleration over the 
solution-based system was up to 7 orders of magnitude. These experiments were carried out at 
pH 8 but they are still remarkable since the relative rates for the vesicle based hydrolysis of 
BNPP at pH ≈ 7 is 5 orders of magnitude faster than the background reaction. The reactivity 
of flexible structures containing mononuclear complexes that are held in close proximity to 
each other through non-covalent interactions has been reported using gold nanoparticles.[123–
125] The nanoparticle bound complexes could be referred to as semi-covalent systems given 





Figure 3.6. Although these structures are relatively rigid, they arguably become more similar 
to membranes when used in conjunction with long flexible complexes.  
 
Figure 3.5. The Zn(II) catalysts used in the highly reactive vesicle system reported by König et al.[122] 
The investigation of HPNPP transesterification promoted by the complexes in       
Figure 3.6 shows that the incorporation of the 1,4,7-triazacyclononane (TACN) complex into 
a nanoparticle system significantly increases the rate of the reaction.[123] 
 
Figure 3.6. The relative rates for transesterification of HPNPP were normalised to the mononuclear 
complex and revealed a 4-fold and 629-fold rate acceleration for the micellar complex and the 
functionalised nanoparticle, respectively. 
Despite the fact that the micellar complex is more reactive than the mononuclear 
equivalent it is still 2 orders of magnitude slower than the nanoparticle system.Bonomi et 
al.[126] reported the activity of a similar system for the hydrolysis of the DNA model 



































Figure 3.7. The relative rate constants observed for the hydrolysis of BNPP for the covalently linked 
dinuclear Zn(II) complex (left), the mononuclear complex (middle) and the nanoparticle based complex 
(right). 
was compared to the nanoparticle system which revealed over 2 orders of magnitude higher 
reactivity in favor of the latter. Interestingly the reactivity of the flexible nanoparticle system 
is significantly higher than the covalently linked dinuclear equivalent. Even the mononuclear 
complex appears more reactive than the dinuclear complex despite the fact that the binding 
constant for dimethylphosphate (measured by its inhibition effect) is 3-fold greater for the 
latter. 
Recently a gold nanoparticle system was reported to cleave HPNPP with a second-order 
rate constant of 250 M-1 s-1, see Figure 3.8, representing the most reactive Zn(II) based system 
in aqueous media to date.[68] The structure is very similar to the previously reported TACN 
nanoparticle system. The two most reactive systems studied indicate a substantial effect of the 
linker length on the reactivity. The observed reactivity appears to be highly dependent on the 
environment around the catalytic units since the introduction of a more polar polyethylene 
glycol linker reduces the activity of the system. 
Remarkably the increased rates seem to be mainly due to an increase in kcat since the KM 
is very similar between the structures. An orthogonal measure for the lipophilicity of the 
nanoconstruct was obtained using the compound 6-nitrobenzisoxazole-3-carboxylate (NBIC) 











































for NBIC correlates well with the difference in reactivity of the nanoparticle system observed 
for HPNPP transesterification which led to the conclusion that the reduced polarity of the 
environment around the nanoparticles is the largest contributor to the observed reactivity. 
 
Figure 3.8. The structure of the linker between the gold nanoparticle and the catalytic head group appears 
to significant affect the activity of the system. 
The reactivity of the hydrolytic systems presented above is cooperative and thus the 
association enhances the reactivity non-linearly with respect to the complex concentration. 
The embedding of structures into membranes has proven this to be the case for many 
complexes and is therefore a tantalisingly simple method of achieving cooperative reactivity. 
 
3.2 - Aims 
 
The aim of the membrane based complexes is to examine the potential for association of 
mononuclear complexes on the surface of vesicles to yield more reactive systems. The non-
covalent association on the surface of vesicles permits the formation of more flexible catalytic 
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3.3 - Synthesis of the membrane ligands 
 
Ligands L3-1 and L3-2 were synthesised using the same procedure used for the 
synthesis of L2-3, see Chapter 2, using the precursor tert-butyl N-[6-(iodomethyl)-2-
pyridyl]carbamate (X3). The precursor (X3) was reacted with either hexadecylamine or 
butylamine in dry DMF with DIPEA at 70 °C for 12 hours, see Scheme 3.1.  
 
 
Scheme 3.1. The synthesis of L3-1 (top) and L3-2 (bottom) from the same precursor X3. The yields were  
55 % and 100 % for L3-1 and 60 % and 100 % for L3-2 for the respective synthetic steps. 
 
3.4 - Results and discussion 
 
The membrane-like structures used in this study are vesicles based on a phospholipid 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or a quarternary alkyl amine 
dimethyldioctadecylammonium chloride (DMDODA). The structure consist two layers of 
surfactant molecules arranged with their lipophilic appendages facing each other and the 
hydrophilic head groups facing the solution. This structure is usually referred to as a 
membrane bilayer or vesicle, see Figure 3.9. 
The methods by which the vesicles were produced are discussed below but the main 
feature of interest is the lipophilic inner layer that allows hydrophobic alkyl anchoring. A 
concern in terms of size is the potential issue of light scattering affecting the UV 
measurements thus initially 50 nm vesicles were made. 
Among the first compounds to be considered in this project for studies of membrane 
based interaction was the 2-aminopyridyl ligand, see Figure 3.10. The Zn(II) coordinating 

















Figure 3.9 The schematic structure of the surfactant and the vesicle. 
Although complex 2-4 was more reactive it was also less stable in solution. The aim 
was to study if it was possible to achieve similar activity as seen for 2-3 simply by 
encouraging non-covalent interaction in solution.  
Cholesterol is a component of natural cell membranes and had successfully been used to 
embed cholesterol-dansylamide probes into membrane surfaces.[115] Although initial attempts 
were made to synthesise the compound it was abandoned in favor of the simpler alkyl ligands 
that could be synthesised in two steps starting from the intermediate (X3), see Scheme 3.1. 
 
Figure 3.10. The proposed structure for the potential cholesterol ligand. 
The use of a long aliphatic tail allows the complex to embed itself into the membrane 
and freely associate with other monomeric units thus avoiding the use of the alkoxy-bridging 

















The structural requirements for the membrane complex 3-1, see Figure 3.11, are simple 
and include a lipophilic tail and the catalytic head group comprised of the monomeric Zn(II) 
binding 2-aminopyridyl moiety. Due to the polar Zn(II) complex component, the structure of 
the complex is very similar to a surfactant. The monomeric complex 3-2 serves as a control 
compound that mimics the catalytic head group of 3-1 but lacks the means for a strong 
lipophilic interaction with membranes. 
 
Figure 3.11. The structure of the membrane embedding complex 3-1 and the water soluble control 3-2. 
Complex 3-2 is not only a control compound for 3-1 but can arguably also be used as a 
comparison to 2-3 despite the lack of the coordinated alkoxy group. The simple mononuclear 
3-2 was initially envisioned to reach the reactivity of the complex 2-3 if it could be held in 
close proximity to another unit of 3-2. The potential added advantage of 3-2, apart from 
flexibility, is avoiding the reduction in Lewis acidity of the Zn(II) and electrostatic repulsion 
of the anionic substrate due to the alkoxy-bridging unit. 
The complexation of ligand L3-1 with Zn(OTf)2 was analysed using NMR 
spectroscopy, see Figure 3.12, in MeOD-d4 due to the poor solubility of the compound in 
D2O. The concentration of ligand is significantly higher than for the kinetic experiment but 
was necessary due to the set parameters of the NMR spectrometer. The NMR spectrum of 3-1 
is consistent with a 1:1 complex and shows that a complex is formed. 
The membrane interaction is based on the idea of introducing a catalyst containing a 
long alkyl tail into the lipophilic layer of a membrane. The structure itself is made up of a 
surfactant, in this case DMPC, which is from the phophatidylcholine family of lipids, see 
Figure 3.13, and is one of the major components in biological cell membranes.  
DMPC vesicles were made by dissolving the surfactant in the desired buffer and using a 
bespoke syringe as an extrusion device. The liquid was passed through a silicone membrane 





     
Figure 3.12. The partial 1H-NMR spectrum in MeOD-d4for L3-1 60 mM (top) and after addition of 60 mM 
Zn(OTf)2 complex 3-1 (bottom).  
vesicles which reduce the effects of light scattering (increases with size) that would interfere 
with the measurements if larger structures were made. 
 
Figure 3.13. The structure of the phospholipid 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 
The liquid was passed through the membrane 21 times ending on the opposite side to 
the initial state (i.e. an odd number of extrusions) to eliminate any risk of retaining structures 
in the initial solution that were larger than specified. 
 
Figure 3.14. An illustrative drawing of the membrane extrusion device with the 50 nm pore membrane 
(red) in the middle. 
The size of the vesicles are only stable for a few days (3-4 days) if the solution was kept 
at 4 °C and thus the time window for reproducible experiments is limited. Another issue that 
needs to be considered is the “flip-flop” mechanism, see Figure 3.15, which allows the 
movement of the membrane components between the inner and outer leaflets. This is not an 
issue when the structure is entirely homogeneous since the movement occurs in both 
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on multi-component systems working in conjunction with each other and are therefore not 
homogeneous. The introduction of an alien component into one leaflet of a preformed 
membrane leads to a concentration gradient between the outer and inner leaflet and since the 
membrane structure is fluid a dynamic equilibrium will be established over time. 
 
Figure 3.15. An illustrative example of flip flop between the outer and inner leaflet of a membrane bilayer 
(top). The representation of the DMPC (red) and 3-1 (green) as presented in the membrane (bottom). 
In the case of DMPC the half-time for the flip-flop has been determined using exchange 
experiments at 50 °C and estimates the upper limit to be around 40 minutes.[127,128] The flip-
flop rate will not translate directly to the case of 3-1 but since we are not investigating that 
particular mechanism the estimation for DMPC serves as a useful approximation for the 
longest time that the system requires to reach equilibrium. It has previously been suggested 
that cationic species might actually have a shorter half-time for the flip-flop mechanism.[115] 
The practical implications of this is that if the progression of the reaction is monitored on a 
time scale similar to that of the intramembrane flip-flop the effective concentration of catalyst 
exposed to the solution will be varying. This was not taken into consideration for the initial 
experiments since the aim was to qualitatively verify the existence of reactivity. 
The initial experiments were performed using vesicles made from 200 µM DMPC with 
a 10 % loading of the catalytic complex 3-1 at pH 7.4 and 50 µM HPNPP with 0.1 M ionic 
strength (NaNO3). The vesicle solution was incubated with the complex for approximately 10 
minutes prior to the addition of the substrate. No reaction was seen over 2 hours which led to 
the conclusion that the complex was either too dilute or being inhibited by the DMPC.  
DMPC contains a phosphate diester with aliphatic ester groups that is very unlikely to 
Half time = 0.7 h
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hydrolyse by action of the catalyst but is nevertheless a potential candidate for binding to the 
complex, inhibiting potential action on the substrate. Given the position of the phosphate 
group at the vesicle interface it is very likely that the high local concentration of the DMPC 
competes with the relatively low solution concentration of HPNPP. Similar Zn(II) complexes, 
see Figure 3.16, have been used as fluorescent probes for phosphatidylserine in biological 
systems which further supports these concerns.[129,130] The dinuclear complex 2-3, see  
Chapter 2, has been reported to bind tightly (Kd ≈ 80 nM) to lipopolysaccharide (LPS) 
attached to gold surfaces.[131] 
 
Figure 3.16. The structure of the Zn(II) complexes used in literature for phosphatidylserine 
detection.[129,130] 
The likelihood of inhibition of the complex by DMPC was addressed by simply 
introducing the surfactant as an “observer” in a reaction involving the substrate and a catalytic 
complex of known activity. Complex 2-3 is the dinuclear equivalent of 3-1 and was expected 
to provide a reasonable benchmark for the potential inhibitory effect of DMPC. The 
experiments were performed using 100 µM 2-3 and 20 µM HPNPPi and then repeated to 
include 10 µM DMPC vesicles, see Figure 3.17. There was no difference in the rate of 
reaction between the two experiments and the conclusion is that the DMPC does not inhibit 
the reaction.  
There have been similar phospholipids used in conjunction with metal complexes that 
catalyse phosphate diester hydrolysis and no inhibition has been reported by the 
surfactant.[122]  
The concern regarding the concentration of the complex was tested using 2-3 at varying 
concentrations and monitoring the reactivity. The concentration of 20 µM 3-1 at which 
activity was not seen would create 10 µM of dimer, and so this is the key concentration for 













































Figure 3.17. The observed effect of DMPC on reactivity of 100 µM 2-3 studied using 20 µM HPNPPi (red) 
and after the addition of 10 µM DMPC (blue). The activity was monitored at pH 7.33 in 50 mM HEPES 
and 0.1 M ionic strength (NaNO3). 
This experiment was also performed for 3-2 which yielded the same result i.e. a 
complex concentration of 20 µM is too dilute to observe activity as can be seen in          
Figure 3.18.  
Since it is clear that a higher effective (i.e. locally within the supramolecular structure) 
concentration of 3-1 is likely required to observe activity, the formation of micelles using 
complex 3-1 alone was investigated. Given the structure of 3-1 it could potentially behave like 
a surfactant and therefore it is worth trying to form micelles at similar concentration (20 µM) 
as previously investigated with DMPC. This experiment would prove whether it was possible 
to form stable/reactive micelles in solution using only 3-1 and achieve the maximum surface 
concentration of the complex. 
Reaction progress was monitored at 400 nm after the addition of 3-1 to a buffered 
solution containing HPNPP. An increase in absorbance was observed over 10 minutes which 
would suggest significant activity although not as reactive as 2-3. Upon closer inspection of 
the reaction mixture it was apparent that the increase in absorbance was not due solely to a 
specific band at 400 nm that corresponds to product formation, and so this change could not 
be clearly assigned to the transesterification reaction. A UV-scan from 200-600 nm confirmed 
that the increased absorbance was actually caused by light scattering of the complex, 






















Figure 3.18. The activity of 3-2 at 20 µM (red), 200 µM (blue) and 400 µM (green) with 50 µM HPNPPi in 
50 mM HEPES at pH 7.32 and 0.1 M ionic strength (NaNO3). 
wavelength spectrum. The same changes were observed even in the absence of substrate and 
so any potential reaction can only be a small fraction of the observed changes in absorbance. 
A more thorough attempt to form soluble structures using only 3-1 was made were        
1 mM 3-1 was added to a solution containing 50 mM buffer and sonicated, see Figure 3.19. 
Sonicating the solution reduced the size of the light-scattering structures but the solution was 
not stable and a few minutes after sonication the absorbance increased. It was concluded that 
the complex does not form stable structures in aqueous solutions without the aid of other 
surfactants at these concentrations. 
Since the DMPC vesicles had a limited lifetime and with limited access to the 
membrane extrusion device, the procedure for the micelle/vesicle manufacture was changed 
to sonication using Sanyo Soniprep 150 with a titanium probe (10 µm amplitude for 2 min). 
The vesicles were studied in solution using dynamic light scattering (DLS) and the 
structures were found to be relatively uniform in size (50 ± 3 nm). The surfactant was also 
changed to a simpler tetraalkyl amine, dimethyldioctadecylammonium chloride (DMDODA), 
see Figure 3.20.  
The long alkyl tails forms a lipophilic layer that could potentially accommodate the 
aliphatic anchor of 3-1 and the cationic head group eliminates the risk of an inhibitory binding 




















Figure 3.19. The attempted formation of stable micelles using 1 mM 3-1. The initial conditions were 50 
mM HEPES buffer at pH 6.9, 0.1 M ionic strength (NaNO3) and 50 µM HPNPPi (green) after which 3-1 
was added (red) and sonicated (blue) but a few minutes later the absorbance was increasing (black). 
The surfactant stock solution was made by dissolving solid DMDODA in water to 
approximately 10 mM and sonicating the mixture until a homogeneous cloudy solution was 
obtained. 
 
Figure 3.20. The structure of the surfactant dimethyldioctadecylammonium chloride (DMDODA). 
The catalyst was added to water together with surfactant prior to sonication. The 
complex 3-1 (2 mM) was sonicated together with DMDODA (2 mM) for approximately         
5 minutes using a titanium probe sonicator until the solution turned clear. The solution was 
allowed to cool down to ambient temperature and the subsequent experiments were performed 
using 50 mM HEPES buffer at pH 6.9 and 50 µM HPNPP with 0.1 M ionic strength (NaNO3). 
 Under these conditions, there was obvious precipitation in the reaction solution. This 
seems to indicate that the complex was not stabilised enough by the DMDODA to remain in 
solution. Additional experiments revealed that the source of the precipitation was mainly 
DMDODA that interacts with the salt (NaNO3). The influence of the salt on precipitation 






















The same result was obtained with NaCl and the decision was made to omit the salt 
altogether from subsequent experiments since the surfactant itself was found to precipitate.  
This method of formation of the vesicles with the complex 3-1 leads to a homogeneity 
between the inner and outer leaflet of the structure and it is therefore not necessary to account 
for the flip flop mechanism (see Figure 3.15). If this assumption is correct the effective 
concentration of 3-1 exposed to the bulk solution on the exterior of the vesicle would be half 
the total concentration of 3-1. The experiments presented here have not been corrected for the 
effective concentration and simply use the bulk complex concentration. 
Initial experiments with 3-1 were performed at pH 6.9 and a complex concentration of  
1 mM with 100 µM HPNPP and no salt to control the ionic strength, see Figure 3.21. The 
reaction was confirmed by UV-vis analysis that showed an increasing absorbance band at  
400 nm that was consistent with the release of 4-nitrophenolate.  
 
Figure 3.21. The initial rate of reaction of 1 mM HPNPP in the presence 1 mM 3-1 in 1 mM DMDODA at 
pH 6.9 in 50 mM HEPES. 
Observed rate constants were determined from the initial rate of the reaction and the 
apparent second-order rate constant from this initial test was estimated to be 0.7 M-1 s-1 at    
pH 6.9, see Table 3.1. 
Further experiments with the HPNPP were performed using complex 3-1 and 
complex3-2 as a control in a solution with DMDODA at various pH. The less lipophilic 



























Experiment Initial rate (× 10-7) (M s-1)  k2 (M-1 s-1) log k2 
1 6.86 (± 0.02)  0.69 (± 0.002) -0.16 
2 7.10 (± 0.07) 0.71 (± 0.007) -0.15 
 
Table 3.1. The apparent second-order rate constants for the transesterification of HPNPP catalysed by 
complex 3-1 performed in duplicate at in 50 mM HEPES at pH 6.9. The second-order rate constants were 
calculated from the initial rate divided by the concentration of the complex and substrate. 
localisation of the complex at the aggregate interface.The experiments were performed using 
1 mM complex in 1 mM DMDODA and 100 µM HPNPP at pH 7 – 10 with no salt to adjust 
ionic strength. The solution stability of the aggregates seemed to deteriorate with increasing 
pH and this was particularly evident for complex 3-1 above pH 8. It is not clear why this is 
the case but it does indicate a difference in behavior compared to 3-2. A single ionisation 
model was fitted to the data obtained for 3-2 plotted versus pH, see Figure 3.22, using 
Equation 3.1, see Chapter 8.3. Although the complex 3-2 has two ionisable species (metal 
bound water molecules) only one deprotonation can be assigned with certainty since the 
second deprotonation occurs at a pH outside the monitored interval.  
 =  	× 	 
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[]   (Equation 3.1) 
 
Figure 3.22. The apparent second-order rate constant at varying pH for the transesterification of HPNPP 
(1 × 10-4 M) using 3-1 (red) and 3-2 (blue) both at 1 × 10-3 M with DMDODA 1 × 10-3 M in HEPES/CHES 






















The kinetic complex pKa and k2max were determined for 3-1 and 3-2. The rate constant 
for the transesterification of HPNPP by 3-1 measured at pH 8.7 was excluded from the fit 
since the stability of the complex in solution deteriorates at high pH. The first pKa (pKa1) for 
complex 3-1 (7.30 ± 0.11) and 3-2 (7.68 ± 0.07) are relatively similar although the limiting 
second-order rate constants differ by more than one order of magnitude, 0.16 (± 0.01) M-1 s-1 
and 3.59 (± 0.43) M-1 s-1, respectively. The first deprotonation (pKa1) leads to the active 
complex being formed and the second deprotonation (pKa2), which was not accurately 
determined here, leads to reduced activity due to formation of the inactive complex, see 
Scheme 3.2. 
 
Scheme 3.2. The proposed protonation states for the complex 3-2. 
The obtained rate constant and kinetic pKa-value were in good agreement with literature 
data for the complex 3-3 which differs from 3-2 by one methyl group, see Figure 3.23.  
 

























































Complex 3-3 had been analysed with HPNPP (and BNPP) from which the kinetic pKa 
were obtained. The complex has also been potentiometrically titrated and the results are 













3-2 7.68 (± 0.07) - - - 0.16 (± 0.01) 
3-3 7.7 10.7 8.01 10.18 0.28 
 
Table 3.2. The rate constants with HPNPP pKa for 3-2 compared to 3-3 from literature.[14]  
Given the remarkable effects of CO2 on 2-3, the effects on 3-2 were explored. The 
treatment of 3-2 with CO2 led to a significant reduction in observed activity although the 
effect was not as dramatic as for 2-3, see Figure 3.24. 
 
Figure 3.24. The effects of CO2 on the reactivity of 1 mM 3-2 with 50 µM HPNPPi in 50 mM HEPES at pH 
7.4 and 0.1 M ionic strength (NaNO3). The unaltered reaction (blue) and the CO2 treated (red). 
A more detailed investigation of the inhibition by carbonate is seen in Figure 3.25 for 
the assumed competitive inhibition[51] by Na2CO3. Equation 3.2 yielded a good fit to the plot 
where k equals the observed rate constant, k0 the observed rate constant in the absence of 




























The Ki is estimated to be approximately 0.79 (± 0.04) × 10-3 mM, see Figure 3.25, 
which is relatively close to the estimated Ki of 1.20 mM for complex 2-1. The only available 
experimental data for inhibition obtained for 2-3 to compare with these data are for 
dimethylphosphate (DMP) which was estimated to be 0.60 mM at pH 6.9 (0.37 mM in 
previous report[51]). Since there is no experimental data for Na2CO3 inhibition for the complex 
2-3 the comparison can only be qualitative.  
 
Figure 3.25. Inhibition by Na2CO3 of the action of 1 mM 3-2 and on 50 µM HPNPPi in 50 mM HEPES at 
pH 7.4 in 0.1 M ionic strength (NaNO3). 
It is clear that complex 3-2 is not as strongly inhibited by the carbonate as the dinuclear 
complexes. This is not surprising given the bridging bidentate fashion with which the 
carbonate is likely to bind to the dinuclear complexes, see Figure 3.26.  
 



















The fact that the Ki for the inhibition by DMP of 2-3 is so low would indicate the Ki of 
the dianionic carbonate would be significantly lower.  
In keeping with the previous comparison between the mono- and dinuclear complexes, 
2-3 and 3-2, a mononuclear equivalent of 2-4 was synthesised. Ligand L3-4 was synthesised 
using the same procedure as for 3-2 but using the precursor tert-butyl N-[6-(iodomethyl)-2-
pyridyl]-N-methyl-carbamate (X4), see Scheme 3.3.  
The highly reactive complex 2-4 suffered significant drawbacks in terms of pH 
instability and therefore could not be fully investigated. The mononuclear analogue could 
possibly display a more stable behavior over a wider pH range and indicate the true role of the 
methylamino group in the 2-pyridyl position. 
 
Scheme 3.3. The synthesis of ligand L3-4 from the precursor X4. The yields were 51 % and 90 %, 
respectively. 
Unfortunately L3-4 was not analysed kinetically partly due to problems related to 
solubility and precipitation under the experimental conditions. The high activity observed for 
2-4 could be due to the methylated amino functionality in the 2-pyridine position forming a 
less polar environment around the catalysts which has been reported to increase reaction 
rates.[69,122] 
For many reactions performed in MeOH the observed rate constants have been reported 
to increase compared to water.[69,132] The effects on the reaction rate that have been observed 
in the membrane interface compared to free solution reactions can indicate the level of MeOH 










The improved rates for the membrane bound complex could be due to either the reduced 
polarity at the membrane-solution interface or due to the formation of a dinuclear-like 
structure through complex-complex association. Saturation experiments in the presence of 
surfactant would indicate if the observed rate increase is due to tighter binding or higher 
reactivity of the bound substrate. Varying the ratio between surfactant and complex would 
reveal whether it is the environment or the association of the complexes that causes the 
observed effect. 
It is not entirely clear whether it is the formation of dinuclear-like structures or medium 
effects that causes the observed rate increase although it has previously been suggested that 
the main contribution is due to the latter for nanoparticle based systems. Additionally, the 
effect of the less polar medium on reactivity appears to be greater for kcat than KM which does 
not change as much.[68] 
It has been reported by Scrimin et al. that substrates that decrease the polarity of the 
nanoparticle monolayer affect the reaction pathway.[133] This suggests that embedding the 
catalytic head group further down in the lipophilic membrane might affect the reactivity since 
the environment becomes less polar than at the interface. 
 
3.5 - Conclusion 
 
The observed difference in rate of phosphate diester hydrolysis for the vesicle based 
system 3-1 compared to the solution based system 3-2 was determined to be more than 1 
order of magnitude in favor of the former at pH 6.9. 
Without further experiments detailing the effect of changing the local environment 
around the complex versus the association of complexes in supramolecular structures it is 
difficult to confidently assign the reactivity to a certain property or behavior of the complex. 
It is clear that there is a significant change upon addition of the complex to the 
membrane structure and it would therefore be interesting to study the behavior of the 
preformed dinuclear complex 2-3 in this environment since that would reveal the contribution 




3.6 - Future work 
 
Given the observed effect of the vesicle structure presented herein and the reported gold 
nanoparticle systems in literature, the use of reactive membrane-like environments appears to 
be a viable alternative to reactions in solution. There has been a lot of research related to 
reactive nanosystems which implies its potential.[134] 
The introduction of a dinuclear complex 2-3 into a membrane would indicate the effect 
of the environment compared to 3-1. In order to efficiently embed the dinuclear complex 2-3 
it would be necessary to modify its structure to include a membrane embedding structure, see 
Figure 3.27.  
 
Figure 3.27. The suggested structure of potential membrane embedding dinuclear complexes. 
Another interesting system that could be used to study the membrane-like structure that 
share similarities with both the surfactant based vesicles and the nanoparticles is the use of 
core-polymerisable micelles, see Figure 3.28. These systems could be designed to form 
micelles in solution of a certain size and composition followed by polymerisation to stabilise 
the structure formed. This structure would also make adjustments of embedding depth 
possible by copolymerisation with polymerisable lipophilic molecules of various lengths.  
It is also possible to pre-associate the complexes in the desired catalytic arrangement 
using substrate analogues. The best explanation to date for the catalytic activity of the 
membrane-based complexes is the reduced polarity of the environment although the exact 
interactions are not well understood. If the medium effect is the main contributor to the 
reactivity it is possible to imagine that the design of a solvent excluding environment could 
lead to a highly reactive system. 




Figure 3.28. The proposed structural analogue of membranes using polymerisable complexes. 
The use of templating in polymerisation could also be applied to more complex 
structures where the catalytic structure internalised in a less hydrophilic environment than the 
membrane-solvent interface. Although these structures would be more rigid than in the 
membrane structure the use of substrate templating should provide the complexes in the most 
appropriate configuration. 
An example of this can be found in the work by Zhao et al. where the lipophilic 
environment is suggested to accelerate the nucleophilic reactions by several orders of 
magnitude. [135] They used simple surfactant place holders in the micelles that did not contain 
a polymerisable functionality. The non-covalently bound surfactants can diffuse out of the 
structure post polymerisation which leaves channels into the lipophilic core that can 
accommodate the substrates. 
A similar structure is not farfetched from a synthetic view point in the case of phosphate 
diester hydrolytic complexes since there are a multitude of commercially available 
polymerisable units that could be incorporated in the structure of a metal complex. These 
approaches provide a variety of possible environments that could be used to explore the 

















Chapter 4 - Peptide based complexes 
 
4.1 - Introduction 
 
The use of peptidic scaffolds for catalytic purposes is the quintessential design of 
enzymes in nature and it is therefore logical to extend this concept to artificial catalysts that 
aim to mimic enzymatic activity. This research field began with the studies of the structures 
of natural enzymes but has boldly evolved into de novo design of artificial peptidic 
scaffolds.[108,136–138] 
The disadvantages of enzymes and large proteins in terms of the bulkiness of their 
structure and their inherent structural vulnerabilities (temperature, pH, degradation etc.) can 
be at least partially circumvented if smaller peptidic analogues are used. 
 
Figure 4.1. The structure (monomer) of the E-coli alkaline phosphatase enzyme. The structure contains   
α-helices (green), β-sheets (red) and random coils (yellow) (PDB code: 3TG0).[45] 
The central structural features of the active sites of enzymes can be simulated using the 
structural units that are available in peptide chemistry (α-helix, β-sheet or random coil), see 
Figure 4.1. These structures provide a scaffold that is better defined than membranes but still 
allows for flexibility. The final structure depends on the linear peptide sequence which can be 
altered to include residues with varying structural propensity.  
It is worth noting that linear peptide sequences have been used to promote internuclear 
association, see Figure 4.2. These compounds use the linear distance between the residues in 
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the structure of the peptide.[130,139] The interactions cannot be said to employ supramolecular 
non-covalent interactions but rather uses spatially controlled intramolecular association due to 
the intrinsic spacing in the sequence. 
 
Figure 4.2. The polyglycine is used as a linear spacer between the Zn(II) nuclei. 
The role of the well defined protein structure is to arrange the relevant residues that are 
involved in catalysis to interact in the enzyme's active site. This can be translated into 
structural requirements for artificial peptide-based scaffolds. It is clear that the random coil 
structure is of little help in organising a well defined structure but the α-helix and β-sheet are 
viable candidates.  
The β-sheet structure is well known for its ability to form stable structures, in some 
cases with disastrous consequences like for example Amyloid beta fibrils in Alzheimer’s 
disease.[140,141] In a less sombre context the β-sheets form extensive interactions in enzymes 
and provide essential active site residues in the desired arrangement, see Figure 4.3. The 
proximity of the β-sheet is the desired feature for simple artificial catalyst[34,142] since this 
could potentially allow for proximal incorporation of mononuclear complexes. 
 
Figure 4.3. The structure of carbonic anhydrase II (left) with the three active site histidine residues, His94, 
His96 and His119, of the β-sheet (right) visualised (PDB code: 2CBA).[45] 
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The β-sheet structure has been utilised by Yamada et al. in a cyclic peptide, see     
Figure 4.4, which incorporates two mononuclear Zn(II) complexes for HPNPP 
transesterification. 
 
Figure 4.4. The two kinetically equivalent mechanisms that have been proposed for the transesterification 
of HPNPP using the cyclic β-sheet structure (left)[143] and the helical heptapeptide (right)[144]. 
The use of helical peptide structures as general scaffolds for catalytic units has been 
reported in the literature.[145,146] The peptidic structures have been reported to catalyse the 
transesterification of HPNPP using Zn(II) in short heptapeptides that form relatively stable α-
helix structures[144,147] supporting the design concept. The heptapeptide complex, see Figure 
4.4, caused a 5-fold rate acceleration compared to the mononuclear complex. HPNPP is 
proposed to coordinate to one metal ion through the non-bridging oxygen of the phosphate 
while the other metal nucleus activates the nucleophile though direct coordination. The 
mechanism differs from the proposed double-Lewis activation of the non-bridging oxygens 
for the more closely associated nuclei of dinuclear complexes.[51]  
Helix-loop-helix structures have been extensively reviewed and studied by Baltzer et al. 
as scaffold for catalytically active residues[145,148–157] which in most cases include histidines. 
Other examples include the use of metal complexes in helix-loop-helix structures for 
phosphate binding[146] and hydrolysis[158]. The mechanism for the transesterification of 
HPNPP in the helix-loop-helix complex has been proposed to be similar to the mechanism in 
Figure 4.4.  
Another interesting example has been reported by Copeland et al. where a helical 
peptide containing a His2 coordinated Zn(II) or a β-sheet structure containing a AspGlu2 




DNA binding intercalator and a catalytic unit in one supramolecular structure is arguably a 
more accurate representation of the two processes that occur in enzymes (recognition and 
catalysis). These structures have been proven to cleave both supercoiled plasmid and linear 
DNA and are enticing given their nuclease-like two-pronged approach to binding and 
catalysis. 
 
Figure 4.5. The trihelix structure studied by Pecoraro et al. for catalytic activity. The metal binding sites 
include Hg(II) (yellow) and Zn(II) (grey) (PDB code: 3PBJ).[45] 
Pecoraro et al. demonstrated the potential to design an active site analogue of the 
enzyme carbonic anhydrase using a trimeric coiled-coil structure containing His3 coordinated 
Zn(II). Additionally, the trimer contained a thio-coordinated Hg(II) structural unit to further 
stabilise the interhelical interaction, see Figure 4.5.[160,161] 
        
Figure 4.6. The Zn(II) coordination sites in the trihelix (left) with the Hg(II) site removed for clarity and 




The helices form a central cavity around the active site which could be modified to 
mimic the interactions in the secondary coordination sphere. 
The catalytically active site containing Zn(II) is very similar to the coordination sphere 
around Zn(II) in the enzyme carbonic anhydrase II (CAII).[99] The trihelical system has the 
highest reactivity towards CO2 hydration reported for any synthetic catalyst. The reported rate 
constant for hydration for the helical system (1.8 × 105 M-1 s-1) is approximately 500-fold 
lower than for CAII (9.7 × 107 M-1 s-1).[162] The similarities in Zn(II) coordination between 
the trimeric coiled-coil structure and the CAII active site is illustrated in Figure 4.6. 
 Given the apparent success of using helices and coiled-coil structures in the literature, 
as presented above, it would conceivably be possible to employ the well-defined structure in 
our investigation.  
Coiled-coils have been extensively studied in the past and are used in several in vivo 
processes.[163,164] One particular coiled-coil structure that has got the desirable properties of 
having a well defined structure and the ability to bind the phosphate diester biopolymer DNA 
is the basic leucine zipper domain which is sometimes referred to as GCN4-bZIP, see    
Figure 4.7.  
GCN4-p1 is a 33 amino acid sequence, Ac-RMKQ LEDKVEE LLSKNYH LENEVAR 
LKKLVGE R, found in the yeast transcriptional activator GCN4-bZIP and consists of the 
leucine zipper sequence. The peptide forms a parallel two-stranded coiled-coil structure that 
has been studied extensively for its folding properties due to its relative simplicity.  
The 33 amino acid sequence is the C-terminal segment of the GCN4-bZIP protein, see 
Figure 4.7, where the N-terminal is rich in basic residues that interact with the cationic DNA. 
The helices part at the N-terminal of the GCN4-p1 where the peptide helices become rich in 
basic residues and bind on either side of the DNA helix.[165]  
There have been numerous studies conducted on the stability of the GCN4-p1 
employing N- and C-terminal truncation of the sequence. The folding properties of the 





Figure 4.7 The structure of GCN4-bZIP bound to a DNA double helix. The blue segment of the coiled-coil 
structure represents the basic residue rich sequence responsible for peptide-DNA interaction and the 
green segment represents the GCN4-p1 leucine zipper. The structure was obtained from RCSB Protein 
Data Bank (PDB code: 1YSA).[45] 
 
4.1.1 - Solid Phase Peptide Synthesis (SPPS) 
 
The first paper on solid phase peptide synthesis was published in 1963 by R. B. 
Merrifield where he described the synthesis of a tetrapeptide covalently linked to a polymer 
support.[166] The principles of SPPS are ingenious yet simple. The idea is to perform reactions 
with one reactant attached to an insoluble macroscopic solid support making purification a 
simple matter. The solid support is a cross-linked polymer with linkers to which an amino 
acid can be attached. The first amino acid forms an ester or amide bond to the solid support 
and subsequent amino acids attach to the first amino acid by formation of an amide bond in a 
condensation reaction. The reaction is usually carried out in a container with a filter on one 
end which is impermeable for the macroscopic polymer particles but allows the reaction 
solution through. This is a very simple way to separate the product from the unreacted starting 
material and reaction byproducts. The synthetic procedure is of such simplicity and so 
repetitive, see Chapter 8.9.2, that an automated synthesis machine is usually employed for this 
purpose. The chemical principles of SPPS are highly dependent on the protecting groups on 
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the amino acids. There are many different types of protecting groups that the peptide chemist 
can employ but the general idea is to have so called temporary and permanent protecting 
groups, see Figure 4.8. The temporary protecting groups are as the name implies designed to 
provide protection only for a limited period of time and are located on the growing end of the 
peptide. The permanent protecting groups on the other hand are attached to the amino acid 
side chains and are designed to resist the reaction condition during chain elongation. 
 
Figure 4.8. The schematic representation of the protecting group (PG) strategy used for Fmoc solid phase 
peptide synthesis. 
These permanent protecting groups are usually removed by the same conditions that 
cleave the peptide of the solid support. The actual cleaving of the peptide from the resin is 
usually complete within minutes or seconds, depending on the sensitivity of the linker but the 
reaction is usually allowed to proceed for up to an hour or two. This is because the permanent 
protecting groups that are supposed to be cleaved off under these conditions require longer 
exposure.  
It is worth noting that the most prevalent SPPS methodology today uses 
fluorenylmethyloxycarbonyl (Fmoc)[167–169] as the temporary protecting group, see         
Figure 4.9. Fmoc is removed in the presence of a non-sterically hindered base (usually 20 % 
piperidine in DMF) which allows the use of acid-labile protecting groups elsewhere on the 
peptide (including the linker to the solid support). This is a much safer synthesis protocol 
compared to the original synthesis proposed by Merrifield that utilised hydrofluoric acid. 
 









The couplings of amino acids in the SPPS require the use of activating agents. The 
coupling reagents promote the formation of the peptide bond by forming an activated ester, 
see Chapter 8.9.1, with the carboxyl moiety. The coupling reagents that have been used in this 
synthesis are HBTU and HATU, represented as their guanidinium salts[170] with 
hexafluorophosphate counterions in Figure 4.10. 
 
Figure 4.10. The coupling reagents used in the amide bond formation. 
Additional factors affecting the synthetic outcome of the SPPS are solvent, linker 
functionality and polymeric support. The standard solvent used for most SPPS procedures is 
dimethylformamide (DMF) unless solubility limitations prompt the use of a different solvent.  
The linkers that allow the amino acid to attach to the otherwise inert polymer can have a 
wide range of functions and degree of lability toward acids/bases. The linker functionality that 
has been used herein is the 2-chlorotrityl chloride linker, see Figure 4.11, which is arguable 
the most popular linker for SPPS. Cleavage is achieved upon treatment with mildly acidic 
conditions and yields the free peptide acid.  
 







The polymeric support that is most commonly used alongside the trityl linker is 
polystyrene. The accessibility of the internalised linker functionalities in the polymer support 
(only 1% of the linkers are on the surface) depends on the degree of crosslinking in the 
polymer (usually 1-2 %). For some purposes there might be a need to change the swelling 
properties of the polymer which can be achieved using commercial equivalents (polyamide or 
polyethylene glycols). 
The alternative approach for obtaining the peptide is enzymatic expression of proteins. 
There has been substantial development in the area of enzymatic expression of proteins using 
unnatural amino acids and post-synthesis chemical modifications of proteins.[171,172] The main 
argument against the use of enzymatic expression and in favor of SPPS is the orthogonality of 
the protecting groups in standard Fmoc-chemistry. The lack of protecting groups limits the 
possible chemical functionalisations that can be selectively preformed. Additionally, the 
enzymatic expression is usually performed on smaller scales than SPPS which limits the 
amount of product that can be obtained. 
 
4.1.2 - Circular dichroism spectroscopy 
 
Circular dichroism spectroscopy (CD) is a widely used method for analysing the 
secondary structure of proteins.[173,174] The technique is based on the circularly polarised light 
interacting with molecules of chiral character that are either chiral in nature or become chiral 
due to asymmetric binding or other interactions in their environment. Short peptide sequences 
usually adapt α-helical, β-sheet or random coil structures that each produces different CD 
profiles. Larger proteins can contain multiple segments which can each be any of the 
mentioned secondary structures.  
The CD spectra for proteins are therefore less characteristic of each individual structure 
and display weighted average spectra compared to short peptides. The protein CD usually 
presents a combined profile averaging the contribution from each structure. Although short 
peptides usually appear to adapt only one of the secondary structures it is can contain the 
characteristics of the other two. 
Alternative methods used to study peptide or protein structures include x-ray 
crystallography and NMR-spectroscopy. X-ray structures very accurately represent the atomic 
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arrangement in a protein but the disadvantage is that the crystallisation only displays one rigid 
conformation of the protein rather than the dynamic structure in solution. NMR analysis 
provides a way to analyse the protein structure in solution although the concentrations 
required for observing the NMR signals can cause precipitation of some proteins. 
Additionally, there might be a need for isotopic labeling of proteins which can be a significant 
investment of effort. 
Circular dichorism provides an easy, fast and non-destructive method for structural 
characterisation of peptides and proteins. 
 
4.2 - Aims 
 
The aim of the peptide based approach is similar to that of the membrane based 
complexes, see Chapter 3. The non-covalent association between the mononuclear peptide 
based complexes provides a more flexible system but additionally offers better control of the 
internuclear distance compared to vesicles. The peptide structure provides a more flexible 
system than the covalently bound dinuclear complexes but a more rigid system than the 
vesicles. 
 
4.3 - Results and discussion 
 
4.3.1 - The truncated GCN4 sequence 
 
The GCN4 leucine zipper was selected for the association of the mononuclear 
complexes mainly for its well-defined structure. The coiled-coil configuration provides 
structural rigidity compared to solution or membrane based interactions yet still allows for 
flexibility. The GCN4 transcriptional activator is a DNA binding protein, thus the 
incorporation of the complex into the peptide also provides a proof of concept for the future 
integration of catalyst with synthetic peptides that bind phosphate diester biomolecules. An 




The peptide is based on the coiled-coil sequence VEELLSKNWH LENEVARLKK 
LVKQGGC[175] which itself is a N-terminally truncated version of GCN4-p1, Ac-RMKQ 
LEDKVEELLSKNYHLENEVARLKKLVGER, that had previously been studied.[176] The 
truncated sequence consists of 27 amino acids forming the characteristic coiled-coil sequence 
found in leucine zipper peptides exemplified by GCN4-p1 in Figure 4.12. 
 
Figure 4.12 The homodimeric structure of the peptide GCN4-p1 as determined by O’Shea et al.[176] The 
characteristic coiled-coil intertwining of GCN4-p1 (left) and the view from the C-terminus along axis of 
the coiled coil (right) with the internal hydrophobic residues leucine/valine (blue) visible. The structure 
was obtained from Protein Data Bank (PDB code: 2ZTA).[45] 
The selected sequence that was decided upon was a short (16 amino acids) sequence 
located at the C-terminus of the GCN4-p19-35 -c” reported by Bunagan et al.[175] without the C-
terminal GC (the glycine-cysteine disulfide linker). This sequence is similar to native GCN4-
p1 in which the first two C-terminal heptad repeats have been suggested to be the likely 
sources of interhelical association.[177] 
It is worth noting that the selected peptide contains a so called “trigger” 
sequence[163,178,179] that has been found to be essential for initiation of the coiled-coil 
formation. The coiled-coil promoting subdomain has been found in many proteins to consist 
of a sequence of 13 amino acids with limited sequence variation.  
The peptide GCN4-p19-35 -c” was truncated from the N-terminus after His10 in order to 
avoid the potential interference by the amino acid as a potential allosteric coordination site for 
the Zinc (II). Since the truncated peptide lacks a chromophore, tyrosine was added to the N-
termius in order to enable UV-detection. Tryptophan was the chromophore in                
GCN4-p19-35 -c” but tyrosine is present in the native GCN4-p1. Additionally, the sensitivity of 
tryptophan to chemical modification further favors the more robust tyrosine.  
The fully protected peptide sequence was purchase from Severn biotech on a 
polystyrene solid support as Fmoc-LENEVARLKKLVKQG-2-Cl trt resin (i.e. Fmoc-GCN4-
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p1(18-33)-c”- 2-chlorotrityl resin) which is C-terminal end of GCN4-p19-35 -c” from the work by 
Bunagan et al.[175]  
The resin supported peptide can be used to obtain a longer peptide sequence growing 
from the N-terminal to mimic the GCN4-p19-35 -c”, apart from the C-terminal GC. The 
synthesis could be either step-wise using standard Fmoc chemistry or a fragment 
condensation with the truncated N-terminal sequence. 
In order to confirm the potential of the coiled-coil approach to support association of 
mononuclear complexes the distances between the Zn(II) nuclei in dinuclear complexes of 
known activity needs to be determined. The concept of introducing mononuclear complexes 
into molecular peptidic scaffolds is highly dependent on the distances in the final structures. If 
the distance between the helices is too large the mononuclear complexes will not be able to 
form dinuclear structures. The structures will therefore not be expected to provide double 
Lewis activation to the substrate and the observed reactivity will likely be that of the 
mononuclear unit. 
The most reactive Zn(II) complex towards HPNPP transesterification to date in 
literature is the dinuclear complex 2-3 studied in Chapter 2. The crystal structure published by 
Williams et al.[51] provides a good starting point from which to estimate the internuclear 
distances, see Figure 4.13. The distance between the Zn(II) nuclei can be estimated to be 3.7 
Å which is too short to allow for interactions between the coiled-coil helices since the 
interhelical distance is estimated to be approximately 6 Å. 
 
Figure 4.13. The graphical representation of the x-ray structure of complex 2-3 coordinated to 4-
nitrophenyl phosphate (PNPP).[51] The calculated internuclear distances for Zn1-Zn2 (≈ 3.7 Å) and the 

























The interhelical distance was estimated using the crystal structure for the native coiled-
coil peptide (PDB code: 1YSA), see Figure 4.25. The distance between the tertiary nitrogens 
of the ligand is slightly larger (4.9 Å) but still falls short of bridging the interhelical gap.  
These measurements of the complex 2-3 are not true representations of the length of the 
mononuclear analogue. The actual distances in these complexes needs to include the length of 
the flexible linker, see Figure 4.14, which is estimated to be 6.3 Å using molecular modelling 
of the three dimensional structure. Combining the distances relevant to these structures gives 
a total reach of two mononuclear complexes of around 12 Å in addition the distance between 
the central nitrogen of each ligand (4.9 Å). This indicates that the interhelical gap can be 
bridged with relative ease given the flexibility of the ligands. 
      
Figure 4.14. The structure of the acetylated control ligand L4-2 for the C-terminal peptide ligand L4-1 is 
presented for illustration (not from crystal structure) and the geometry was optimised using the MMFF94 
computational force field with 5 × 104 iterations.[180] The distance between the carbon of the amide 
functionality (representing the peptide backbone) and the tertiary amine (representing the central 
nitrogen in the mononuclear catalyst) is approximately 6.3 Å.[181] 
 
4.3.2 - The C-terminal functionalisation 
 
The peptide ligand was synthesised using the tert-butyl N-[6-(iodomethyl)-2-
pyridyl]carbamate precursor (X3) from Chapter 2. The propyl linker was synthesised from 
1,3-dibromopropane and attached to the Boc-protected amino pyridyl through SN2 
displacement of the iodine by the amine. The resulting intermediates L4-1’ and L4-1’’, see 












Scheme 4.1. The synthesis of the precursor for peptide complex 4-1. (i) NaN3, DMF, 70 °C, 89 %; (ii) 
Triphenylphosphine, Et2O/Hexane, 1 M HCl, 41 %; (iii) tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate, 
DIPEA, DMF, 70 °C, 37 %; (iv) H-Cube (40 bar H2 at 40 °C), Pd/C, EtOAc, 100 %. 
The peptide was purchased as Fmoc-LENEVARLKKLVKQG-OH attached to a 2-
chlorotrityl funtionalised polystyrene resin. This allows for modification of the N-terminus 
though selective coupling of various amino acids.  
The desired sequence was synthesised through standard Fmoc protocol synthesis. The 
selected sequence (Ac-YLENEVARLKKLVKQG) was synthesised using the purchased 
sequence by solid phase peptide synthesis (SPPS) adding Tyrosine (Y) on the N-terminal 
followed by acetylation. The Tyrosine was initially inserted into the sequence to provide the 
peptide with a chromophore that would allow for UV determination of the concentration. This 
became redundant in the final determination of the concentration once the intermediate L4-1’’ 
was attached as shall be presented below. 
Once the sequence was synthesised it was cleaved off the solid support using mildly 
acidic conditions (1-5% TFA/DCM) that leaves the permanent side chain protecting groups 
intact, see Figure 4.15.  
The attachment of the precursor ligand L4-1’’ to the peptide proceeds through standard 
amide bond formation using the HBTU or HATU activated C-terminus of the peptide 









Figure 4.15. The fully protected Ac-YLENEVARLKKLVKQG-OH with the carboxyl on the C-terminus 
unprotected. 
The precursor L4-1’’ was attached to the peptide Ac-YLENEVARLKKLVKQG-OH and 
purified by extraction. The fully protected product was deprotected using the cleavage 
mixture TFA/TIS/H2O (90/5/5) and subsequently purified using HPLC to afford the product 
L4-1. 
 
Scheme 4.2 The coupling of L4-1’’ to the peptide yielding L4-1. The yield was 5 % over 2 steps. 
Ligand L4-2 was synthesised as a control compound to determine whether the peptidic 
scaffold contributes to association and if the concept of association promoted rate acceleration 
introduced in Chapter 3 holds true. 
The ligand was synthesised in the same way as described for the precursor L4-1’’ 














Scheme 4.3. The synthesis of compound L4-2. The yields were 42 % and 39 %, respectively. 
TFA/DCM (90/10) in order to remove the protecting group and purified to yield compound 
L4-2, see Scheme 4.3.  
In order to obtain accurate data for the structural and kinetic experiments with the 
peptidic complex 4-1 it is important to determine the concentration as precisely as possible. 
Given the small scale at which the compound L4-1 was synthesised and its polar nature, it is 
highly likely that the peptide retains relatively large amounts of water even after freeze 
drying. It is therefore reasonable to assume that the gravimetric analysis is not the best way to 
determine the amount of L4-1. UV analysis of L4-2 should provide an accurate estimation of 
the amount of L4-1 obtained. 
  
Figure 4.16. The UV absorbance traces (left) for L4-2 (red) and peptide L4-1 (blue) shown and the linear 
fit of the calibration curve for L4-2 from the absorbance at 295 nm (right). 
The concentration of the peptide was determined using a calibration curve obtained 
from UV measurements at various concentrations of ligand L4-2, see Figure 4.16. Compound 
L4-1 was diluted and the absorbance reading was intrapolated in calibration curve yielding a 
total estimated amount of approximately 15 mg L4-1.  

































































Figure 4.17. The observed rate constant versus pH for 4-1 (blue) and 4-2 (red). The concentrations of the 
complexes were 0.4 mM and 1 mM, respectively, but the rate constants were normalised at 1 mM complex 
concentration. The substrate was 50 µM HPNPP and the buffer was 50 mM HEPES or CHES with 0.1 M 
ionic strength (NaNO3). The complex 4-1 required an excess (6-fold) of Zn(OTf)2 for activity to be 
observed possibly due to some interfering coordination of the metal ion to other residues in the peptide 
sequence, see Figure 8.14 in Chapter 8.9.4. 
ligand versus the reactivity of the corresponding non-peptidic ligand L4-2. The two-fold 
ionisation model, Equation 4.1, see Chapter 8.3, was fitted to the data although the second 
deprotonation pKa2 was not well defined by the data points in Figure 4.17 and was instead 
fixed to the value obtained from the potentiometric titration, see Table 4.1. The kinetic pKa1 
for 4-2 was determined to be 7.96 (± 0.03) and the limiting pseudo-first-order rate constant for    
1 mM complex was determined to be 3.73 (± 0.15) × 10-4 s-1. 






&[][]L (Equation 4.1) 
The complex 4-2 was also titrated potentiometrically and the determined parameters are 
shown in Table 4.1. The potentiometric pKa1 is in good agreement with the kinetically 
determined values. 
Complex (LH2)2+ (LZn)2+ 
pKa1 pKa2 log Kf pKa1 pKa2 
4-2 7.51 5.43 6.12 8.03 10.62 
 




















Complex 4-1 was used at 0.4 mM concentration with 6-fold excess Zn(OTf)2 since 
activity was not observed at 1 equivalent metal ion. The rate at 0.4 mM was normalised to 
equal 1 mM which is in excellent agreement with the data obtained for 4-2, see Figure 4.17. 
It is evident that the observed activity for the peptidic complex 4-1 is the same as the 
non-peptidic complex 4-2 which suggests that the association between the peptide strands is 
minimal and thus the peptidic complex 4-1 behaves similarly to the non-peptidic 4-2. 
The secondary structure and potential dimerisation of the peptides was studied using 
circular dichroism (CD) spectroscopy. Compound L4-1 is clearly forming an α-helical 
structure as can be seen in Figure 4.18 characterised by a local minimum at 222 nm and a 
global minimum at 208 where the ellipticity is presented in millidegrees (mdeg). 
 
Figure 4.18 . The CD scan of 25 µM L4-1 in 1 mM HEPES (pH 7.4) at 25 °C shows the characteristic       
α-helical profile. The ellipticity is presented in millidegrees (mdeg). 
In order to study the interhelical interactions a temperature scan is required where the 
change is typically monitored at 222 nm, see Figure 4.19. The sigmoidal character of the plot 
indicates the loss of coiled-coil interaction with increased temperature and the melting 
temperature (Tm) of the dimer is determined at the inflection point.  
An issue encountered when using 100 µM 4-1 was the high absorbance (particularly at 
short wavelengths) that caused noisy, unreliable and ultimately faulty readings to be obtained 
below 205 nm at higher concentrations of L4-1. The measurements seemed to be affected by 























Figure 4.19. The α-helical profile (a) and sigmoidal temperature melting curve indicating coiled-coil 
dissociation(b, bottom) and the melting profile after guanidinium hydrochloride treatment (b, top) for the 
truncated GCN4 peptide (GCN4-p19-35 -c”) as reported by Bunagan et al.[175] Reprinted (adapted) with 
permission from Bunagan, M. R., Cristian, L., DeGrado, W. F. & Gai, F. Truncation of a cross-linked 
GCN4-p1 coiled coil leads to ultrafast folding. Biochemistry 45, 10981–6 (2006). Copyright 2006 American 
Chemical Society. 
HEPES, no NaNO3) than in the kinetic experiments. The Zn counter ion had to be replaced 
with OTf since the nitrate, and possibly residual TFA, seemed to be at least partly responsible 
for the high absorbance at shorter wavelengths.  
The CD profiles of 100 µM L4-1 in 1 mM HEPES (pH 7.4) at 5 °C and 95 °C, see 
Figure 4.20, show the decreased signal at 222 nm which is expected at higher temperatures. 
The CD temperature profile for L4-1 is not sigmoidal but rather seems to indicate a Tm < 5 °C 
which is not very useful for most practical applications.  
The CD profile for complex 4-1 (100 µM L4-1 and 1 mM Zn(OTf)2) and after the 
addition of 80 µM HPO42- to encourage potential association yielded similar melting curves. 
The change in ellipticity indicates a loss of secondary structure with increasing temperature, 
which can be expected, but the transition from coiled-coil structure to free monomers is not 
well defined (sigmoidal profile Figure 4.19). This lack of dimerisation strongly suggests that 
the results obtained for the catalytic activity of 4-1 behaving similarly to the 4-2, see      
Figure 4.17, are because both complexes are monomeric.  
It is likely that the short peptide sequence in L4-1 does not have sufficient non-covalent 
interactions to form stable dimers and it is therefore suggested that terminal covalent 




Figure 4.20. The difference of the CD profiles (left) at 5 °C (red) and 95 °C (blue). The temperature scan 
profile (right) at 222nm from 5 °C to 95 °C for 100 µM 4-1 (red) with 1 mM Zn(OTf)2 (blue) and with 1 
mM Zn(OTf)2 and 80 µM HPO42-(green). The ellipticity is presented in millidegrees (mdeg). 
The covalent bond would technically render the claim of non-covalent association 
invalid. However, the attachment at opposite ends of the peptide sequence of the two 
complexes will arguably have to involve non-covalent interactions to form the desired dimeric 
structure locally.  
 
4.3.3 - The disulfide-bridged peptide 
 
The covalent interaction that seems most appropriate to encourage association of the 
helical peptide sequences is the formation of disulfide bridges since this has already 
successfully been used by Bunagan et al.[175] The peptide GCN4-p19-35 -c” uses a C-terminal 
disulfide bridge and a similar bridge should be readily obtainable through the introduction of 
cysteine into the peptide sequence.  
Although the literature procedure uses C-terminal cysteines the purchased sequence 
would not allow for easy incorporation of standard Fmoc amino acids at the C-terminus 
without significantly altering the synthetic strategy.  
Since the procedure for introducing the ligand at the C-terminus has already been 














































interhelical disulfide bond at the N-terminus. The final ligand L4-3, see Figure 4.21, would be 
identical to L4-1 apart from the two additional amino acids.  
 
Figure 4.21. The structure of L4-3 is identical to L4-1 except for the additional N-terminal cysteine and 
Glycine. 
Building on the previously used sequence, glycine and cysteine were coupled to the N-
terminus to give, Ac-CGYLENEVARLKKLVKQG-OH. The sequence was decided upon using 
single residue mutations with crystallographic software on the structure of the native GCN4-
p1 (PDB code: 2ZTA). The selected residues ensured the closest interaction between the 
cysteine side chains (2.2 Å), see Figure 4.22. 
 
Figure 4.22. The graphical representation of the sequence CGYLENEVARLKKLVKQG with the N-
terminal cysteines visualised. The cys-cys distance was measured to be 2.2 Å.[45] 
The synthesis was performed using standard a SPPS Fmoc-protocol, see Chapter 8.9.2. 
The ligand L4-1’’ was coupled to the C-terminus as previously described.  
An indication that this approach had not proceeded smoothly was the distinct smell of 
thiol emanating from the reaction vessel after treatment with the cleavage mixture to obtain 
the ligand L4-3. Purification of the cleavage mixture was attempted by HPLC and the crude 
mixture was analysed by mass spectrometry but the efforts were fruitless. The peptide 
sequence Ac-CGYLENEVARLKKLVKQG itself, without the ligand L4-1’’, was analysed and 





The disulfide-bridged approach was envisioned to be an easy way to encourage 
association of the peptide helices but the problems encountered indicated a more substantial 
synthetic obstacle. 
It is important to keep in mind that despite the structural role of the disulfide bridge in 
many enzymes and proteins[182–186] the issue that could arise in the context of Zn(II) 
complexes is the accessibility of the thiol side chains. The cysteines might interfere with 
metal ion binding since thiols are known to coordinate to Zn(II)[40,187,188] as well as other 
metal ions like Au(I)[189] and Hg(II).[161] 
 
4.3.4 - The mid-sequence functionalisation 
 
The incorporation of a ligand is not limited to either terminus of a peptide sequence but 
in this particular case these conditions had to be adhered to. Since the peptide sequence was 
purchased fully synthesised it was not possible to selectively introduce a ligand at a specified 
position. 
If the sequence was to be synthesised from start the ligand could be incorporated as a 
Fmoc-protected unnatural amino acid. The easiest starting point is to look at commercially 
available Fmoc protected amino acids that could be functionalised on the side chain residue. 
In the context of the GCN4 peptide structure there are a number of interactions that 
need to be taken into consideration when selecting residues to replace. Certain residues play 
an important role in the dimerisation process and should therefore not be altered, see      
Figure 4.23. The helical wheel representation indicates the position of the residues that are 
involved in intra- and interhelical interactions where the heptad repeat is indicated by the 
letter abcdefg, see Figure 4.23. The core lipophilic residues are indicated by the letter a and d 
whereas the other residues interplay through electrostatic interactions (dashed lines).  
In order to achieve mid-sequence interhelical interaction between potential ligands one 
would have to try to avoid disrupting the salt bridges. The importance of salt bridges has been 
highlighted by Meier et al. for a coiled-coil peptide containing two heptad repeats. The 
targeted mutations of residues involved in an essential interhelical salt bridge lead to loss of 




Figure 4.23. A helical wheel representation of GCN4-p1 viewed from the N-terminal down the axis of the 
helices with the heptad repeat represented as (abcdefg). The dashed lines represent intra- and interhelical 
salt bridges seen in the x-ray crystal structure.[176] From O’Shea, E. K., Klemm, J. D., Kim, P. S. & Alber, 
T. x-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254, 539–44 
(1991). Reprinted with permission from AAAS. 
It appears more difficult than expected to functionalise the peptide with unnatural amino 
acids in a, at least in theory, non-offensive way. The solution would have to include plain trial 
and error in the replacement of appropriately distanced residues. It is not an entirely random 
process and there is some room for rationale. The Zn(II) complex would most probably be 
cationic and it would seem reasonable to target cationic residues for replacement.  
With all these possible ways to destabilise the coiled-coil structure it might seem like 
the mid-sequence modification of the leucine zipper peptide can be turned into a research 
field in itself. The fact that interhelical interaction are of essence to the structure clashes with 
the concept of introducing interhelical ligand interactions. This leaves the intrahelical 
interactions as a potential scaffold for the ligands since the secondary structure is more robust 
than the tertiary coiled-coil structure.  
For intrahelical interactions the most innocuous residues would appear to be the “f” 
positioned DSKN but changing these amino acids has also been reported to destabilise the 
structure.[177]  
In this particular case we will not dwell on the potential detrimental effect of residue 
replacement but rather focus on the possibility to synthesise and incorporate a catalytically 
active Zn(II) complex. 
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The initial amino acids that would be directly compatible with ligand L4-1’’ were the 
Fmoc protected Aspartic and Glutamic acids due to their carboxyl functionalities on the side 
chain. These would allow for standard amide bond formation with the amine of the ligand. It 
quickly became apparent that the stability of the Fmoc group under these conditions would be 
a problem since the free primary amine of ligand L4-1’’ could lead to deprotection.  
In the case of Fmoc synthesis there was no room for unprotected primary amines to 
participate. This also means that the reverse case is not a possibility where amino acids with 
amine functionalities on the side chains couple to carboxy-functionalised ligands. 
It is clear that an orthogonal process is needed and the most suitable approach that was 
reasonably accessible utilised the azide-alkyne cycloaddition also known as a “click reaction”, 
see Scheme 4.4. 
 
Scheme 4.4. The Cu catalysed “click” cycloaddition. 
The first ligand to be synthesised was L4-4, see Scheme 4.5, to prove the potential of 
the reaction and to study the effects of having the triazole functionality in close proximity to 
the Zn(II). The synthesis was not as effortless as the trivial name “click reaction” would 
suggest since the solubility of the starting materials in the solvent system was not very high 
(reaction in MeOH was also attempted[191]). A new solvent system (CH2Cl2/MeOH), see 
Scheme 4.5, that had been suggested in literature[192] which claimed to significantly improve 
reaction rates and yields was used instead. Despite this new solvent system being employed it 
still required multiple attempts to yield sufficient amounts of product. The removal of the 
residual Cu(I) was somewhat problematic given the chelating nature of the compound and 
adding excess EDTA was of little help in this case. Only after flash chromatography was the 
undesired metal ion removed.  
Ligand L4-4 was successfully synthesised and the reactivity of its Zn(II) equivalent 4-4 
towards phosphate diester hydrolysis was studied using HPNPPi, see Figure 4.24, a substrate 
which was first used in Chapter 3. The HPNPPi is the more reactive isomer (10-fold more 








Scheme 4.5. The synthesis of L4-4 that was used as a control for the reactivity of future triazole ligands. 
The yields were 47 % and 32 %, respectively. 
Complex 4-4 was used in 0.4 mM concentration with 50 µM HPNPPi at various pH. 
The complex 3-2 was used at the same concentration but only at pH 7.3 as a control to verify 
that the triazole had marginal effect on the reactivity.  
The single ionisation model in Equation 4.2, see Chapter 8.3, was fitted to the data in 
Figure 4.24 since the second deprotonation that is expected for the tridentate mononuclear 
complexes (see Chapter 3) was not well defined within the pH-range studied here. 
 =  	× 	 

[]   (Equation 4.2) 
The kinetic pKa1 corresponding to the first deprotonation was determined to be         
8.02 (± 0.04) and the limiting pseudo-first-order rate constant was determined to be              
3.70 (± 0.17) × 10-3 s-1 for 4-4. This is in good agreement with the reported acidity of 3-2, 3-3 
and 4-2 which indicates similarity in the microenvironment of the Zn(II). Additionally, the 
pseudo-first-order rate constant for the 4-4 is almost identical to 4-2 if the 10-fold increased 
reactivity of HPNPPi is taken into account.  
These data show that the triazole-based ligand is a viable option for introducing ligands 
into molecular scaffolds, and behaves like an inert linker. The coupling method is completely 













Figure 4.24. The reactivity of 0.4 mM 4-4 (red) and for comparison 0.4 mM 3-2 (blue) towards the 
transesterification of 50 µM HPNPPi in 50 mM HEPES/CHES at various pH with 0.1 M ionic strength 
(NaNO3). 
post synthesis of the full peptide. The only requirement is that one of the two functionalities, 
azide or alkyne, is integrated into the sequence. 
It was decided that the best course of action is to synthesise an unnatural amino acid 
containing the ligand prior to the synthesis of the peptide. This would allow direct 
incorporation of the amino acid into the sequence without further modifications. Synthesis of 
the envisioned compound L4-5’ was attempted, see Scheme 4.6, under various conditions but 
only yielded a mixture of compounds that appeared similar to the starting materials. Thus, the 
mid-sequence incorporation strategy could not be tested.  
Despite suffering a setback in the synthetic procedure the possibility of introducing 
functionalised amino acids in a controlled fashion at any desired position along the sequence 
is still tantalising. The cycloadditon reaction has been used to incorporate metal binding 
cyclams[193] into amino acids in literature which begs the question as to why the reaction 
failed in this case. The potential causes for this is that the procedure that was used in 
attempted synthesis for L4-5’ was different from the procedure reported by Todd et al.[193] 





















Scheme 4.6. The attempted synthesis of L4-5’. 
 
4.3.5 - The N-terminal functionalisation 
 
The interhelical distance for the GCN4-p1 peptide dimer is very similar at either end of 
the coiled-coil structure. The measurements between the carbonyl in the amide bonds near the 
N- and C-terminus (RMKQLEDKVELLSKNYHLENEVARLKKLVGER) were calculated using 
the crystal structure obtained by Ellenberger et al.[165] and determined to be 6.5 Å and 6.0 Å, 
respectively, see Figure 4.25.  
It is possible that the fraying might cause the distance to increase between the helices 
but that would require the sequence to be elongated towards the N-terminal to become more 
like the bZIP binding region, see Figure 4.7, or modified to remove arginine (R) and not 
acetylated to allow local unfolding.[194]  
The possible functionalisation of the N-terminal is an alternative to the C-terminal 
functionalisation since the interhelical distances will most likely be very similar. The ligand 
would be introduced at the N-terminus of the peptide sequence using the standard coupling 
procedure for amide bond formation. Ligand L4-6’ was successfully synthesised according to 































Figure 4.25. The interhelical distance near the N- and C-termius of the GCN4 leucine zipper. This is the 
same segment shown in Figure 4.7 with the N-terminus to the left and C-terminus to the right. The 
selected residues were closest to a true representation of the most proximal distance between the helices 
while still being at opposite ends of the sequence. The structure was obtained from RCSB Protein Data 
Bank (PDB code: 1YSA). [45] 
Although the disulfide-linked C-terminus approach has successfully been used in 
literature[175] this approach allows for the introduction of a covalent linker between the C-
terminus of two helices without the need for cysteine, see the section Future work.  
 
Scheme 4.7. The synthesis of L4-6’. The yields were 45 % and 100 %, respectively. 
 
4.4 - Conclusion 
 
The C-terminally functionalised peptide, L4-1 is in essence the GCN4-p118-33-c’’ with 
an acetylated N-terminal tyrosine and a deleted C-terminal GC (the glycine-cysteine disulfide 
linker). The acetylation of the N-terminus mimics the continuation of the amide sequence i.e. 
the free amino functionality is neutralised. The lack of capping has been proven to cause 
structural instability especially at lower pH for parallel coiled-coils due to unfavorable inter- 










The apparent lack of coiled-coil formation for the sequence studied here can be 
interpreted in light of the sequence truncation study by Lump et al.[194] where the N-terminal 
truncation beyond the 11th amino acid in the sequence leads to mainly unfolded peptide 
sequences. The lack of a melting temperature for the peptide structure which is evident from 
the Tm < 0 °C, despite the existence of secondary structure (ellipticity, mdeg222nm, see Figure 
4.20), is consistent with results obtained for the peptide L4-1.  
Both N- and C-terminal truncations seem to reduce the coiled-coil folding of the GCN4-
p1 which might indicate that the tertiary interactions between multiple shorter subdomains of 
the peptide is of greater importance for the folding than the helical propensity of the overall 
sequence. This concept of secondary structure domains playing an important role in driving 
the association of coiled-coil helices has also been studied by Matthews et al.[177] 
As previously mentioned one possibility to increase the interaction is making the 
peptide sequences longer to increase interaction between α-helices, although this would be 
going against the aim of making small molecular catalysts. One can argue that the peptide 
sequence will still be relatively small compared to the large protein structures of enzyme that 
we are aiming to mimic. 
 
4.5 - Future work 
 
It is worth investigating the potential of the covalent linkage between the truncated 
GCN4 sequences presented in this chapter despite the apparent lack of dimerisation between 
the helices. A potential future modification of the GCN4 sequence would be the introduction 
of an alkyl diamine that forms amide bonds at the C-terminus.  
Although the synthesis of the alkyl-linked dimer in Scheme 4.8 was not attempted the 
synthesis of the control compound L4-8 yielded a crude mixture that was analysed, see 
Scheme 4.9.  
The crude reaction mixture from the synthesis of L4-6 was analysed using LC-MS 
which appeared to contain mainly product (found m/z 543.3 [MH+]) although no further 
analysis/purification was carried out. If the association is not achieved after covalently linking 




Scheme 4.8. The proposed synthesis of the covalently linked dimer. 
The lack of dimerisation observed for the peptide sequence used here could be resolved 
by extending the sequence. The truncation of the GCN4-p1 has previously been studied, as 
mentioned above, but when the sequence is shortened the destabilising effects have been 
offset by cross-linking as in the work of Bunagan et al.[175]  
 
Scheme 4.9. The synthesis of the control ligand for the N-terminal functionalisation. 
Despite the possible introduction of a cross-linking moiety, the sequence is still 
significantly shorter than the cross-linked sequence from literature, i.e. GCN4-p19-35 -c”, 
which leaves a variable pertaining to the length unresolved. The solution is to either study the 
folding properties of the short cross-linked peptides or lengthening and cross-linking the 
sequence to resemble GCN4-p19-35 -c”.  
It is worth considering the intrahelical functionalisation of the GCN4-bZIP at the N-
terminal where the complexes are interacting with the DNA structure, see Figure 4.7, since 
this could provide a model for future DNA cleaving artificial nucleases which will be 















Chapter 5 - Nucleophilic complexes 
 
5.1 - Introduction 
 
A key structural difference between RNA and DNA is the lack of a 2’-OH in the latter. 
The difference in reactivity between RNA and DNA is approximately 5 orders of magnitude 
for the base-catalysed cleavage and is due to the presence of this intramolecular nucleophile. 
This means that the reactivity observed for some complexes towards HPNPP does not 
necessarily translate to the DNA analogue bis-(4-nitrophenol) phosphate (BNPP).[14] The 
answer to this is to incorporate a nucleophile into the structure of the metal complex that 
would in effect become an intramolecular nucleophile when the substrate binds, see       
Figure 5.1. 
 
Figure 5.1. Introducing a nucleophilic appendage leads to substantial rate increase for BNPP cleavage.[14] 
A widely used nucleophile is the alkoxide moiety that is incorporated into the metal 
complex and coordinates to the metal ion. The coordinated nucleophile provides a better 
nucleophile than metal-bound water in small mononuclear Zn(II) complexes[14,195] for the 
hydrolysis of BNPP. However, the main disadvantage with this approach is that the reaction 
principally becomes a transesterification rather than a hydrolysis. The resulting 
phosphorylated nucleophile is stable and does not dephosphorylate readily thus rendering the 
entire complex a stochiometric reagent rather than a catalyst. 
It has been reported by our lab that the use of a hydrated aldehyde nucleophile[132] 
overcomes this issue since the phosphorylated hydrate can decompose back into the aldehyde, 
releasing the phosphate. The aldehyde complex required some structural modification for 
synthetic reasons. The oxidation of the alcohol to the aldehyde led to loss of product most 
k2(BNPP) no reactivity 4.2 x 10-4 (M-1 s-1)
k2(HPNPP) 3.9 x 10
-2 (M-1 s-1) 2.1 x 10-2 (M-1 s-1)
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likely due to an elimination process, see Scheme 5.12. The methylation of the β-position of 
the alcohol resolved this issue and additionally increased the activity 6-fold compared to the 
native non-methylated complex, Figure 5.2. The reactivity of the aldehyde hydrate is equal to 
the corresponding alcohol and the reactive nucleophile has been suggested to be the non 
metal-ion bound oxygen of the hydrate. 
 
Figure 5.2. The dimethylated complexes that were reported for the hydrolysis of BNPP.[132] 
This led to the hypothesis that efficient complexes could be created by using a          
non-coordinated nucleophile. The use of a non-coordinated approach offers the benefit of 
proximal localisation of the nucleophile without the deactivating interaction with the metal 
nucleus.  
The requirement of having a coordinating atom next to a highly reactive non-
coordinating nucleophile can be satisfied by the use of hydroxylamine derivatives where the 
nitrogen coordinates and the oxygen is the active nucleophile. The hydroxyl amine (NH2OH) 
is a particularly effective nucleophile due to the α-effect (an electronegative atom with an 
unshared lone pair is directly attached “α-position” to the nucleophilic species). The influence 
of the α-effect on rate of hydrolysis of the DNA analogue 2,4-dinitrophenylethyl phosphate 
was compared to the most common nucleophile OH-. The difference in reactivity between the 
OH- and NH2O- was 735-fold in favor of the latter, despite its lower pKa.[196] 
The oxime functionality has been used successfully for the hydrolysis of carboxylic 
esters[197,198] and was initially reported by Breslow et al. in 1965.[199] The nucleophilic 
complex consisted of a pyridine oxime that was intended to serve as a model for the enzyme 
carboxypeptidase A.  
Similar oxime-containing complexes have been reported to efficiently hydrolyse 
phosphate esters.[200–202] Very recently a complex was studied by our lab using an oxime 
nucleophile, see Figure 5.3.[203] This resulted in the most reactive complex for the hydrolysis 
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of BNPP reported to date. This complex is the basis on which the nucleophilic complexes 
presented in this work were designed. 
  
Figure 5.3. The most reactive complex reported to date for the hydrolysis of BNPP.[203] 
In the previous chapter the concept of peptide-based artificial complexes was 
introduced. The complexes were primarily aimed at the transesterification of the RNA 
analogue HPNPP but this could be extended to include DNA analogues. GCN4-bZIP is a 
known DNA-binding structure which makes the incorporation of DNA-cleaving complexes a 
particularly enticing concept.  
The incorporation of the complex in Figure 5.3 into a peptide sequence would require 
some structural modification in order to introduce an anchoring point. The synthetically most 
accessible attachment points are the gem-dimethyl alkylating site (b) or the aldoxime (a), see 
Figure 5.4. 
 
Figure 5.4. The proposed sites for anchoring to the peptidic scaffold of GCN4-bZIP (left) and the ketoxime 
complex (right). 
The functionalisation of position (b) in Figure 5.4 would result in a complex that is very 
similar in structure and most likely also in behavior to the native complex. The 
functionalisation at position (a) would on the other hand yield a chemically different 












(ketoxime) compound that has not been investigated. Both approaches where considered and 
their synthetic procedures will be briefly discussed in the Chapter 5.7.  
It has been suggest that the difference between the reactivity of aldoxime and ketoxime 
pyridines towards 4-nitrophenyl acetate (pNPA) is 10-fold in favor of the latter.[204] This led 
to the synthesis of a ketoxime complex in Figure 5.4.  
 
5.2 - Aims 
 
The aim of the nucleophilic approach to phosphate diester hydrolysis is to broaden the 
group of potential substrates to include less reactive DNA-like compounds. The structure of 
the ligand is probed using methylation in order to determine the potential sites for the 
attachment of supramolecular scaffolds (for example peptides). The incorporation of methyl 
groups will also be used to study the stability of the complexes towards chemical modification 
since certain chemical modifications (oxidation) have proven to be problematic in their 
absence, see Scheme 5.12. 
 
5.3 - Synthetic procedure 
 
The synthesis of the nucleophilic side chain for ligand L5-1 was achieved by alkylating 
acetoacetamide with MeI followed by reduction using LiAlH4 according to Scheme 5.1.  
 
Scheme 5.1. The synthesis of the nucleophilic appendage for the ligand L5-1. The yields were 76 % and   
95 %, respectively. 
The nucleophilic tail was then coupled to the precursor 2-(iodomethyl)-6-methyl-
pyridine (X2) to yield ligand L5-1 using the standard SN2 procedure used for previous 








Scheme 5.2. The synthesis of L5-1 using the standard SN2 procedure from Chapter 2. The yield was 82 %. 
The ligand L5-1 was converted to L5-2 through Dess-Martin oxidation followed by 
hydroxylamine functionalisation to yield L5-3, see Scheme 5.3. 
 
Scheme 5.3. The synthesis of L5-2 and L5-3 from L5-1. The yields were 42 % and 77 %, respectively. 
The ligands were incubated with equimolar amounts of Zn(NO)3 and stored as the 
corresponding complexes, see Figure 5.5, at 4 °C until use in the kinetic experiments.  
 
Figure 5.5 The proposed structures of the Zn complexes. 
A series of pyridyl oxime compounds were synthesised, see Figure 5.6, and studied to 
investigate whether the activity of the complex 5-3 is simply due to the oxime nucleophile and 
metal ion being in close proximity to each other or if the larger structural arrangement and 
formation of a microenvironment in the catalyst is required.  
These oximes were synthesised using their corresponding aldehyde/ketone and 

































Figure 5.6 The pyridyl oximes synthesised as reference complexes for the nucleophilicity towards pNPA. 
Sigma Aldrich and used without further purification. The Zn(II) complexes in Figure 5.6 were 
kinetically analysed to see if they were as reactive as the larger complex 5-3 which includes a 
tetracoordinated Zn(II) and a different geometry of the coordinated oxime.  
 
5.4 - Results and discussion 
 
All oxime compounds presented were used with 1 molar equivalent of Zn(NO3)2 except 
for 5-6 which was used with 2 equivalents of Zn although it is most likely that only one metal 
ion coordinates to the ligand. The coordination of the simple pyridyl oxime ligands to the 
metal ions is bidentate (5-4, 5-5 and 5-6) and tridentate (5-7) for which the reported formation 
constants with Zn(II) are relatively small (log Kf ≈ 2).  
An issue that arises from the low formation constants and lack of coordination to the 
metal centers is highlighted in studies of the crystal structures formed with these types of 
compounds. The nature of the coordination has been crystallographically confirmed to occur 
through the pyridyl and oxime nitrogen atoms. Ligands L5-4 and L5-5 along with other 
oximes have been studied at various ligand (CL) to metal (CM) ratios (CL:CM, 1:1 to 1:8). The 
results also indicate that multiple ligands can bind to one metal ion (MLn, n = 1, 2 or 3). In the 
case of L5-4 complexed with Ni(II) the crystal structures have indicated the existence of 
dimeric complexes. The suggested structures each consist of a nickel center coordinated to 
three molecules of L5-4 in an octahedral coordination. The trimeric units are interacting 
























representative of all metal ions since Cu(II) have been reported to form different complexes 
with pyridyl oximes[205,206] but they do indicate the tendency of the ligands to form these 
multicoordinate structures.  
In the case of Ni(II) the metal ion titration versus rate of reaction indicates a strong 
preference for a 1:2 Metal:Ligand complex even at 5-fold excess of metal ion. The reactivity 
of the Zn(II) complex on the other hand was still increasing even after the addition of up to 5 
equivalents of metal ions over ligand which is consistent with the equilibrium being shifted to 
form more of the active complex, see Scheme 5.4. The complex formation constant for of 




Scheme 5.4. The equilibrium is shifted to complex formation. Adding more Zn(II) 
compensates for the low Kf of oxime complexes. 
In light of the data obtained for these types of compounds, the suggestion is to use 
excess amount of metal ions to encourage the formation of 1:1 complexes when the binding 
constant is low.  
The use of up to 10-fold excess Zn(II) has been recommended for the complexes in 
Figure 5.6. The results presented herein are largely in accordance with the reported data 
despite the use of equimolar amounts of Zn(NO3)2. The use of the metal ion with similar 
oximic ligands has been reported to increase the rate of nucleophilic attack on pNPA by up to 
two orders of magnitude compared to the free basic oximate.[198] 
Complex 5-3 on the other hand can be assumed to bind the metal ion relatively tightly 
based on the reported binding constant for its aldoxime analogue (Kd ≈ 12 mM).[203] For 5-1 
and 5-3 the coordination from the ligand can be tetradentate if the nucleophile coordinates to 
the nuclei which has been proposed for similar nucleophilic complexes.[14,203]  
The activity of the respective complexes was studied using bis-(4-nitrophenol) 
phosphate (BNPP) and 4-nitrophenyl acetate (pNPA) to investigate their ability to activate 
phosphate diesters and the nucleophilicity of the respective oximes.  
Complex 5-2 was not used successfully in the kinetic analysis due to inconsistency and 
irreproducibility of the results obtained. The complex was intermittently reactive at different 
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pH but not in a reproducible way. This complex would have been interesting to study given its 
similarity to the aldehyde hydrate in Figure 5.2. All other complexes yielded measureable 
activity and were compared to literature reports where appropriate.  
In order to investigate the nucleophilicity of the oximes the substrate must not bind to 
the Zn(II) in order to exclude any contribution from Lewis acidic activation. The pNPA is not 
expected to bind to the metal ion of the complexes and it is significantly more labile. The 
observed increase in rate for the hydrolysis of pNPA compared to the background reaction 
under the same conditions corresponds to a nucleophilic attack by the oxime. 
The metal ions are thought to aid the activation of the oxime nucleophile (reducing the 
pKa of nucleophile) and to aid in turnover by way of a metal coordinated hydroxide, see 
Scheme 5.5.[204] The reactivation or turnover has not been demonstrated here since 
subsaturating concentrations of substrate were used.  
 
Scheme 5.5. Proposed mechanism for the cleavage of pNPA using oximes illustrated by 5-4. 
The reactivity of the complexes towards the hydrolysis of pNPA was monitored at      
pH 7.4, see Table 5.1. The relative rates for the nucleophilic attack on pNPA revealed that the 
nucleophilicity of 5-3 and 5-5 are similar. The pNPA is not expected to bind to Zn(II) and this 
activity is assumed to provide a useful measure of the nucleophilicity of the oximes with 
minimal or no contribution from Lewis activation of pNPA. The most reactive complex 5-3, 
with an oxime nucleophile, was over 103-fold more reactive than its alcohol equivalent 5-1. 
Although the data set is too small to draw extensive conclusions regarding consistency of 
activity for different compounds bearing similar nucleophilic moieties, these results do 





Complex kobs (× 10-5) (s-1) kobs ratio (k5-x/k5-1) 
5-1 3.92 (± 0.0006) 1.0 
5-3 7540 (± 47) 1900 
5-4 462 (± 0.81) 120 
5-5 6110 (± 22) 1600 
5-6 542 (± 0.92) 140 
5-7 156 (± 0.10) 40 
 
Table 5.1. kobs for the various complexes (1 mM) in 50 mM HEPES ( pH 7.4) and 0.1 M ionic strength 
(NaNO3) with 50 µM pNPA. Complex 5-6 was used with 2 mM Zn(NO3)2 and kinetic experiment for 5-7 
were performed in 24 % EtOH as reported in literature.[197] 
(and 5-3) compared to 5-4 is one methyl group (aldoxime/ketoxime). This small local 
structural change leads to an order of magnitude difference in reactivity which is consistent 
with previously reported data.[204] 
Interestingly the metal free equivalents of the oximes (L5-4 and L5-5) were reported to 
display a reverse relationship[204], where the ketoxime is less reactive than its aldoxime 
equivalent, see Table 5.2.  
Compound Metal log Kf (M) pKa k2 (M-1 s-1) 
L5-4 - - 10.0 45 (± 1) 
L5-4 Cu(II) 4.7 3.2 0.003 (± 0.001) 
L5-4 Ni(II) 4.2 6.2 0.46 (± 0.03) 
L5-4 Zn(II) 2.2 6.5 9.4 (± 0.1) 
L5-5 - - 10.8 22 (± 1) 
L5-5 Cu(II) 5.9 3.5 0.2 (± 0.1) 
L5-5 Ni(II) 5.0 6.1 6.5 (± 0.5) 
L5-5 Zn(II) 2.6 7.0 200 (± 5) 
 
Table 5.2. The second-order rate constant for the cleavage of pNPA at 25 °C with oximic ligands using 
metal ions is presented in the table. [ligand] = 0.1 - 1 mM, [metal] = 0.02 M and [buffer] = 0.05 M. Table 
adapted from Mancin, F., Tecilla, P. & Tonellato, U. Activation of Oximic Nucleophiles by Coordination 
of Transition Metal Ions. European J. Org. Chem. 2000, 1045–1050 (2000). 
The BNPP transesterification was studied using the same nucleophilic complexes as 
presented in Table 5.1 at 1 mM complex concentration, see Table 5.3. Complex 5-3 is clearly 
the most reactive, surpassing 5-5 by over 2 orders of magnitude. This stands in stark contrast 
to the relative rates for pNPA that determine the nucleophilicity of the complexes where these 
two complexes have practically the same reactivity. This could be due to either more effective 
Lewis acidic activation and/or a more favorable geometry of the nucleophile in 5-3. 
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Complex Initial rate (× 10-12) (M s-1) kobs ratio (k5-x/k5-4) 
5-1 97.45 (± 0.02) 50 
5-3 12321 (± 188) 6200 
5-4 1.99 (± 0.02) 1 
5-5 21.71 (± 0.02) 11 
5-6 8.79 (± 0.03) 4 
5-7 2.38 - 88.04 1.2 - 44 
 
Table 5.3. The transesterification rate for 1 mM complex in 50 mM HEPES (pH 7.4) with 0.1 M ionic 
strength (NaNO3) and 50 µM BNPP. Complex 5-6 was used with 2 mM Zn(NO3)2 and kinetic experiment 
for 5-7 was performed in 24 % EtOH as reported in literature.[197] Complex 5-1 was monitored at pH 7.3 
and the UV-profile for complex 5-7 was not linear (see Chapter 8.10.2) and is therefore presented as an 
interval for the slowest and fastest rates observed. 
Further data to support these considerations is the rate constant for the complex 5-1, 
which is two to three orders of magnitude slower than the oximes in the hydrolysis of pNPA 
but is comparable to the oximes for BNPP hydrolysis. The least reactive complex was 5-4 
(although the data obtained for 5-7 is unreliable and could not be evaluated). The relative 
activities observed for 5-4 and 5-5 towards BNPP are consistent with the previously observed 
(pNPA) ratio for ketoxime/aldoxime (10:1). The second-order rate constant for the BNPP 
transesterification was studied using complexes 5-1 and 5-3, see Figure 5.7.  
A scheme where the monoanionic ionic form was assumed to be the only active species, 
see Chapter 8.3, was fitted to the pH-rate profile for 5-3 using Equation 5.1 yielding two  
pKa-values corresponding to the two deprotonations of the complex.  






&[][]L (Equation 5.1) 
The two-fold deprotonation observed for Zn(II) complexes have usually been 
considered to signify the release of the acidic protons of metal bound water. This holds true 
for many tridentate ligands that leave two potential coordination sites that can be occupied by 
water, see Chapter 3. In the case of the tridentate complexes discussed in Chapter 3, the first 
deprotonation leads to increased activity and represents the formation of a metal bound aqua-
hydroxo complex in which the water molecule can be displaced by a substrate. The second 
deprotonation leads to the formation of a M(OH)2 species that does not allow for substrate 
binding and therefore leads to reduced activity. Since the two metal-bound water molecules 




Figure 5.7. The second-order rate constant for 5-1 (blue) and 5-3 (red) in 50 mM HEPES or CHES with 
0.1 M ionic strength (NaNO3) at various pH. The data obtained for 5-1 was only reliable up to pH 8 due to 
precipitation at higher pH. 
to determine which of the two is deprotonated first. This becomes more important in the case 
where there are two non-identical acidic nucleophilic species bound to the metal ion. 
In this case 5-1 and 5-3 are both tetradentate with nucleophilic moieties (alkoxy and 
oxime, respectively) occupying one coordination site of the Zn(II). This indicates that the 
kinetic pKa-values represent the deprotonation of the nucleophile (alkoxy or oxime) and a 
metal bound water molecule, see Scheme 5.6.  
The kinetic pKa-values for 5-3, 6.74 and 9.72, are difficult to assign to either one of the 
two potential acidic protons although data in the literature suggest that the coordination of 
oximes to metal ions reduce their pKa to between 6.5 and 8.[204] If the metal induced pKa 
reduction is taken to be representative of the oxime system, the first pKa would represent the 
oxime and the second would represent the water. Regardless of which of the two (aqua or 
oxime) is deprotonated first, the reactive structure must be the form where the oxime is 
deprotonated and the other metal bound species is water. Even if the water is the first to be 
deprotonated the dynamic equilibrium would produce some of the desired deprotonated 
oxime. 
The limiting second-order rate constant for 5-3 was determined from the fit in       
Figure 5.7 to be 0.29 (± 0.01) M-1 s-1. Since it was not possible to fit the equation for two 























Scheme 5.6. The representation of the protonation states of the complex 5-3. 
of the limiting second-order rate constants.The closest comparison that can be made is at     
pH 8 where the apparent second-order rate constants reveal a 600-fold rate increase for 5-3 
over 5-1. The data indicate that the activity of the complex 5-1 is highly pH dependent since a 
pH increase of 0.5 translates into one order of magnitude increased reactivity. The steep 
increase indicates that the measured activity for 5-1 in this particular pH-range is below the 
pKa of the nucleophile of the complex, and suggests that more than one deprotonation is 
required to form the active species. 
The mechanism by which the substrate is transesterified needs to be investigated to 
further understand the interactions involved. The UV profile for the transesterification of 
BNPP with 5-1, see Figure 5.8, is a plot of absorbance points (400 nm) measured over time 
and was carried out in order to follow the single and potentially double displacement of PNP.  
Two different concentrations of 5-1 (1 mM and 10 mM) were used to allow slow and 
fast monitoring of the progression of the reaction. The absorbance for 50 µM BNPP             
(at 400 nm and pH 8) would be 0.8 respectively 1.6 corresponding to one or both                   
4-nitrophenolate (50 µM) being displaced.  
The pseudo-first-order rate constant k’ (s-1) was obtained using Equation 5.2, where the 
absorbance at 400 nm, Abs400nm, at any given time, t, is proportional to the concentration of  
4-nitrophenol released, [PNP]. 










































At 1 mM the reaction was monitored for a long time but not long enough to accurately 
determine the potential two-stage cleavage of BNPP. Therefore the increase in concentration 
of 5-1 aims to allow for faster monitoring of the reaction. Unfortunately the 10 mM 5-1 
reaction produced a cloudy solution and could not be used to draw accurate conclusions 
regarding the reaction product although the observed pseudo-first-order rate was more than 1 
order of magnitude greater than the 1 mM 5-1 experiment.  
 
Figure 5.8. The transesterification of 50 µM BNPP using 1 mM (red) and 10 mM (blue) 5-1 in 50 mM 
HEPES at pH 8 with 0.1 M ionic strength (NaNO3). 
Although the experiments have not yielded conclusive results about the mechanism, 
data from the literature using similar mononuclear nucleophilic complexes suggest that the 
reaction mainly proceeds by the transesterification involving two units of nucleophilic 
catalyst.[14] The first nucleophilic attack on BNPP forms the transesterified phosphate with    
4-nitrophenol and the ligand, see Scheme 5.7.  
The nucleophile is at this stage covalently bound to the phosphate and this likely breaks 
the coordination to the metal ion since it would otherwise be forced to take the configuration 
of a distorted eight-membered ring. Once this occurs the metal ion can coordinate another 
molecule of BNPP if the substrate is in excess compared to the complex, which is not the case 
here. Therefore the further release of PNP must come from the recruitment of an additional 
molecule of the complex that transesterifies the phosphate a second time producing the second 
equivalent of PNP.[14] In the case of BNPP reacting with 5-3 the UV profile indicates full 































Scheme 5.7. The transesterification mechanism as suggested in literature[14] for BNPP by the nucleophilic 
complex 5-1 starting with the active hydroxo form of the complex. 
 
 
Figure 5.9. The UV profile at 400 nm for 5-3 indicates the (double) displacement of 100 µM 4-nitrophenol 



























































































































consistent with the two-fold displacement of PNP from BNPP (50 µM). A first-order equation 
was accurately fit to the data points, see Figure 5.9, and did not display any deviation over 
time. This indicates that the second displacement occurs much faster than the first and thus 
the first displacement is rate limiting. 
 
5.5 - Further investigations 
 
The structures of compounds L5-1 and L5-8, see Figure 5.10, allow comparison of the 
influence of the dimethyl alkylation on activity in a similar way as has been reported in 
literature for complexes with nucleophilic primary alcohols.[132] 
 
Figure 5.10. The structure of the analogous compounds L5-1 and L5-8. 
Having steric interactions that could force the metal nucleus and nucleophile into closer 
proximity of each other has been reported to form more efficient interactions. The ligand L5-8 
was successfully made after substantial synthetic effort to obtain the commercially 
unavailable 4-aminobutan-2-ol appendage. 
The synthesis of the 4-aminobutan-2-ol starting material was more labor intensive than 
was initially expected given the simple structure of the compound. An initial attempt involved 
the reduction of acetoacetamide, see Scheme 5.8.  
 
Scheme 5.8. The attempted reduction of acetoacetamide. 
This direct route only yielded small amounts of product as assessed by 1H NMR 








Scheme 5.9. The synthesis of the precursor 3-[tert-butyl(diphenyl)silyl]oxybutan-1-amine (X5) for ligand 
L5-8. The starting material 4-hydroxybutan-2-one was reacted with (i) TsCl, Pyridine, DCM, 21 %; (ii) 
NaBH4, EtOH, 81 %; (iii) tBDPS-Cl, imidazole, THF; (iv) NaN3, DMF, 87 % over 2 steps; (v) H-Cube, H2, 
10 % Pd/C, EtOAc, 100%. 
more elaborate synthetic route, see Scheme 5.9. The first reaction in step (i), see Scheme 5.9, 
was particularly sensitive to heat and multiple batches of the product were lost due to heating 
during solvent removal until the solvent was changed to DCM and not heated above 30 °C. 
The tosylated product needed to be purified from the reaction mixture relatively promptly in 
order to avoid further decomposition.  
The reduction in step (ii) using NaBH4 was simple and efficient although a slightly 
improved yield was achieved using BH3-THF reduction. The displacement of the tosylate in 
step (iii) in Scheme 5.9 was initially attempted using NaN3, step (vi), and phthalimide, step 
(vii) and (viii), but both approaches failed to yield sufficient amounts of product, see Scheme 
5.10. This was most likely due to the small and relatively volatile target compound being lost 
in the workup.  
The target compound was made less volatile and easier to detect by the incorporation of 
a temporary protecting group tert-butyldiphenylsilane (tBDPS). The formation of the azide in 
step (iv) proceeded without problem as did the final reduction step (v), see Scheme 5.9 to 
yield the protected target compound X5.  
The attachment of the precursor (X2) was achieved using the same procedure as for   
L5-1, see Scheme 5.2. Removal of the tBDPS protecting group was achieved using 
tetrabutylammonium fluoride (TBAF) in good yield, see Scheme 5.11.  










Scheme 5.10. The attempted synthesis of 4-aminobutan-2-ol. The displacement of tosylate using (vi) NaN3, 
DMF (vii) Potassium phthalimide, DMF (viii) hydrazine hydrate, EtOH, reflux. 
have been studied in literature.[132,195] The gem-dimethyl unit was initially incorporated to 
counter the elimination observed in efforts to synthesise the aldehyde equivalent. The ketone 
is considered to be less sensitive to this elimination process and thus could possibly yield the 
 
Scheme 5.11. The synthetic route for the synthesis of L5-8 using precursor X5. The precursor X5 was 
reacted with (i) 2-(iodomethyl)-6-methyl-pyridine, 31 %; (X2), DIPEA, DMF (ii) TBAF, THF, 87 %. 
 

































desired compound. The attempt to oxidise L5-8 to the corresponding ketone, see Scheme 
5.12, was unsuccessful and the resulting reaction mixture was reminiscent of the attempted 
oxidation of L2-1, see Chapter 2.6. 
 
5.6 - Conclusion 
 
The increased reactivity that was observed for the ketoxime (5-5) over the aldoxime   
(5-4) was initially thought to be due to the Thorpe-Ingold effect where the steric compression 
leads to the nucleophile adapting a more favorable geometry for the nucleophilic attack. This 
effect can be illustrated by the reported effective molarities (EM)[21] of the intramolecular 
nucleophilic attack on the mesylates in Figure 5.11.  
This would hold true if this difference in reactivity was observed for the Michaelis 
complex (with a coordinating substrate) where the oxime becomes an intramolecular 
component for 5-5 (BNPP) and 5-4 (BNPP). It appears that this difference in activity is also 
observed for the non-coordinating substrate pNPA (not forming a Michaelis complex) which 
seems to indicate that some other mechanism than simple Thorpe-Ingold compression is 
involved. 
Additionally, it appears that complex 5-3 (0.29 ± 0.01 M-1 s-1) is less reactive than its 
aldoxime equivalent (0.80 ± 0.08 M-1 s-1) that had previously been studied[203] which is not 
consistent with the expected increased reactivity for the ketoxime (10-fold) over the aldoxime. 
 
Figure 5.11. The increase in effective molarity with increasing steric interaction. 
The 3-fold lower second-order rate constant for 5-3 could therefore represent a 30-fold 
reduction compared to the expected reactivity. The formation of an inactive dimer, see Figure 
5.12, in the context of oximic complexes has been reported in literature[197] and the 
dimerisation is a potential factor that could cause the observed decrease in activity since it 





would prevent the substrate from binding to the complex.[207] Although this was not 
investigated here, similar complexes indicate this behavior.[203] 
The dimer has been suggested to cause a reduction in activity since less of the purported 
active monomeric complex will be available to bind the substrate. This is indicated by a non-
linear relationship between the rate and complex concentration which has been reported for 
the aldoxime complex.  
 
Figure 5.12. The proposed structure of the dimerisation of 5-3 showing the internuclear coordination (red 
dashed bonds) with potential steric interactions highlighted (red ellipse). 
In contrast, complex 5-3 displays a linear relationship in the region of 0.2 mM to 1 mM 
with no indication of curvature. This does however not exclude the formation of dimeric 
structures since a linear relationship would also be observed if the dimerisation constant is 
much higher or lower than concentration range in which the complex is studied.  
Interestingly, the linear plots indicate a negative intercept with the Y-axis (initial rate), 
see Figure 5.13, which in not consistent with the expected positive intercept for the formation 
of an inactive dimer. This could potentially indicate that the dimer is a reactive species. 
The expected rate increase for the ketoxime 5-3 (10-fold) and the observed rate decrease     
(3-fold) equals an overall discrepancy of 30-fold. 
Despite this apparent reduction in reactivity between 5-3 and its aldoxime equivalent, 







Figure 5.13. The initial rate versus concentration of complex 5-3 at various pH (7-8) displays a linear 
relationship. 
 
5.7 - Future work 
 
The concept of peptidic complexes discussed in Chapter 4 was based on the peptide 
coiled-coil structure GCN4-bZIP which is known to bind DNA.[165,208] This inspired the work 
on nucleophilic complexes that could be incorporated into the peptide backbone.  
The non-nucleophilic complexes presented in Chapter 4 have similar structural features 
to complexes that are known to hydrolyse BNPP but the introduction of a nucleophile has 
been shown to increase the rate of reaction, depending on the nucleophilic functionality, by 
orders of magnitude.[14]  
The data presented here show the importance of having a structural arrangement that 
allows for coordination and Lewis activation of the substrate as well as having a highly 
nucleophilic group in the proximity of the substrate. 
The structure of the potential ligands for peptide incorporation could be either an 
aldoxime or ketoxime, see Figure 5.14. The synthesis of these complexes would require many 












































































Chapter 6 - Final conclusion 
 
This project has involved the study of the effects on reactivity of the microenvironment 
around dinuclear core in small molecular Zn(II) complexes though the interactions with the 2-
pyridine substituents (H, Me, NH2 and NHMe) of the ligand structure. The investigation into 
the effects of these functionalities on ground state and transition state binding indicated that 
the use of potential hydrogen bond donor (NH2, NHMe) leads to substantial stabilisation of 
the transition state. The main contribution to activity is electrostatic stabilisation of the 
transition state structure by the dinuclear cationic core although the hydrogen bonding in the 
microenvironment is representative of the additional interactions found in secondary 
coordination sphere around metal ions in enzymes active sites. 
Additionally, attention was focused on the effects of the alkoxy-bridging functionality 
between that is considered undesirable from an electrostatic point of view. The reactivity of 
the dinuclear complexes containing a neutral oxazole bridging group was only moderate in 
comparison to the alkoxy-bridged equivalents. 
The investigation into the effects of altering the structure of the internuclear bridging 
functionality (alkoxy) precedes the complete removal of the covalent internuclear linkage in 
order to study the association of mononuclear complexes in larger structural arrangements. 
The non-covalent interactions were studied by incorporating mononuclear Zn(II) 
complexes into the association-promoting environments of membranes and peptidic coiled-
coil structures. The membrane-based approach yielded more than an order of magnitude 
difference in reactivity between the membrane anchored complex and the solution based 
equivalent although this result is most likely due to medium effects at the membrane interface. 
The effect could be further studied for rate enhancement if highly reactive dinuclear 
complexes could be embedded in the membrane via a lipophilic appendage. 
The peptide-based approach was not successful due to the inability of the short 
sequence to for the coiled-coil structures. This could be solved by extending the peptide 
sequence or alternatively investigating the possibility of intrahelical association. 
The nucleophilic complexes were studied for potential future incorporation in DNA 
binding peptide sequences. The effects of relatively small structural changes resulted in 
substantial differences in rate. The dimerisation could potentially be the cause of the reduced 
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activity although this is counter intuitive since a bulkier structure should disfavor close 
interaction. 
These different approaches for the investigation of potential rate-enhancing interactions 
are small steps on the way to the ultimate goal of artificial catalyst with enzyme-like rate 
acceleration. The potential future application of the small molecular catalysts has been 
demonstrated in literature[209,210] in the form of oligonucleotide based artificial nucleases 
(OBAN). The OBAN’s consist of neocuproine functionalized nucleosides in a carefully 
selected oligonucleotide sequence, see Figure 6.1. The oligonucleotide provides a sequence 
specific interaction with RNA and the neocuproine complex acts as the cleaving unit. 
 
Figure 6.1. The structure of the neocuproine-Zn(II) complex used in literature to cleave RNA. 
The knowledge gained through the research into catalytic phosphate diester hydrolysis 
is the tantalising prospect of artificial nucleases for therapeutic purposes, although given the 













Chapter 7  - Experimental 
 
7.1 - Instrumentation 
 
All commercially acquired chemicals were used without further purification unless otherwise 
stated. The TLC analyses were performed using Merck 60 F254nm silica coated aluminium 
sheets and the flash chromatographic purifications were performed using Fluorochem silica 
gel 40-60 µ 60Å. All HPLC purifications were performed using a Waters Xbridge OBD 130 
Å C-18 19 x 250 mm column or a Phenomenex Kinetex XB-C18 100 Å 5µm 21.2 x 250 mm 
column in a MeCN/H2O solvent system with 0.1 % TFA unless otherwise stated. 
The 1H NMR, 13C NMR and 31P NMR analyses were performed using Bruker AV1-250, 
AV1-400, DPX-400 or AV3HD400 corresponding to the frequencies 250MHz and 400 MHz 
for 1H, 101 MHz and 63 MHz for 13C and 162 MHz for 31P NMR in CDCl3, MeOH-d4 or 
D2O. 
The spectra are reported relative to the TMS standard and the multiplicity is reported as: 
singlet (s), broad singlet (br s), doublet (d), triplet (t), quartet (q) and multiplet (m). 
 




6-methylpyridin-2-amine (30.00 g, 277.42 mmol) was dissolved in DCM (150 ml). The 
solution was stirred and di-tert-butyl-dicarbonate (60.55 g, 277.42 mmol) was added to the 
solution along with more DCM (150 ml). Triethylamine (42.30 ml, 305.16 mmol) was added 
to the stirred solution followed by slow addition of solid DMAP (0.68 g, 5.55 mmol). The 
reaction was stirred and after a few minutes vigorous. The reaction was left stirring over night 
after which the solvent was evaporated yielding a yellow/orange viscous liquid. The crude 
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mixture was purified using flash chromatography Et2O/Hexane (50/50). The product appears 
as a faint blue spot on fluorescent TLC plates at 254 nm (with a r.f-value of 0.65). The 
product was obtained in good yield (80 %) as a clear viscous liquid that sometimes 
crystallises into a white solid (46.00 g, 220.88 mmol). 
1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 1H, Py-H), 7.56 (t, J = 7.9 Hz, 1H, Py-H), 
7.45 (br s, 1H, NHBoc), 6.82 (d, J = 7.4 Hz, 1H, Py-H), 2.44 (s, 3H, CH3), 1.52 (s, 9H, 
(CH3)3) 
13C NMR (101 MHz, CDCl3) δ 156.76(Py-CH3), 152.44 (C=O), 151.20 (Py-NHBoc), 138.42 
(Py-H), 117.93 (Py-H), 109.03 (Py-H), 80.75 (C(CH3)3), 28.26 (CH3)3, 24.01 (Py-CH3) 
 
tert-butyl N-(6-methyl-1-oxido-pyridin-1-ium-2-yl)carbamate 
tert-butyl N-(6-methyl-2-pyridyl)carbamate (5.56 g, 26.72 mmol) was dissolved in DCM  
(100 ml) and stirred in an ice bath. After 10 min stirring mCPBA 77% (6.59 g, 38.16 mmol) 
was added and the reaction mixture was left stirring and allowed to adapt room temperature 
over night. The reaction mixture went from clear to cloudy to orange during the reaction. The 
crude mixture was washed with saturated NaHCO3 solution until no more effervescence was 
observed and the organic phase was dried over Na2SO4. The product was concentrated under 
reduced pressure and was obtained in 97 % yield (5.82 g, 25.95 mmol) as a viscous orange 
liquid. TLC revealed only one spot with an r.f-value of 0.28 in 75/25 EtOAc/Hexane. 
1H NMR (400 MHz, CDCl3) δ 9.43 (s, 1H, NHBoc), 8.01 (d, J = 8.4 Hz, 1H, Py-H), 7.19 (t, J 
= 8.1 Hz, 1H, Py-H), 6.88 (d, J = 7.6 Hz, 1H, Py-H), 2.54 (s, 3H, (CH3), 1.52 (s, 9H, ((CH3)3) 
13C NMR (101 MHz, CDCl3) δ 151.68 (C=O), 147.13 (Py-CH3), 144.61 (Py-NHBoc), 126.89 







 [6-[acetyl(tert-butoxycarbonyl)amino]-2-pyridyl]methyl acetate 
tert-butyl l N-(6-methyl-1-oxido-pyridin-1-ium-2-yl)carbamate (28.38 g, 126.55 mmol) was 
dissolved in Ac2O (250 ml, 2644.73 mmol) and stirred at 70 °C over night. The excess Ac2O 
was evaporated in vaccuo and the crude mixture was purified by flash chromatography using 
EtOAc/Hexane (75/25). The title compound (8.74 g, 28.35 mmol) was not the major 
component of the mixture but it was isolated with a r.f-value of 0.74 in 22 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.80 (t, J = 7.8 Hz, 1H, Py-H), 7.35 (d, J = 7.3 Hz, 1H, Py-H), 
7.10 (d, J = 7.8 Hz, 1H, Py-H), 5.20 (s, 2H, Py-CH2), 2.60 (s, 3H, CH3C=O), 2.14 (s, 3H, 
CH3C=O), 1.36 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 172.93 (C=OCH3), 170.48 (C=OCH3), 155.69 (Py-CH2), 
151.93 (Py-N(Ac)Boc), 151.66 N(Ac)C=OC(CH3)3) , 138.85 (Py-H), 122.41 (Py-H), 121.07 
(Py-H), 83.61 (C(CH3)3), 66.26 (Py-CH2), 27.76 ((CH3)3), 26.16 (C=OCH3), 20.85 (C=OCH3) 
 
[6-(tert-butoxycarbonylamino)-2-pyridyl]methyl acetate 
The purification of [6-[acetyl(tert-butoxycarbonyl)amino]-2-pyridyl]methyl acetate using 
EtOAc/Hexane (75/25) also yielded the title compound in small amounts with a r.f-value of 
0.83. 
1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.4 Hz, 1H, Py-H), 7.67 (dd, 8.1, 7.8 Hz, 1H, Py-




13C NMR (101 MHz, CDCl3) δ 170.61 (C=OCH3), 153.97 (Py-CH2), 152.31 
(NHC=OC(CH3)3), 151.61 (Py-NHBoc), 138.88 (Py-H), 116.35 (Py-H), 111.43 (Py-H), 81.03 
(C(CH3)3), 66.42 (Py-CH2), 28.23 ((CH3)3), 20.92 (C=OCH3) 
 
tert-butyl N-[6-(hydroxymethyl)-2-pyridyl]carbamate 
[6-[acetyl(tert-butoxycarbonyl)amino]-2-pyridyl]methyl acetate (8.74 g, 28.35 mmol) was 
dissolved in MeOH (30 ml) and stirred while saturated NaOH solution (2 ml) was added 
dropwise. The solution went from yellow to orange/brown upon addition of NaOH. The 
reaction mixture was stirred for 1 hour after which the solvent was evaporated. Water was 
added to the reaction mixture and the compound was extracted with Et2O and dried over 
MgSO4. The title compound has a r.f-value of 0.64 in EtOAc/Hexane (75/25). The product 
did not require any further purification after the extraction and was obtained in 86% yield 
(5.48 g, 24.44 mmol) as a viscous yellow liquid, 
 
1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.3 Hz, 1H, Py-H), 7.68 (dd, J = 8.2, 7.5 Hz, 1H, 
Py-H), 7.43 (s, 1H, NHBoc), 6.92 (d, J = 7.5 Hz, 1H, Py-H), 4.67 (s, 2H, Py-CH2), 3.50 (s, 
1H, CH2OH), 1.55 (s, 9H, (CH3)3 ) 
 
13C NMR (101 MHz, CDCl3) δ 157.36 (Py-CH2), 152.18 (C=O), 151.06 (Py-NHBoc), 139.04 
(Py-H), 114.95 (Py-H), 110.56 (Py-H), 81.24 (C(CH3)3), 63.73 (Py-CH2), 28.25 ((CH3)3) 
 
HRMS (ESI-TOF) m/z: Calculated for C11H17N2O3: 225.1234  







tert-butyl N-[6-(hydroxymethyl)-2-pyridyl]carbamate (5.48 g, 24.44 mmol) was dissolved in 
dry THF (100ml) and dry distilled triethylamine (4.40ml, 31.77 mmol) was added under N2(g). 
The reaction mixture was stirred in an ice bath and after 10 min methanesulfonyl chloride 
(2.27 ml, 29.32 mmol) was added dropwise. The solution turned cloudy due to formation of 
triethylammonium chloride salt. The reaction was stirred and allowed to adapt room 
temperature over night. To the reaction mixture was added saturated NH4Cl solution and Et2O 
(100 ml x 3). The organic layer was dried over MgSO4 and concentrated in vaccuo. The 
product was obtained as a viscous yellow liquid (6.96 g, 23.02 mmol) in 94 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.4 Hz, 1H, Py-H), 7.73 (dd, J = 8.4, 7.4 Hz, 1H, 
Py-H), 7.42 (s, 1H, NHBoc), 7.12 (d, J = 7.4 Hz, 1H, Py-H), 5.20 (s, 2H, Py-CH2), 3.06 (s, 
3H, SO3CH3), 1.54 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 152.17 (Py-CH2), 151.82 (C=O), 151.65 (Py-NHBoc), 139.25 




[6-(tert-butoxycarbonylamino)-2-pyridyl]methyl methanesulfonate (1.03 g, 3.41 mmol) was 
dissolved in dry THF (30 ml) and stirred. Lithium iodide (0.91 g, 6.82 mmol) was added and 
the reaction mixture was heated to 50 °C for 1 hour. The reaction was poured into saturated 
NH4Cl solution and extracted with CHCl3 (100 ml x 3). The organic phase was dark 
purple/red colour and was washed with 10% Na2S2O3 which turned the organic phase yellow. 
174 
 
The organic phase was dried over MgSO4 and concentrated in vaccuo to give a yellow/orange 
viscous liquid (1.08 g, 3.24 mmol) in 95 % yield.  
The product tends to turn pink/purple after prolonged periods in organic solution especially 
when exposed to light. 
1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.3 Hz, 1H, Py-H), 7.60 (dd, J = 8.3, 7.4 Hz, 1H, 
Py-H), 7.32 (s, 1H, NHBoc), 7.04 (d, J = 7.4 Hz, 1H, Py-H), 4.39 (s, 2H, Py-CH2-I), 1.53 (s, 
9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 156.38 (Py-CH2), 152.20 (C=O), 151.57 (Py-NHBoc), 139.09 
(Py-H), 117.19 (Py-H), 111.19 (Py-H), 81.09 (C(CH3)3), 28.24 ((CH3)3), 5.93 (Py-CH2-I) 
 
tert-butyl N-methyl-N-(6-methyl-2-pyridyl)carbamate 
NaH 60% in mineral oil (5.76 g, 144.05 mmol) was suspended in dry DMF under N2(g). tert-
butyl N-(6-methyl-2-pyridyl)carbamate (15.00 g, 72.03 mmol) was dissolved in dry DMF and 
slowly added to the stirring NaH suspension. After 10 min of stirring Methyl iodide (5.38 g, 
86.43 mmol) was added to the reaction mixture and stirred over night. 
The product was isolated (17.17 g, 77.24 mmol) in quantitative yield with some residual DMF 
accounting for the slight excess in mass. 
1H NMR (400 MHz, CDCl3) δ 7.52 (t, J = 7.8 Hz, 1H, Py-H), 7.39 (d, J = 8.2 Hz, 1H, Py-H), 
6.88 (d, J = 7.3 Hz, 1H, Py-H), 3.39 (s, 3H, Py-NCH3Boc), 2.50 (s, 3H, Py-CH3), 1.51 (s, 9H, 
(CH3)3) 
13C NMR (101 MHz, CDCl3) δ 156.50 (Py-CH3), 154.62 (Py-NCH3Boc), 154.50 (C=O), 
137.13 (Py-H), 118.70 (Py-H), 116.42 (Py-H), 80.83 (C(CH3)3), 34.43 (NCH3Boc), 28.33 






tert-butyl N-methyl-N-(6-methyl-2-pyridyl)carbamate (17.17 g, 77.24 mmol) was dissolved in 
DCM (200 ml) and stirred in an ice bath. After 10 min stirring mCPBA 77% (19.04 g, 110.35 
mmol) was added and the reaction mixture was left stirring and allowed to adapt room 
temperature over night. The reaction mixture went from clear to cloudy to orange during the 
reaction. The crude mixture was washed with saturated NaHCO3 solution until no more 
effervescence was observed and the organic phase was dried over MgSO4. The product was 
concentrated under reduced pressure and was obtained in quantitative yield (18.65 g, 78.27 
mmol) as a viscous orange liquid. 
1H NMR (400 MHz, CDCl3) δ 7.19 (m, 3H, Py-H), 3.20 (s, 3H, Py-NCH3Boc), 2.55 (s, 3H, 
Py-CH3), 1.43 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 154.17 (C=O), 149.97 (Py-CH3), 148.37 (Py-NCH3Boc), 
124.88 (Py-H), 124.29 (Py-H), 123.44 (Py-H), 81.29 (C(CH3)3), 34.69 (NCH3Boc), 28.14 
((CH3)3), 18.18 (Py-CH3) 
 
 [6-[tert-butoxycarbonyl(methyl)amino]-2-pyridyl]methyl acetate 
NaH 60% in mineral oil tert-butyl N-methyl-N-(6-methyl-1-oxido-pyridin-1-ium-2-
yl)carbamate (18.65 g, 78.27 mmol) was dissolved in Ac2O (100 ml, 1057.89 mmol) and 
stirred at 70 °C over night. The excess Ac2O was evaporated in vaccuo and the product was 
isolated (20.45 g, 72.95 mmol) in 93 % yield. TLC of reaction revealed product at r.f-value 
0.44 in Et2O/Hexane (50/50). 
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1H NMR (400 MHz, CDCl3) δ 7.62 (m, 2H, Py-H), 7.04 (dd, J = 5.3, 2.9 Hz, 1H, Py-H), 5.16 
(s, 1H, Py-CH2), 3.39 (s, 3H, Py-NCH3Boc), 2.17 (s, 3H, Py-CH2-COOCH3), 1.52 (s, 9H, 
(CH3)3) 
13C NMR (101 MHz, CDCl3) δ 170.68 (CH3C=O), 154.75 (Py-NCH3Boc), 154.37 (Py-CH2), 
153.57 (CH3NCOOC(CH3)3), 137.49 (Py-H), 118.10 (Py-H), 116.61 (Py-H), 81.18 (C(CH3)3), 
66.61 (Py-CH2), 34.13 (NCH3Boc), 28.30 ((CH3)3), 20.96 (CH3C=O) 
 
tert-butyl-N-[6-(hydroxymethyl)-2-pyridyl]-N-methyl-carbamate 
[6-[tert-butoxycarbonyl(methyl)amino]-2-pyridyl]methyl acetate (3.75 g, 13.36 mmol) was 
dissolved in MeOH (30 ml) and stirred while saturated NaOH solution (2 ml) was added 
dropwise. The solution went from yellow to orange/brown upon addition of NaOH. The 
reaction mixture was stirred for 1 hour after which the solvent was evaporated. Water was 
added to the reaction mixture and the compound was extracted with CHCl3 and dried over 
MgSO4. The solvent was removed under reduced pressure. The product was obtained in 80 % 
yield (2.56 g, 10.73 mmol) as a viscous yellow liquid. 
1H NMR (400 MHz, CDCl3) δ 7.62 (m, 2H, Py-H), 6.94 (d, J = 7.0 Hz, 1H, Py-H), 4.72 (s, 
2H, Py-CH2), 3.68 (br s, 1H, Py-CH2OH), 3.43 (s, 3H, NCH3Boc), 1.54 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 156.79 (Py-CH2), 154.30 (CH3NCOOC(CH3)3), 137.65 (Py-








 [6-[tert-butoxycarbonyl(methyl)amino]-2-pyridyl]methyl methanesulfonate 
tert-butyl N-[6-(hydroxymethyl)-2-pyridyl]-N-methyl-carbamate (2.56 g, 10.73 mmol) was 
dissolved in dry THF (50 ml) and dry distilled triethylamine (2.23 ml, 16.09 mmol) was 
added under N2(g). The reaction mixture was stirred in an ice bath and after 10 min 
methanesulfonyl chloride (1.00 ml, 12.88 mmol) was added dropwise. The solution turned 
cloudy due to formation of triethylammonium chloride salt. The reaction was stirred and 
allowed to adapt room temperature over night. To the reaction mixture was added saturated 
NH4Cl solution and Et2O (100 ml x 3). The organic layer was dried over MgSO4 and 
concentrated in vaccuo. The product was obtained as a viscous yellow liquid (3.09 g, 9.78 
mmol) in 91 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 1H, Py-H), 7.68 (dd, J = 8.3, 7.3 Hz, 1H, 
Py-H), 7.16 (d, J = 7.2 Hz, 1H, Py-H), 5.27 (s, 2H, Py-CH2), 3.40 (s, 3H, NCH3Boc), 3.09 (s, 
3H, SO3CH3), 1.54 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 154.99 (Py-NCH3Boc), 154.29 (Py-CH2), 151.19 
(CH3NCOOC(CH3)3), 137.83 (Py-H), 118.83 (Py-H), 117.41 (Py-H), 81.47 (C(CH3)3), 71.57 
(Py-CH2), 38.08 (SO3CH3), 34.07 (NCH3Boc), 28.29 ((CH3)3) 
 
tert-butyl-N-[6-(iodomethyl)-2-pyridyl]-N-methyl-carbamate 
[6-[tert-butoxycarbonyl(methyl)amino]-2-pyridyl]methyl methanesulfonate (3.09 g, 9.78 
mmol) was dissolved in dry THF (50 ml) and stirred. Lithium iodide (2.62 g, 19.56 mmol) 
was added and the reaction mixture was heated to 50 °C for 1 hour. The reaction was poured 
into saturated NH4Cl solution and extracted with CHCl3 (100 ml x 3). The organic phase was 
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dark purple/red colour and was washed with 10% Na2S2O3 which turned the organic phase 
yellow. The organic phase was dried over MgSO4 and concentrated in vaccuo to give a 
yellow/orange viscous liquid in similar yield to the non-methylated tert-butyl N-[6-
(iodomethyl)-2-pyridyl]carbamate. The product was obtained in 90% yield (3.06 g, 8.80 
mmol). 
1H NMR (400 MHz, CDCl3) δ 7.59 (dd, J = 8.2, 1.0 Hz, 1H, Py-H), 7.55 (dd, J = 8.3, 7.0 Hz, 
1H, Py-H), 7.08 (dd, J = 6.9, 1.2 Hz, 1H, Py-H), 4.46 (s, 2H, Py-CH2), 3.42 (s, 3H, 
NCH3Boc), 1.54 (s, 9H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 155.80 (Py-CH2), 154.72 (Py-NCH3Boc), 154.36 
(CH3NCOOC(CH3)3), 137.70 (Py-H), 117.74 (Py-H), 117.64 (Py-H), 81.23 (C(CH3)3), 34.15 
(NCH3Boc), 28.32 ((CH3)3), 6.63 (CH2-I) 
 
 (6-methyl-2-pyridyl)methyl methanesulfonate 
(6-methyl-2-pyridyl)methanol (5.82 g, 47.26 mmol) was dissolved in dry THF (100 ml) and 
dry distilled triethylamine (9.83 ml, 70.89 mmol) was added under N2(g). The reaction mixture 
was stirred in an ice bath and after 10 min methanesulfonyl chloride (4.39 ml, 56.71 mmol) 
was added dropwise. The solution turned cloudy due to formation of triethylammonium 
chloride salt. The reaction was stirred and allowed to adapt room temperature over night. To 
the reaction mixture was added saturated NH4Cl solution and Et2O (100 ml x 3). The organic 
layer was dried over MgSO4 and concentrated in vaccuo. The product was yellow in solution 
but turned deep red when solvent was removed. The product was obtained as a viscous red 
liquid (9.44 g, 46.90 mmol) in 99 % yield. The product did not require any further purification 
and the r.f-value on the compound is 0.45 (in 100 % Et2O). 
1H NMR (400 MHz, CDCl3) δ 7.63 (t, J = 7.7 Hz, 1H, Py-H), 7.26 (d, J = 7.7 Hz, 1H, Py-H), 




13C NMR (101 MHz, CDCl3) δ 158.57 (Py-CH3), 152.84 (Py-CH2), 137.29 (Py-H), 123.30 
(Py-H), 119.42 (Py-H), 71.85 (Py-CH2), 38.06 (SO3CH3), 24.31 (Py-CH3) 
HRMS (ESI-TOF) m/z: Calculated for C8H12NO3S: 202.0538 
Found: 202.0528 [M+H]+  
 
2-(iodomethyl)-6-methyl-pyridine 
(6-methyl-2-pyridyl)methyl methanesulfonate (7.21 g, 35.83 mmol) was dissolved in dry THF 
(50 ml) and stirred. Lithium iodide (5.75 g, 42.99 mmol) was added and the reaction mixture 
was heated to 50 °C for 1 hour. The reaction was poured into saturated NH4Cl solution and 
extracted with CHCl3 (100 ml x 3). The organic phase was dark purple/red colour and was 
washed with 10% Na2S2O3 which turned the organic phase yellow. The organic phase was 
dried over MgSO4 and concentrated in vaccuo to give a red viscous liquid (8.11 g, 34.82 
mmol) in 97 % yield. The product did not require any further purification and the r.f-value on 
the compound is 0.69 (in 100 % Et2O). 
1H NMR (400 MHz, CDCl3) δ 7.51 (t, J = 7.7 Hz, 1H, Py-H), 7.20 (d, J = 7.7 Hz, 1H, Py-H), 
7.00 (d, J = 7.7 Hz, 1H, Py-H), 4.48 (s, 2H, Py-CH2), 2.53 (s, 3H, Py-CH3) 
13C NMR (101 MHz, CDCl3) δ 158.37 (Py-CH3), 157.59 (Py-CH2), 137.16 (Py-H), 122.15 
(Py-H), 119.90 (Py-H), 24.47 (Py-CH2), 6.76 (Py-CH3) 
HRMS (ESI-TOF) m/z: Calculated for C7H9IN: 233.9774 









2-(bromomethyl)pyridin-1-ium bromide (1.00 g, 3.95 mmol) was dissolved in dry DMF and 
1,3-diamino-2-propanol (0.07 g, 0.79 mmol) was added to the solution. DIPEA (2.75 ml, 
15.81 mmol) was added and the solution was stirred at 70 °C over night. The solvent was 
removed under reduced pressure and the dark brown crude oil was purified using flash 
chromatography in MeOH/EtOAc (50/50) to yield the title compound as a brown liquid (0.09 
g, 0.20 mmol) in 25 % yield.  
1H NMR (250 MHz, CDCl3) δ 8.50 (ddd, J = 4.9, 1.7, 0.8 Hz, 4H, Py-H), 7.58 (td, J = 7.6, 
1.8 Hz, 4H, Py-H), 7.36 (d, J = 7.8 Hz, 4H, Py-H), 7.11 (ddd, J = 7.4, 4.9, 1.1 Hz, 4H, Py-H), 
3.99 (m, 1H, (CH2)2CHOH), 3.87 (d, J = 2.9 Hz, 8H, Py-CH2), 2.65 (dd, J = 11.5, 5.9 Hz, 4H, 
(CH2)2CHOH) 
13C NMR (63 MHz, CDCl3) δ 159.54 (Py-H), 148.96 (Py-H), 136.33 (Py-H), 123.05 (Py-H), 
121.91 (Py-CH2), 67.31 ((CH2)2CHOH), 60.85 (Py-CH2), 59.09 ((CH2)2CHOH) 
HRMS (ESI-TOF) m/z: Calculated for C27H29N6OZn: 517.1694  
Found: 517.1689 [M-+Zn2+]+  
 
1,3-bis[bis[(6-methyl-2-pyridyl)methyl]amino]propan-2-ol 
2-(iodomethyl)-6-methyl-pyridine (2.00 g, 8.58 mmol) was dissolved in dry DMF and 1,3-
diamino-2-propanol (0.15 g, 1.72 mmol) was added to the solution. DIPEA (5.98 ml, 34.33 
mmol) was added and the solution was stirred at 70 °C over night. The solvent was removed 







to yield the title compound as a brown liquid (0.20 g, 0.39 mmol) in 23 % yield with a r.f-
value of 0.21 in MeOH/EtOAc (20/80). 
1H NMR (400 MHz, MeOD) δ 7.62 (t, J = 7.7 Hz, 4H, Py-H), 7.30 (d, J = 7.7 Hz, 4H, Py-H), 
7.11 (d, J = 7.7 Hz, 4H, Py-H), 3.97 (ddd, J = 11.9, 7.7, 4.4 Hz, 1H, (CH2)2CHOH), 3.79 (d, J 
= 3.2 Hz, 8H, Py-CH2), 2.66 (dd, J = 13.3, 4.4 Hz, 1H), 2.57 (ddd, J = 61.4 Hz, J = 13.3, 4.4 
Hz, 4H, (CH2)2CHOH), 2.48 (s, 12H, Py-CH3) 
13C NMR (101 MHz, MeOD) δ 158.47 (Py-CH3), 157.27 (Py-CH2), 137.36 (Py-H), 121.81 
(Py-H), 120.39 (Py-H), 67.14 (CH2)2CHOH, 60.37 (Py-CH2), 59.14, 22.38 (Py-CH3) 
HRMS (ESI-TOF) m/z: Calculated for C31H37N6OZn: 573.2320 





tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (1.38 g, 4.12 mmol) was dissolved in dry 
DMF (30 ml) and 1,3-diamino-2-propanol (0.07 g, 0.82 mmol) was added to the solution. 
DIPEA (2.87 ml, 16.48 mmol) was added and the reaction mixture was stirred at 70 °C over 
night. The solvent was removed under reduced pressure and the dark brown crude oil was 
purified using flash chromatography to yield the title compound as a clear liquid (0.24 g, 0.26 
mmol) in 31 % yield with a r.f-value of 0.22 in MeOH/EtOAc (10/90). 
1H NMR (250 MHz, CDCl3) δ 7.78 (d, J = 8.2 Hz, 4H, Py-H), 7.63 (s, 4H, NHBoc), 7.57 (m, 
4H, Py-H), 6.97 (d, J = 7.3 Hz, 4H, Py-H), 3.91 (s, 1H, (CH2)2CHOH)), 3.74 (q, J = 14.6 Hz, 
















13C NMR (63 MHz, CDCl3) δ 157.48 (Py-CH2), 152.38 (NHCOOtBu), 151.36 (Py-NHBoc), 
138.52(Py-H), 117.70 (Py-H), 110.46 (Py-H), 80.90 (C(CH3)3), 66.97 ((CH2)2CHOH), 60.18 





pyridyl]carbamate (0.23 g, 0.26 mmol) was dissolved in 10 ml DCM/TFA (50/50) and the 
reaction was stirred for 1 hour. The solvent was removed under reduced pressure to yield the 
title compound as a yellow liquid in quantitative yield. 
1H NMR (400 MHz, MeOD) δ 7.40 (dd, J = 8.0, 7.5 Hz, 4H, Py-H), 6.69 (d, J = 7.2 Hz, 4H, 
Py-H), 6.44 (d, J = 8.2 Hz, 4H, Py-H), 3.93 (t, J = 7.8, 4.1 Hz, 1H, (CH2)2CHOH)), 3.61 (s, 
8H, Py-CH2), 2.57 (ddd, J = 20.8, 13.3, 6.0 Hz, 4H, (CH2)2CHOH)) 
13C NMR (101 MHz, MeOD) δ 159.10 (Py-NH2), 156.57 (Py-CH2), 138.25 (Py-H), 111.90 
(Py-H), 107.15 (Py-H), 66.85 (CH2)2CHOH), 60.20 (Py-CH2), 58.80 (CH2)2CHOH) 
HRMS (ESI-TOF) m/z: Calculated for C27H35N10O: 515.2995  











tert-butyl N-[6-(iodomethyl)-2-pyridyl]-N-methyl-carbamate (1.50 g, 4.31 mmol) was 
dissolved in DMF (40 ml) and 1,3-diamino-2-propanol (0.08 g, 0.86 mmol), DIPEA (3.00 ml, 
17.23 mmol) were added and the reaction mixture was stirred at 70 °C over night. The solvent 
was removed under reduced pressure and the dark brown crude oil was purified using flash 
chromatography in Et2O/Hexane (50/50) to yield the title compound as a clear liquid (0.34 g, 
0.35 mmol) in 41 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.52 (m, 8H, Py-H), 7.08 (dd, J = 6.8 Hz, J = 1.2 Hz, 4H, Py-
H), 3.98 (m, 1H, (CH2)2CHOH), 3.81 (q, J = 14.8 Hz, 4H, Py-CH2), 3.38 (s, 12H, NCH3Boc), 
2.68 (ddd, J = 21.0, 13.1, 6.0 Hz, 4H, (CH2)2CHOH), 1.51 (s, 36H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 157.35 (Py-CH2), 154.54 (NCH3COOtBu), 154.42 (Py-
NCH3Boc), 137.13 (Py-H), 118.16 (Py-H), 117.22 (Py-H), 80.97 (C(CH3)3), 66.77 











pyridyl]-N-methyl-carbamate (0.34 g, 0.35 mmol) was dissolved in 10 ml DCM/TFA (10/90) 
and the reaction was stirred for 1 hour. The solvent was removed by blowing N2(g) at the 
solution and NaOH(aq) was added. The product was extracted with CHCl3 and dried over 
MgSO4. The crude was purified using flash chromatography in EtOAc/MeOH (50/50) 
followed by 100 % MeOH flush to yield the title compound as a clear liquid (0.10 g, 0.18 
mmol) in 50 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.36 (t, J = 7.8 Hz, 4H, Py-H), 6.69 (d, J = 7.2 Hz, 4H, Py-H), 
6.21 (d, J = 8.2 Hz, 1H, Py-H), 3.95 (s, 1H, (CH2)2CHOH), 3.69 (m, 8H, Py-CH2), 2.86 (s, 
12H, NCH3), 2.65 (ddd, J = 20.7, 13.1, 5.8 Hz, 4H, (CH2)2CHOH) 
13C NMR (101 MHz, CDCl3) δ 159.20 (Py-NH2), 158.10 (Py-CH2), 137.92 (Py-H), 111.82 
(Py-H), 103.46 (Py-H), 67.19 ((CH2)2CHOH), 60.57 (Py-CH2), 58.99 ((CH2)2CHOH), 29.24 
(NCH3) 
HRMS (ESI-TOF) m/z: Calculated for C31H41N10OZn: 633.2756  
Found: 633.2741 [M-+Zn2+]+  
 
2-(6-methyl-2-pyridyl)isoindoline-1,3-dione 
6-methylpyridin-2-amine (20.00 g, 184.95 mmol) and phthalic anhydride (27.39 g, 184.95 
mmol) was weighed in a flask, stirred and heated in a heating mantle to 190 °C for 1 hour. 
The solids melted into a liquid during heating and solidified after cooling down to afford the 
title compound (43.00 g, 180.49 mmol) in 97 % yield with a r.f-value of 0.64 in 100 % 
EtOAc. 
1H NMR (250 MHz, CDCl3) δ 7.98 (m, 2H, Py-H), 7.80 (m, 3H, Py-H & Ph-H), 7.24 (t, J = 
7.4 Hz, 2H, Py-H), 2.64 (s, 3H, Py-CH3) 
13C NMR (63 MHz, CDCl3) δ 166.83 (Py-N(CO)2), 159.18 (Py-CH3), 145.39 (Py-N(CO)2), 
138.44 (Py-H), 134.45 (Ph-H), 131.95 (Ph-CO), 123.86 (Ph-H), 123.38 (Py-H), 119.41 (Py-
H), 24.31 (Py-CH3) 
185 
 
7.2.1 - Synthesis of substrate (HPNPP)  
 
1-[(4-methoxyphenyl)-diphenyl-methoxy]propan-2-ol 
1,2-propanediol (4.83 ml, 65.71 mmol) and 4-monomethoxy trityl chloride (16.23 g, 52.57 
mmol) were dissolved in dry THF(50 ml). Imidazole (3.58 g, 52.57 mmol) was added and the 
reaction mixture was stirred over night. The crude reaction mixture was added to H2O, 
extracted thrice with EtOAc and the resulting organic phase was dried over Na2SO4 and 
purified using flash chromatography. The title compound was obtained as a viscous clear 
liquid (13.17 g, 37.80 mmol) in 72 % yield with a r.f-value of 0.31 in Et2O/Hexane (50/50). 
1H NMR (400 MHz, CDCl3) δ 7.47 (m, 4H, Ph-H), 7.30 (m, 8H, Ph-H), 6.87 (m, 2H, Ph-H), 
4.01 (m, 1H, CH2CH(CH3)OH), 3.83 (s, 3H, Ph-OCH3), 3.09 (ddd, J = 17.2, 9.2, 5.6 Hz, 2H, 
CH2CH(CH3)OH), 2.44 (br s, 1H, CH2CH(CH3)OH), 1.13 (d, J = 6.4 Hz, 3H, 
CH2CH(CH3)OH) 
13C NMR (101 MHz, CDCl3) δ 158.61 (Ph-OCH3), 144.41 (Ph-C), 144.37 (Ph-C), 135.56 
(Ph-C), 130.37 (Ph-H), 128.40 (Ph-H), 127.87 (Ph-H), 126.97 (Ph-H), 113.14 (Ph-H), 86.34 









1-[(4-methoxyphenyl)-diphenyl-methoxy]propan-2-ol (7.00 g, 20.09 mmol) and Imidazole 
(3.58 g, 52.57 mmol) were dissolved in dry DMF (40 ml). tert-Butyldimethylsilyl chloride 
(9.08 g, 60.27 mmol) was added and the reaction mixture was stirred over night. The crude 
reaction mixture was added to H2O, extracted CHCl3 and resulting organic phase was dried 
over MgSO4 followed by solvent removal under reduced pressure. The resulting crude liquid 
was purified using flash chromatography. The title compound was obtained as a viscous clear 
liquid in quantitative yield with a r.f-value of 0.76 in Et2O/Hexane (50/50).  
 
1H NMR (400 MHz, CDCl3) δ 7.51 (m, 4H, Ph-H), 7.31 (m, 8H, Ph-H), 6.85 (m, 2H, Ph-H), 
3.99 (m, 1H, CH2CH(CH3)OH), 3.82 (s, 3H, Ph-OCH3), 3.00 (ddd, J = 103.4, 9.1, 5.7 Hz, 2H, 
CH2CH(CH3)OH), 1.17 (d, J = 6.2 Hz, 3H, CH2CH(CH3)OH), 0.92 (s, 9H, SiC(CH3)3), 0.09 
(d, J = 3.2 Hz, 6H, Si(CH3)2) 
13C NMR (101 MHz, CDCl3) δ 158.43 (Ph-OCH3), 144.87 (Ph-C), 144.73 (Ph-C), 136.09 
(Ph-C), 130.43 (Ph-H), 128.58 (Ph-H), 128.54 (Ph-H), 127.68 (Ph-H), 126.72 (Ph-H), 112.97 
(Ph-H), 86.01 (C(Ph)3), 69.39 (CH2CH(CH3)OH), 68.13 (CH2CH(CH3)OH), 55.21 (Ph-












Imidazole (17.29 g, 253.96 mmol) and tert-Butyldimethylsilyl chloride (19.14 g, 126.98 
mmol) were dissolved in dry DMF (200 ml) and stirred in an ice bath. Ethyl (2S)-2-
hydroxypropanoate (9.65 ml, 84.65 mmol) was added slowly and the reaction was stirred over 
night at room temperature. H2O was added to the reaction mixture followed by extraction with 
Et2O. The volatile solvent was removed under reduced pressure and the residual DMF was 
removed with an additional extraction with Et2O from H2O. The solvent was removed under 
reduced pressure to afford the title compound as a clear liquid (19.47 g, 83.80 mmol) in 99 % 
yield. 
1H NMR (400 MHz, CDCl3) δ 4.32 (q, J = 6.7 Hz, 1H, CH3CH2OOCCH(CH3)OSi), 4.19 (m, 
2H, CH3CH2OOCCH(CH3)OSi), 1.41 (d, J = 6.8 Hz, 3H, CH3CH2OOCCH(CH3)OSi), 1.29 (t, 
J = 7.1 Hz, 3H, CH3CH2OOCCH(CH3)OSi), 0.92 (s, 9H, SiC(CH3)3), 0.10 (d, J = 12.1 Hz, 
6H, Si(CH3)2) 
13C NMR (101 MHz, CDCl3) δ 174.14 (CH3CH2OOCCH(CH3)OSi), 68.46 
(CH3CH2OOCCH(CH3)OSi), 60.74 (CH3CH2OOCCH(CH3)OSi), 25.71 (CH3)3, 21.31 
(CH3CH2OOCCH(CH3)OSi), 18.33 (SiC(CH3)3), 14.19 (CH3CH2OOCCH(CH3)OSi), -4.95 




g, 4.32 mmol) was dissolved in 95 % AcOH (20 ml) and stirred over night. To the light 










mixture was stirred in an ice bath and Na2CO3 was added in small portions until effervescence 
stopped. The crude mixture was extracted thrice with DCM, dried over MgSO4 and the 
solvent was removed under reduced pressure. The obtained yellow oil was distilled using a 
kügelrohr distillator at 150 °C at 2 mbar with a CO2(s)/Acetone trap. The title compound was 
obtained as a clear liquid (0.15 g, 0.79 mmol) in 18 % yield. 
Alternative synthesis:  
 
(2S)-2-[tert-butyl(dimethyl)silyl]oxypropan-1-ol 
ethyl (2S)-2-[tert-butyl(dimethyl)silyl]oxypropanoate (15.00 g, 64.55 mmol) was dissolved in 
dry THF (100 ml) and stirred in an ice bath under N2(g) and 1M BH3-THF complex (100 ml, 
100 mmol) was added over 15 min. The reaction mixture was allowed to reach room 
temperature and then stirred at reflux for 3 hours. The reaction mixture was allowed to cool to 
room temperature and H2O was added slowly followed by three extractions with Et2O. The 
organic phase was washed with brine and dried over MgSO4. The solvent was removed under 
reduced pressure to afford the title compound (11.13 g, 58.47 mmol) in 90 % yield. 
1H NMR (400 MHz, CDCl3) δ 3.93 (m, J = 6.3, 3.6 Hz, 1H, HOCH2CH(CH3)OH), 3.45 (ddd, 
J = 17.5, 10.9, 5.1 Hz, 2H, HOCH2CH(CH3)OH), 1.93 (s, 1H, HOCH2CH(CH3)OH), 1.14 (d, 
J = 6.2 Hz, 3H, HOCH2CH(CH3)OH), 0.92 (s, 9H, SiC(CH3)3), 0.11 (s, 6H, Si(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 69.06 (CH2CH(CH3)OH), 68.18 (CH2CH(CH3)OH), 25.82 







[(2S)-2-[tert-butyl(dimethyl)silyl]oxypropyl] (4-nitrophenyl) hydrogen phosphate 
4-Nitrophenylphosphodichloridate (4.00 g, 15.63 mmol) was dissolved in dry THF and stirred 
in an ice bath under N2(g). 2-[tert-butyl(dimethyl)silyl]oxypropan-1-ol (2.68 g, 14.06 mmol) 
and dry Et3N (5.85 ml, 42.19 mmol) were dissolved in dry THF and slowly added to the 
stirring reaction mixture. The reaction was stirred at room temperature for 4 hours followed 
by the addition of H2O (0.3 ml). The reaction was stirred for 30 min and then excess H2O was 
added. The reaction mixture was extracted with DCM and dried over MgSO4. The crude 
reaction mixture was purified using flash chromatography and the title compound was 
isolated as a light yellow oil with a r.f-value of 0.63 in MeOH/DCM (25/75). 
1H NMR (400 MHz, MeOD) δ 8.20 (d, J = 9.1 Hz, 2H, Ph-H), 7.46 (d, J = 9.0 Hz, 2H, Ph-
H), 3.97 (m, 1H, CH2CH(CH3)OSi), 3.83 (dtd, J = 15.6, 10.0, 5.6 Hz, 2H, CH2CH(CH3)OSi), 
1.13 (d, J = 6.0 Hz, 3H, CH2CH(CH3)OSi), 0.86 (s, 9H, SiC(CH3)3), 0.05 (d, J = 6.9 Hz, 6H, 
Si(CH3)2) 
13C NMR (101 MHz, CDCl3) δ 157.17 (Ph-O), 157.12 (Ph-O), 143.45 (Ph-NO2), 125.29 (Ph-
H), 120.45 (Ph-H), 120.40 (Ph-H), 71.44 (CH2CH(CH3)OSi), 71.40 (CH2CH(CH3)OSi), 
67.52 (CH2CH(CH3)OSi), 67.42 (CH2CH(CH3)OSi), 25.69 (SiC(CH3)3), 20.23 
(CH2CH(CH3)OSi), 18.09 (SiC(CH3)3), -4.83 (Si(CH3)2), -4.91 (Si(CH3)2) 
31P NMR (162 MHz, CDCl3) δ -10.89 
HRMS (ESI-TOF) m/z: Calculated for C15H27NO7PSi: 392.1294 






[(2S)-2-hydroxypropyl] (4-nitrophenyl) hydrogen phosphate 
[(2S)-2-[tert-butyl(dimethyl)silyl]oxypropyl] (4-nitrophenyl) hydrogen phosphate 
spontaneously lost the tert-butyl(dimethyl)silyl protecting group following purification on 
silica over 2 days. The resulting product was purified using Waters Xbridge C-18 column 
with a gradient purification 5-41 % MeCN over 8 min and 254 nm UV-detection. The title 
compound was collected at a retention time of 6.5 min. The product was also analyses by 
TLC with the same mobile phase used for the purification of the fully protected native 
compound i.e. MeOH/DCM (25/75) yielding a r.f-value of 0.41. 
An alternative deprotection procedure was also utilised involving over night treatment with 
Triethylamine trihydrofluoride in three fold molar excess followed by flash chromatography 
to obtain the title compound in a more controlled fashion. 
  
[(2S)-2-hydroxypropyl] (4-nitrophenyl) hydrogen phosphate sodium salt 
Amberlite IR-120 H-form was washed with 2 M NaCl(aq) until the eluent from the column was 
no longer acidic (checked by pH-paper). The resin was washed with 5 column volumes of 
H2O in order to eliminate residual salt. [(2S)-2-hydroxypropyl] (4-nitrophenyl) hydrogen 
phosphate was dissolved in H2O and a small amount of MeOH and passed through the 
column. The solvent was removed by freeze drying to afford the title compound (0.16 g, 0.58 
mmol) in 4 % yield over 3 steps. Analytical HPLC Phenomenex Kinetex XB-C18 100 Å 5 
µm 4.6 x 250 nm, 5-41 % MeCN 8 min gradient, 254 nm detection, retention time 5.3 min. 
1H NMR (400 MHz, MeOD) δ 8.22 (d, J = 8.9 Hz, 2H, Ph-H), 7.43 (dd, J = 9.3, 0.8 Hz, 2H, 




13C NMR (101 MHz, MeOD) δ 158.56 (Ph-O), 158.50 (Ph-O), 143.10 (Ph-NO2), 124.84 (Ph-
H), 120.11 (Ph-H), 120.05 (Ph-H), 71.04 (CH2CH(CH3)OH), 70.98 (CH2CH(CH3)OH), 66.35 
(CH2CH(CH3)OH), 66.27 (CH2CH(CH3)OH), 17.95 (CH2CH(CH3)OH) 
31P NMR (162 MHz, MeOD) δ -5.33. 
HRMS (ESI-TOF) m/z: Calculated for C9H11NO7P: 276.0279  
Found: 276.0284 [M]-  
  
methyl (4-nitrophenyl) hydrogen phosphate sodium salt 
The synthesis of [(2S)-2-[tert-butyl(dimethyl)silyl]oxypropyl] (4-nitrophenyl) hydrogen 
phosphate also yielded a small amount of the title compound due to incomplete hydrolysis of 
the chlorophosphate in the work up step. The subsequent purification using MeOH gave the 
title compound (10 % relative to target compound). Analytical HPLC Phenomenex Kinetex 
XB-C18 100 Å 5 µm 4.6 x 250 nm, 5-41 % MeCN 8 min gradient, 254 nm detection, 
retention time 4.8 min. 
1H NMR (400 MHz, MeOD) δ 8.22 (d, J = 8.9 Hz, 2H, Ph-H), 7.43 (dd, J = 9.3, 0.8 Hz, 2H, 
Ph-H), 3.68 (d, J = 11.2 Hz, 3H, POCH3) 
13C NMR (101 MHz, MeOD) δ 158.56 (Ph-O), 158.50 (Ph-O), 143.10 (Ph-NO2), 124.84 (Ph-
H), 120.11 (Ph-H), 120.05 (Ph-H), 52.32 (POCH3), 52.25 (POCH3) 
31P NMR (162 MHz, MeOD) δ -4.21 
HRMS (ESI-TOF) m/z: Calculated for C7H7NO6P: 232.0016 






The byproduct formed in the synthesis of [6-(tert-butoxycarbonylamino)-2-pyridyl]methyl 
acetate. 
1H NMR (400 MHz, CDCl3) δ 7.63 (dd, J = 8.8, 7.5 Hz, 1H, Py-H), 7.17 (dd, J = 8.8, 0.6 Hz, 
1H, Py-H), 6.76 (d, J = 7.5 Hz, 1H, Py-H), 2.66 (s, 3H, Py-CH3) 
13C NMR (101 MHz, CDCl3) δ 160.57 (C=O), 156.41 (Py-CH3), 139.12 (Py=N), 137.63 (Py-
H), 112.37 (Py-H), 111.56 (Py-H), 16.20 (Py-CH3) 
LRMS (ES+) m/z 151 (MH+)     Calculated m/z 151.0502 (MH+) 
 





tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (1.49 g, 4.46 mmol) was dissolved in dry 
DMF (30 ml) and n-butylamine (0.18 ml, 1.78 mmol) was added. DIPEA was added and the 
reaction mixture was stirred at 70 °C over night. The solvent was removed under reduced 
pressure and the crude liquid was purified using flash chromatography to afford the product 
(0.52 g, 1.08 mmol) in 60 % yield with a r.f-value of 0.28 in Et2O/Hexane (50/50). 
1H NMR (400 MHz, CDCl3) δ 7.90 (s, 2H, NHBoc), 7.76 (d, J = 8.2 Hz, 2H, Py-H), 7.59 (t, J 




CH2N(CH2Py)2), 1.47 (m, 20H, CH2CH2N(CH2Py)2 & (CH3)3), 1.24 (m, 2H, 
CH2CH2CH2CH2N(CH2Py)2), 0.81 (t, J = 7.3 Hz, 2H, CH3CH2CH2CH2N(CH2Py)2) 
13C NMR (101 MHz, CDCl3) δ 158.40 (Py-CH2), 152.52 (NHCOOtBu), 151.27 (Py-NHBoc), 
138.39 (Py-H), 117.36 (Py-H), 110.25 (Py-H), 80.61 C(CH3)3, 59.73 
(CH3CH2CH2CH2N(CH2Py)2), 53.96 (CH3CH2CH2CH2N(CH2Py)2), 29.30 





pyridyl]carbamate (0.52 g, 1.08 mmol) was dissolved in 10 ml DCM/TFA (10/90) and the 
reaction was stirred for 1 hour. The solvent was evaporated to yield the title compound as a 
brown liquid in quantitative yield.  
1H NMR (400 MHz, MeOD) δ 7.81 (dd, J = 8.9, 7.2 Hz, 2H, Py-H), 6.89 (d, J = 8.9 Hz, 2H, 
Py-H), 6.82 (d, J = 7.2 Hz, 2H, Py-H), 3.84 (s, 4H, Py-CH2), 2.59 (m, 2H, CH2N(CH2Py)2), 
1.52 (m, 2H, CH2CH2N(CH2Py)2), 1.28 (m, 2H, CH2CH2CH2CH2N(CH2Py)2), 0.89 (t, J = 7.4 
Hz, 2H, CH3CH2CH2CH2N(CH2Py)2). 
13C NMR (101 MHz, MeOD) δ 155.35 (Py-NH2), 146.48 (Py-CH2), 143.88 (Py-H), 112.17 
(Py-H),111.64(Py-H),55.07(CH3CH2CH2CH2N(CH2Py)2),54.78 
(CH3CH2CH2CH2N(CH2Py)2),27.82(CH3CH2CH2CH2N(CH2Py)2),20.00 
(CH3CH2CH2CH2N(CH2Py)2), 12.70 (CH3CH2CH2CH2N(CH2Py)2) 
HRMS (ESI-TOF) m/z: Calculated for C16H24N5: 286.2032  







tert-butyl N-[6-(iodomethyl)-2-pyridyl]-N-methyl-carbamate (0.50 g, 1.44 mmol) was 
dissolved in dry DMF (20 ml) and n-butylamine (0.06 ml, 0.57 mmol) was added. DIPEA 
was added and the reaction mixture was stirred at 70 °C over night. The solvent was removed 
under reduced pressure and the crude liquid was purified using flash chromatography to 
afford the product (0.15 g, 0.29 mmol) in 51 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.60 (dd, J = 8.1, 7.6 Hz, 2H, Py-H), 7.48 (d, J = 8.1 Hz, 2H, 
Py-H), 7.27 (d, J = 7.3 Hz, 2H, Py-H), 3.76 (s, 4H, Py-CH2), 3.39 (s, 6H, NHCH3), 2.56 (m, 
2H, CH2N(CH2Py)2), 1.52 (m, 20H, CH2CH2N(CH2Py)2 & (CH3)3)) 1.33 (m, 2H, 
CH2CH2CH2CH2N(CH2Py)2), 0.87 (t, J = 7.4 Hz, 3H, CH3CH2CH2CH2N(CH2Py)2)). 
13C NMR (101 MHz, CDCl3) δ 158.30 (Py-CH2), 154.50 (Py-NCH3Boc), 154.38 
(NCH3COOtBu), 137.14 (Py-H), 117.96(Py-H), 117.13 (Py-H), 80.88 C(CH3)3, 60.01 
(CH3CH2CH2CH2N(CH2Py)2) , 54.07 (CH3CH2CH2CH2N(CH2Py)2), 34.27 (NHCH3), 29.52 





amino]methyl]-2-pyridyl]-N-methyl-carbamate (0.15 g, 0.29 mmol) was dissolved in 10 ml 
DCM/TFA (30/70) and the reaction was stirred for 1 hour. The solvent was evaporated to 





1H NMR (400 MHz, CDCl3) δ 7.45 (dd, J = 8.2 Hz , J = 7.3 Hz, 2H, Py-H), 6.90 (d, J = 7.3 
Hz, 2H, Py-H), 6.25 (d, J = 8.2 Hz, 2H, Py-H), 3.65 (s, 4H, Py-CH2), 2.90 (d, J = 5.2 Hz, 6H, 
NHCH3), 2.54 (m, 2H, CH2N(CH2Py)2), 1.53 (m, 2H, CH2CH2N(CH2Py)2)), 1.31 (m, 2H, 
CH2CH2CH2CH2N(CH2Py)2), 0.87 (t, J = 7.4 Hz, 3H, CH3CH2CH2CH2N(CH2Py)2) 
13C NMR (101 MHz, CDCl3) δ 159.17 (Py-NHCH3), 158.71 (Py-CH2), 138.02 (Py-H), 
111.55 (Py-H), 103.19 (Py-H), 60.28 (CH3CH2CH2CH2N(CH2Py)2), 54.08 
(CH3CH2CH2CH2N(CH2Py)2) , 29.34 (CH3CH2CH2CH2N(CH2Py)2), 29.28 (NHCH3), 20.57 
(CH3CH2CH2CH2N(CH2Py)2), 14.11 (CH3CH2CH2CH2N(CH2Py)2) 
HRMS (ESI-TOF) m/z: Calculated for C18H26N5Zn: 376.1480 




tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (1.00 g, 2.99 mmol) was dissolved in 40 ml 
dry MeCN (alternatively dry DMF) and hexadecylamine (0.29 g, 1.20 mmol) was added. The 
alkylamine did not dissolve well in MeCN and the reaction was heated to encourage 
solubilisation. DIPEA (2.09 ml, 11.97 mmol) was added and the reaction was heated to 70 °C 
for 1 hour. The solvent was removed and the crude product was purified using flash 
chromatography to afford the title compound (0.43 g, 0.66 mmol) in 55 % yield with a r.f-
value of 0.72 (in 100 % EtOAc). 
1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H, Py-H), 7.63 (t, J = 7.9 Hz, 2H, Py-H), 
7.31 (s, 2H, NHBoc), 7.17 (d, J = 7.4 Hz, 2H, Py-H), 3.68 (s, 4H, Py-CH2), 2.49 (m, 2H, 
CH3(CH2)14CH2N(CH2)2), 1.52 (s, 18H, (CH3)3), 1.25 (m, 28H, CH3(CH2)14CH2N(CH2)2), 







2-pyridyl]carbamate (0.43 g, 0.66 mmol) was dissolved in 10 ml DCM/TFA (10/90) and the 
reaction was stirred for 1 hour. The solvent was evaporated to yield the title compound as a 
brown liquid in quantitative yield. 
1H NMR (400 MHz, MeOD) δ 7.82 (dd, J = 8.9, 7.2 Hz, 2H, Py-H), 6.89 (d, J = 8.9 Hz, 2H, 
Py-H), 6.82 (d, J = 7.2 Hz, 2H, Py-H), 3.84 (s, 4H, Py-CH2), 2.58 (m, 2H, 
CH3(CH2)14CH2N(CH2)2), 1.52 (m, 2H, CH3(CH2)14CH2N(CH2)2), 1.30 (m, 28H, 
CH3(CH2)14CH2N(CH2)2)), 0.92 (t, J = 6.8 Hz, 3H, CH3(CH2)14CH2N(CH2)2) 
13C NMR (101 MHz, MeOD) δ 155.35 (Py-NH2), 146.56 (Py-CH2), 143.89 (Py-H), 112.15 
(Py-H), 111.64 (Py-H), 55.18 CH3(CH2)14CH2N(CH2)2, 55.07 CH3(CH2)14CH2N(CH2)2, 31.66 
(CH3CH2CH2(CH2)10CH2CH2CH2N(CH2)2),29.20CH3CH2CH2 (CH2)10CH2CH2CH2N(CH2)2), 
26.85(CH3CH2CH2(CH2)10CH2CH2CH2N(CH2)2),25.72 
(CH3CH2CH2(CH2)10CH2CH2CH2N(CH2)2), 2.32 (CH3CH2CH2(CH2)10CH2CH2CH2N(CH2)2), 
13.03 CH3(CH2)14CH2N(CH2)2 
HRMS (ESI-TOF) m/z: Calculated for C28H48N5: 454.3910  
Found: 454.3913 [M+H]+   
 
7.4 - Chapter 4 syntheses 
 
7.4.1 - Peptide synthesis 
 
The synthesis of the peptides was performed using standard Fmoc SPPS protocol was adhered 
to throughout the synthesis, see Chapter 8.9.2. The peptide sequence Fmoc-




solid support with all the protecting groups intact. All couplings were performed at room 
temperature under N2 atmosphere unless otherwise stated. 
Ac-YLENEVARLKKLVKQG-(L4-2)2 
The solid support attached sequence Fmoc-LENEVARLKKLVKQG was allowed to swell in 
DCM followed by DMF. The N-terminus was deprotected using 20% piperidine in DMF 
(agitated under nitrogen) followed by washing of the resin beads. A mixture containing Fmoc-
Tyr(OtBu)-OH, HBTU and DIPEA in DMF was added to the resins and agitated for 3 hours. 
The resin was washed and Fmoc removed using the same procedure as above (20% piperidine 
in DMF). After washing the resin, mixture of Ac2O, DIPEA and DMF was added to the resins 
and agitated for 1 hour followed by washing of the beads. The peptide sequence Ac-
YLENEVARLKKLVKQG was cleaved off the solid support under mildly acidic (1-5% TFA in 
DCM) conditions and the peptide was extracted from water using CHCl3 and Et2O and dried 
over MgSO4. The crude mixture containing the peptide was used (0.46 g, 0.15 mmol) was 
dissolved with HBTU (0.06 g, 0.16 mmol) and DIPEA (0.15 ml, 0.88 mmol) in 5 ml DMF. 
tert-butylN-[6-[[3-aminopropyl-[[6-(tert-butoxycarbonylamino)-2-
pyridyl]methyl]amino]methyl]-2-pyridyl]carbamate (0.21 g, 0.44 mmol) was dissolved in 
DMF and added to the reaction mixture and stirred over night. DMF was evaporated and the 
crude product was passed through a short silica plug. The resulting crude product was treated 
with TFA/TIS/H2O (90/5/5) for 4 hours after which the TFA was removed by blowing 
nitrogen at the liquid. The peptide was purified using a 19 x 250 mm C-18 Waters X-bridge 
column with 25-60 % MeCN (0.1 % TFA), 20 min gradient, 254 nm detection, retention time 
13.7 min. The peptide was freeze dried and obtained in 5 % yield (15 mg, 7 µmol) as a porous 
white solid. 
LRMS (ES+) m/z 1100 (MH2+)     Calculated m/z 1098.6424 (MH2+) 
HRMS (ESI-TOF) m/z: Calculated for C102H169N30O24: 2198.2921  
Found: 2198.2911 [M+H]+   
 
Ac-CGYLENEVARLKKLVKQG-OH 
The peptide sequence was synthesised from Fmoc-LENEVARLKKLVKQG using standard 
Fmoc chemistry with HBTU, Fmoc-Tyr(OtBu)-OH, Fmoc-Gly-OH and Fmoc-Cys(trt)-OH.  
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LRMS (ES+) m/z 1046 (MH2+)     Calculated m/z 1045.5677 (MH2+) 
 




1,3-dibromopropane (20.19 g, 100.00 mmol) was dissolved in DMF (100 ml) and NaN3 
(14.30 g, 220.00 mmol) was added. The reaction mixture was left stirring over night at 80 °C. 
The reaction mixture was added to H2O (500 ml) and extracted with Et2O (3 x 100 ml). The 
organic phases were pooled and washed with H2O (3 x 250 ml) followed by drying over 
MgSO4. The solvent was removed under reduced pressure to afford the title compound as a 
light yellow oil (11.34 g, 89.91 mmol) in 89% yield. 
1H NMR (400 MHz, CDCl3) δ 3.44 (t, J = 6.5 Hz, 2H, CH2), 1.85 (p, J = 6.5 Hz, 4H, N3CH2) 
13C NMR (101 MHz, CDCl3) δ 48.43 (CH2), 28.30 (N3CH2) 
 
3-azidopropan-1-amine 
1,3-dibromopropane (5.00 g, 39.64 mmol) was dissolved in 60 ml EtOAc/Et2O (50/50) and 
stirred in an ice bath. To the stirred solution 60 ml HCl (2 M) was added followed by the 
addition of triphenyl phosphine (10.40 g, 39.64 mmol) in small portions over 30 min then 
stirred vigorously over night. Et2O was added and the organic layer was separated and 
discarded. The aqueous layer was washed thrice with Et2O and the organic layer was 
discarded. The aqueous layer was basified (pH 12) which turned the solution cloudy and the 
basified aqueous layer was extracted thrice with Et2O. The organic layer was dried over 
MgSO4 the solvent was removed under reduced pressure to yield the product as a yellow 





3-Bromopropylamine hydrobromide (14.40 g, 65.78 mmol) dissolved in DMF (150 ml). NaN3 
(5.13 g, 78.94 mmol) was added and the reaction mixture was left stirring over night at 70 °C. 
The solvent was evaporated and H2O was added followed by NaOH until solution was highly 
basic. DCM followed by Et2O was used to extract the product followed by drying of the 
organic phase with MgSO4. The solvent was removed under reduced pressure to afford the 
title compound as an orange liquid (6.48 g, 64.72 mmol) in 98% yield. 
1H NMR (400 MHz, CDCl3) δ 3.32 (t, J = 6.7 Hz, 2H, N3CH2), 2.74 (t, J = 6.8 Hz, 2H, 
CH2NH2), 1.67 (p, J = 6.8 Hz, 2H, CH2), 1.13 (s, 2H, NH2) 




tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (1.50 g, 4.49 mmol) was dissolved in dry 
DMF and 3-azidopropan-1-amine (0.18 g, 1.80 mmol) was added. The reaction mixture was 
stirred and DIPEA (3.13 ml, 17.96 mmol) was added and the reaction was heated at 70 °C 
over night. The solvent was evaporated and the crude reaction mixture was purified using 
flash chromatography. The product was obtained as a porous light yellow solid in 37 % yield 
with a r.f-value of the 0.53 in EtOAc/Hexane (50/50). 
1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.2 Hz, 2H, Py-H), 7.64 (t, J = 7.9 Hz, 2H, Py-H), 
7.47 (s, 2H, NHBoc), 7.10 (d, J = 7.3 Hz, 2H, Py-H), 3.68 (s, 4H, Py-CH2), 3.31 (t, J = 6.8 
Hz, 2H, N3CH2CH2), 2.60 (t, J = 6.9 Hz, 2H, CH2N(CH2Py)2), 1.78 (p, J = 6.8 Hz, 2H, 
N3CH2CH2), 1.52 (s, 18H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 157.69 (Py-CH2), 152.37 (NHCOOtBu), 151.23 (Py-NHBoc), 
138.53 (Py-H), 117.58 (Py-H), 110.35 (Py-H), 80.85 (C(CH3)3), 59.79 (Py-CH2), 51.00 
(CH2N(CH2Py)2) , 49.44 (N3CH2CH2), 28.26 ((CH3)3), 26.53 (N3CH2CH2)  








pyridyl]methyl]amino]methyl]-2-pyridyl]carbamate (0.40 g, 0.78 mmol) was reduced to the 
corresponding amine compound using the ThalesNano H-Cube continuous-flow 
hydrogenation reactor. The compound was dissolved in the EtOAc (30 ml) and a few drops of 
AcOH were added to the reaction mixture. This was used in order to protonate the amine upon 
formation in order to minimise adhesion to the palladium in the catalyst. The catalyst used in 
the hydrogenation was Pd/C (10% on carbon) packed in a cartridge. The reaction solution was 
pumped through the cartridge at 1 ml/min (recirculation) with a H2(g) pressure of 30 bar and a 
temperature of 40 °C. After 2 hours the solvent was evaporated and to afford the title 
compound as a viscous yellow liquid in quantitative yield. 
1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.4 Hz, 2H, Py-H), 7.60 (dd, J = 8.3, 7.4 Hz, 2H, 
Py-H), 7.07 (d, J = 7.2 Hz, 2H, Py-H), 3.64 (s, 4H, Py-CH2), 2.71 (t, J = 6.6 Hz, 2H, 
NH2CH2CH2), 2.54 (t, J = 6.8 Hz, 2H, CH2N(CH2Py)2), 1.67 (p, J = 6.7 Hz, 2H, 
NH2CH2CH2), 1.50 (s, 18H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 155.63 (Py-CH2), 153.34 (NHCOOtBu), 153.16 (Py-NHBoc), 
138.61 (Py-H), 118.14 (Py-H), 112.11 (Py-H), 80.61 (C(CH3)3), 59.52 (Py-CH2), 53.37 












pyridyl]methyl]amino]methyl]-2-pyridyl]carbamate (0.44 g, 0.90 mmol) was dissolved in 
DMF (10 ml) and DIPEA (1.59 ml, 8.96 mmol) was added. Acetic anhydride (0.85 ml, 8.96 
mmol) was added and the reaction was allowed to stir over night under inert atmosphere. The 
solvent was removed and the crude reaction product was purified using flash chromatography 
to afford the title compound as a viscous liquid in 42 % yield (0.20 g, 0.38 mmol) with a r.f-
value of 0.19 (in 100 % EtOAc). 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.1 Hz, 2H, Py-H), 7.65 (dd, J = 8.3, 7.4 Hz, 2H, 
Py-H), 7.26 (s, 2H, NHBoc), 7.05 (d, J = 7.1 Hz, 2H, Py-H), 3.65 (s, 4H, Py-CH2), 3.30 (dd, J 
= 12.0, 5.8 Hz, 2H, CH3CONCH2CH2), 2.59 (t, J = 6.2 Hz, 2H, CH2N(CH2Py)2), 1.89 (s, 3H, 
CH3CON), 1.71 (p, J = 6.7 Hz, 2H, NH2CH2CH2), 1.53 (s, 18H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 169.77 (CH3CON), 157.50 (Py-CH2), 152.26 (NHCOOtBu), 
151.36 (Py-NHBoc), 138.60 (Py-H), 117.91 (Py-H), 110.50 (Py-H), 81.06 (C(CH3)3), 59.71 
(Py-CH2), 52.44 (CH2N(CH2Py)2), 38.50 (CH3CONCH2CH2), 28.26 ((CH3)3), 26.13 




pyridyl]methyl]amino]methyl]-2-pyridyl]carbamate (0.20 g, 0.38 mmol) was placed in a flask 





was then evaporated by blowing N2(g) at the reaction solution. The work up consisted of 
adding H2O/CHCl3 to the crude reaction mixture to which NaOH was added to basify the 
aqueous solution and it was then extracted thrice with CHCl3. The organic phase was dried 
over Na2SO4 and the solvent was removed under reduced pressure to yield the title compound 
(0.049 g, 0.15 mmol) as a viscous liquid in 39 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.40 (dd, J = 8.0, 7.3 Hz, 2H, Py-H), 6.77 (d, J = 7.3 Hz, 2H, 
Py-H), 6.39 (d, J = 8.0 Hz, 2H, Py-H), 4.52 (s, 4H, Py-NH2), 3.58 (s, 4H, Py-CH2), 3.31 (dd, J 
= 11.6, 5.7 Hz, 2H, CH3CONCH2CH2), 2.59 (t, J = 6.0 Hz, 2H, CH2N(CH2Py)2), 1.93 (s, 3H, 
CH3CON), 1.68 (p, J = 6.7 Hz, 2H, CH3CONCH2CH2). 
13C NMR (101 MHz, CDCl3) δ 170.01 (CH3CON), 158.14 (Py-NH2), 157.80 (Py-CH2), 
138.16 (Py-H), 113.22 (Py-H), 106.90 (Py-H), 60.21 (Py-CH2), 52.77 (CH2N(CH2Py)2), 38.60 
(CH3CONCH2CH2), 26.03 (CH3CONCH2CH2), 23.23 (CH3CON) 
HRMS (ESI-TOF) m/z: Calculated for C17H25N6O: 329.2090  





pyridyl]methyl]amino]methyl]-2-pyridyl]carbamate (0.42 g, 0.82 mmol) and prop-2-yn-1-ol 
(0.07 ml, 1.23 mmol) were dissolved in DCM (10 ml). CuSO4· 5 H2O (0.010 g, 0.04 mmol) 
and sodium ascorbate (0.024 g, 0.12 mmol) were dissolved in H2O and added to the DCM 
solution. The biphasic reaction mixture was stirred vigorously for 7 hours and the organic 
phase was separated and dried over MgSO4. The crude green reaction mixture was purified 
using flash chromatography to yield the title compound as a viscous liquid (0.22 g, 0.39 
mmol) in 47 % yield with a r.f-value of 0.51 (in 10/90 MeOH/EtOAc). 
1H NMR (400 MHz, MeOD) δ 7.71 (m, 5H, Py-H & CH=CCH2OH), 7.14 (dd, J = 6.8 Hz, J 




NCH2CH2CH2N(CH2Py)2), 3.70 (s, 4H, Py-CH2), 2.56 (t, J = 6.8 Hz, 2H, 
NCH2CH2CH2N(CH2Py)2), 2.14 (p, J = 6.7 Hz, 2H, NCH2CH2CH2N(CH2Py)2), 1.54 (s, 18H, 
(CH3)3) 
13C NMR (101 MHz, MeOD) δ 157.47 (Py-CH2) , 153.09 (NHCOOtBu), 151.73 (Py-
NHBoc), 147.46 (CH=CCH2OH), 138.31 (Py-H), 122.75 (CH=CCH2OH), 117.69 (Py-H), 
110.51 (Py-H), 80.17 (C(CH3)3), 59.34 (Py-CH2), 55.06 (NCH2CH2CH2N(CH2Py)2), 50.41 





(hydroxymethyl)triazol-1-yl]propyl]amino]methyl]-2-pyridyl]carbamate (0.22 g, 0.39 mmol) 
was dissolved in and TFA/DCM (90/10). The reaction was left to stir for 2 hours and the 
solvent was then evaporated by blowing N2(g) at the reaction solution. The work up consisted 
of adding H2O/DCM to the crude reaction mixture to which NaOH was added to basify the 
aqueous solution and it was then extracted thrice with DCM. The organic phase was dried 
over MgSO4 and the solvent was removed under reduced pressure to yield the title compound 
(0.046 g, 0.12 mmol) as a viscous liquid 32 % yield. 
1H NMR (400 MHz, MeOD) δ 7.75 (s, 1H, CH=CCH2OH), 7.44 (dd, J = 8.2, 7.4 Hz, 2H, Py-
H), 6.77 (d, J = 7.3 Hz, 1H, Py-H), 6.47 (d, J = 8.3 Hz, 1H, Py-H), 4.65 (s, 2H, 
CH=CCH2OH), 4.42 (t, J = 6.9 Hz, 2H, NCH2CH2CH2N(CH2Py)2), 3.59 (s, 4H, Py-CH2), 
2.55 (t, J = 6.8 Hz, 2H, NCH2CH2CH2N(CH2Py)2), 2.10 (p, J = 6.8 Hz, 2H, 
NCH2CH2CH2N(CH2Py)2) 
13C NMR (101 MHz, MeOD) δ 159.01 (Py-NH2), 156.34 (Py-CH2), 147.46 (CH=CCH2OH), 
138.45 (Py-H), 122.73 (CH=CCH2OH), 111.86 (Py-H), 107.28 (Py-H), 59.59 (Py-CH2), 






HRMS (ESI-TOF) m/z: Calculated for C18H25N8O: 369.2151  
Found: 369.2145 [M+H]+   
 
ethyl 2-[bis[[6-(tert-butoxycarbonylamino)-2-pyridyl]methyl]amino]acetate 
tert-butyl N-[6-(iodomethyl)-2-pyridyl]carbamate (1.50 g, 4.49 mmol) was dissolved in dry 
DMF (100 ml). Glycine ethyl ester hydrochloride (0.25 g, 1.80 mmol) was added and the 
reaction mixture was stirred. DIPEA (3.13 ml, 17.96 mmol) was added and the reaction was 
heated in an oil bath to 70 °C over night. The DMF was evaporated under reduced pressure 
and the product was purified using flash chromatography to afford the title compound in 45% 
yield (0.42 g, 0.81 mmol). 
1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.2 Hz, 2H, Py-H), 7.62 (t, J = 8.0 Hz, 2H, Py-H), 
7.42 (s, 1H, NHBoc), 7.14 (d, J = 7.4 Hz, 2H, Py-H), 4.15 (q, J = 7.1 Hz, 2H, COOCH2CH3), 
3.87 (s, 4H, Py-CH2), 3.44 (s, 2H, COCH2), 1.51 (s, 18H, (CH3)3), 1.26 (t, J = 7.1 Hz, 3H, 
COOCH2CH3) 
13C NMR (101 MHz, CDCl3) δ 171.24 (COOCH2CH3), 157.28 (Py-CH2), 152.37 
(NCOOtBu), 151.28 (Py-NHBoc), 138.61 (Py-H), 117.80 (Py-H), 110.47 (Py-H), 80.82 




Ethyl 2-[bis[[6-(tert-butoxycarbonylamino)-2-pyridyl]methyl]amino]acetate (0.31 g, 0.61 
mmol) was dissolved in 30 ml MeOH/EtOH (50/50) and stirred. After 5 min saturated NaOH 





evaporated. Water was added to the reaction mixture and the compound was extracted with 
CHCl3 and dried over MgSO4 and the solvent was evaporated under reduced pressure. The 
product was obtained as a viscous yellow liquid (0.31 g, 0.64 mmol) in quantitative yield. 
1H NMR (400 MHz, CDCl3) δ 9.80 (s, 1H, COOH), 7.95 (d, J = 8.3 Hz, 2H, Py-H), 7.50 (dd, 
J = 8.4, 7.5 Hz, 2H, Py-H), 6.71 (d, J = 7.2 Hz, 2H, Py-H), 3.60 (dd, J = 72.6, 13.7 Hz, 4H, 
Py-CH2), 3.33 (s, 2H, COCH2), 1.51 (s, 18H, (CH3)3). 
13C NMR (101 MHz, CDCl3) δ 179.92 (COOH), 156.00 (Py-CH2), 154.20 (NCOOtBu), 
153.45 (Py-NHBoc), 138.51 (Py-H), 117.43 (Py-H), 111.94 (Py-H), 79.96 (C(CH3)3), 59.59 




2-[bis[[6-(tert-butoxycarbonylamino)-2-pyridyl]methyl]amino]acetic acid (0.26 g, 0.54 
mmol) was dissolved in DMF (25 ml), HBTU (0.23 g, 0.59 mmol) was added and the 
suspension was stirred. DIPEA (0.24 ml, 1.35 mmol) was added and the solution was stirred 
under inert atmosphere. After 1 hour n-butylamine (2.00 ml, 20.24 mmol) was added and the 
reaction mixture was stirred under inert atmosphere over night. The solvent was removed 
under reduced pressure and the crude brown liquid was analysed by LC-MS. The product 















Acetoacetamide (10.00 g, 98.91 mmol) and potassium carbonate (13.67 g, 98.91 mmol) were 
stirred in dry DMF (150 ml) for 30 min after which methyl iodide (6.16 ml, 98.91 mmol) was 
added. The reaction mixture was left to stir over night after which the solid was filtered off. 
To the supernatant was added potassium carbonate (13.67 g, 98.91 mmol) and stirred for 30 
min followed by the addition of methyl iodide (6.16 ml, 98.91 mmol). The reaction mixture 
was stirred over night. The solid was filtered off and the DMF was evaporated. TLC revealed 
a spot with a r.f-value of 0.40 (in 100 % EtOAc) after staining with KMnO4 that was different 
from the starting material. The brown liquid was left to crystallise in the fume hood over 
night. The solid filtered and washed with cold (-18 °C) EtOAc to afford the product as a 
white/yellow solid. After repeated crystallisations the product was obtained (9.74 g, 75.41 
mmol) in 76% yield. 
1H NMR (400 MHz, MeOD) δ 4.91 (s, 2H, CONH2), 2.19 (s, 3H, CH3CO), 1.36 (s, 6H, 
C(CH3)2). 
13C NMR (101 MHz, MeOD) δ 207.96 (CH3CO), 177.25 (CONH2), 55.75 (C(CH3)2), 24.46 
(CH3CO), 21.25 (C(CH3)2) 
 
4-amino-3,3-dimethyl-butan-2-ol 
Lithium aluminium hydride (7.05 g, 185.82 mmol) was charged under nitrogen into an oven 
dried flask and dry THF (200 ml) was slowly added. The flask was stirred under nitrogen at -
78 °C. 2,2-dimethyl-3-oxo-butanamide (6.00 g, 46.45 mmol) was dissolved in dry THF (50 
ml) and slowly added to the stirring LiAlH4 suspension. The reaction was allowed to adapt 
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room temperature over night. The reaction was then heated to reflux for 2 hours. The work up 
consisted of stirring the reaction in an ice bath and slowly adding H2O (≈ 5ml) followed by  
15 % NaOH solution (≈ 5ml). H2O was then added until effervescence stopped. The solid was 
filtered off, washed with Et2O and the organic phases were pooled and dried over MgSO4. 
The solvent was removed under reduced pressure to afford the product as a clear liquid (5.18 
g, 44.20 mmol) in 95 % yield. 
1H NMR (400 MHz, CDCl3) δ 3.73 (q, J = 6.4 Hz, 1H, CHOH), 3.01 (br s, 2H, NH2), 2.75 
(dd, J = 67.0, 12.4 Hz, 2H, CH2NH2), 1.10 (d, J = 6.4 Hz, 3H, CH3CHOH), 0.86 (d, J = 34.1 
Hz, 6H, CH3)2) 
13C NMR (101 MHz, CDCl3) δ 76.44, 53.56, 36.93, 24.06, 18.18 (C(CH3)2), 17.90 (C(CH3)2) 
 
4-[bis[(6-methyl-2-pyridyl)methyl]amino]-3,3-dimethyl-butan-2-ol 
2-(iodomethyl)-6-methyl-pyridine (4.00 g, 17.16 mmol) was dissolved in dry DMF (50 ml) 
and 4-amino-3,3-dimethyl-butan-2-ol (0.80 g, 6.87 mmol) was dissolved in dry DMF and 
added. DIPEA (4.78 g, 27.46 mmol) was added to the solution and the reaction was stirred at 
70 °C over night. The solvent was evaporated and the crude reaction mixture was purified by 
flash chromatography. The product was obtained as a viscous brown liquid (1.86 g, 5.68 
mmol) in 82 % yield. 
1H NMR (400 MHz, CDCl3) δ 7.54 (t, J = 7.7 Hz, 2H, Py-H), 7.25 (d, J = 7.7 Hz, 2H, Py-H), 
7.03 (d, J = 7.6 Hz, 2H, Py-H), 3.85 (dd, J = 81.0, 14.3 Hz, 4H, Py-CH2), 3.49 (q, J = 6.4 Hz, 
1H, CHOH), 2.68 (d, J = 4.4 Hz, 2H, CH2N), 2.56 (s, 6H, Py-CH3), 1.00 (d, J = 6.4 Hz, 3H, 
CH3CHOH), 0.87 (d, J = 75.0 Hz, 6H, (CH3)2) 
13C NMR (101 MHz, CDCl3) δ 155.41 (Py-CH3), 152.42 (Py-CH2), 144.45 (Py-H), 126.09 
(Py-H), 123.75 (Py-H), 73.39 (CHOH), 66.00 (C(CH3)2CH2), 57.48 (Py-CH2), 39.35 
(C(CH3)2), 24.68 (Py-CH3), 20.13 ((CH3)2), 19.95 ((CH3)2), 17.98 (CH3CHOH) 




Found: 328.2381 [M+H]+ 
 
4-[bis[(6-methyl-2-pyridyl)methyl]amino]-3,3-dimethyl-butan-2-one 
4-[bis[(6-methyl-2-pyridyl)methyl]amino]-3,3-dimethyl-butan-2-ol (0.36 g, 1.10 mmol) was 
dissolved in dry DCM and stirred in an ice bath. Dess-Martin periodinane (0.61 g, 1.43 mmol) 
was dissolved in dry DCM and added to the stirred reaction mixture which was stirred for an 
additional 2 hours at room temperature. To the clear reaction mixture was added one 
equivalent of H2O (25 µL, 1.43 mmol) after which the solution turned cloudy and the reaction 
was stirred over night. The reaction mixture had turned green over night and excess H2O was 
added. The organic phase was dried over MgSO4 and purified using flash chromatography 
with MeOH/DCM (10/90) and a r.f-value of 0.55. 
The product was obtained as yellow liquid (0.15 g, 0.46 mmol) in 42 % yield. 
Alternative purification: HPLC (Waters Xbridge C18 column 5-58% MeCN 0.1% TFA, 
gradient 13 min, 254 nm) collected peak at 6.5 min. The fractions were pooled and MeCN 
was evaporated followed by treatment with dilute NaOH solution to neutralise the TFA. The 
product was extracted with CHCl3 and EtOAc followed by drying over MgSO4 to afford the 
product as a yellow liquid  
1H NMR (400 MHz, CDCl3) δ 7.56 (t, J = 7.7 Hz, 2H, Py-H), 7.31 (d, J = 7.7 Hz, 2H, Py-H), 
7.02 (d, J = 7.6 Hz, 2H, Py-H), 3.75 (s, 4H, Py-CH2), 2.92 (s, 2H, CH2N), 2.53 (s, 6H, Py-
CH3), 2.01 (s, 3H, CH3CO), 1.08 (s, 6H, (CH3)2) 
13C NMR (101 MHz, CDCl3) δ 213.75 (C=O), 159.01 (Py-CH3), 157.46 (Py-CH2), 136.60 
(Py-H), 121.44 (Py-H), 120.11 (Py-H), 63.16 (CH2N), 61.98 (Py-CH2), 49.68 (C(CH3)2), 
25.66 (CH3CO), 24.43 (Py-CH3), 23.43 ((CH3)2) 
HRMS (ESI-TOF) m/z: Calculated for C20H28N3O: 326.2227  






4-[bis[(6-methyl-2-pyridyl)methyl]amino]-3,3-dimethyl-butan-2-one (0.076 g, 0.23 mmol) 
was dissolved in 50/50 H2O/EtOH (5 ml). Hydroxylamine hydrochloride (0.018 g, 0.26 
mmol) was added and after it had dissolved 1M NaOH (257 µL, 0.257 mmol) was added and 
the reaction was stirred for 2 hours. The EtOH was evaporated under reduced pressure and the 
crude mixture was extracted with CHCl3 followed by EtOAc. The organic phase was dried 
over MgSO4 and the solvent was removed under reduced pressure to yield the product as a 
viscous light yellow liquid (0.061 g, 0.18 mmol) in 77% yield. Alternatively, purification can 
be performed using flash chromatography with MeOH/DCM (10/90) and a r.f-value of 0.48. 
1H NMR (400 MHz, MeOD) δ 7.69 (t, J = 7.7 Hz, 2H, Py-H), 7.46 (d, J = 7.7 Hz, 2H, Py-H), 
7.15 (d, J = 7.6 Hz, 2H Py-H), 3.76 (s, 4H, Py-CH2), 2.78 (s, 2H, C(CH3)2CH2N), 2.50 (s, 6H, 
Py-CH3), 1.73 (s, 3H, CH3C=NOH), 1.05 (s, 6H, (CH3)2). 
13C NMR (101 MHz, MeOD) δ 161.23 (C=NOH), 158.61 (Py-CH3), 157.06 (Py-CH2), 
137.35 (Py-H), 121.79 (Py-H), 120.67 (Py-H), 62.98 (CH2N), 60.96 (Py-CH2), 41.46 
(C(CH3)2), 23.78 (Py-CH3), 22.32 ((CH3)2), 9.29 (CH3C=NOH) 
HRMS (ESI-TOF) m/z: Calculated for C20H27N4OZn: 403.1476  
Found: 403.1459 [M-+Zn2+]+ 
 
3-oxobutyl 4-methylbenzenesulfonate 
4-hydroxybutan-2-one (15.00 g, 170.24 mmol) was weighed into a flask together with 4-
toluenesulfonyl chloride (48.68 g, 255.36 mmol) and dissolved in dry DCM (250 ml) in an ice 




stirred and allowed to adapt room temperature over night. The reaction was washed with H2O 
(500 ml) and dried over Mg SO4 and the solvent was removed under reduced pressure. The 
crude product was purified using flash chromatography with an r.f-value of 0.53 (in 100 % 
Et2O) to afford the product as a viscous clear liquid (8.95 g, 36.94 mmol) in 21 % yield.  
Note: The title compound is temperature sensitive (avoid temperatures exceeding 30 °C) and 
prolonged sonication may lead to the formation of a black liquid that when analysed indicated 
the presence of the elimination product but-3-en-2-one. The compound should preferably be 
purified as soon as possible after the work up. Once pure it should immediately be used in the 
subsequent reaction or stored under N2(g) at -18 °C. 
1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H, Ph-H), 7.37 (d, J = 8.5 Hz, 2H, Ph-H), 
4.27 (t, J = 6.4 Hz, 2H, COCH2CH2), 2.84 (t, J = 6.3 Hz, 2H, COCH2CH2), 2.47 (s, 3H, Ph-
CH3), 2.16 (s, 2H, CH3CO) 
13C NMR (101 MHz, CDCl3) δ 204.34 (C=O), 145.00 (Ph-SO3), 132.61 (Ph-CH3), 129.90 




3-oxobutyl 4-methylbenzenesulfonate (1.00 g, 4.13 mmol) was dissolved in EtOH (20 ml) and 
stirred in an ice bath. NaBH4 (0.31 g, 8.25 mmol) was added to the stirred solution and the 
reaction was stirred for 1 hour at room temperature. H2O was added and the reaction was 
extracted with DCM and then EtOAc. The organic phases were pooled and dried over MgSO4 
and the solvent was removed under reduced pressure to yield the title compound as a clear 
liquid (0.82 g, 3.36 mmol) in 81 % yield. The crude product did not require further 
purification and according to TLC the r.f-value of the compound was 0.45 (in 100 % Et2O). 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 2H, Ph-H), 7.37 (d, J = 8.0 Hz, 2H, Ph-H), 
4.20 (m, 2H, CHOHCH2CH2), 3.97 (s, 1H, Ph-CH3), 2.47 (s, 3H, ), 1.79 (m, 2H, 
CHOHCH2CH2), 1.21 (d, J = 6.2 Hz, 3H, CH3CHOH) 
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13C NMR (101 MHz, CDCl3) δ 144.86 (Ph-SO3), 132.99 (Ph-CH3), 129.90 (Ph-H), 127.91 





tBDPS-Cl (12.76 g, 46.43 mmol) was dissolved in dry THF (200 ml) and stirred in an ice 
bath. 3-hydroxybutyl 4-methylbenzenesulfonate (3.00 g, 12.28 mmol) was added to the 
reaction mixture followed by imidazole (8.62 g, 126.62 mmol) and the reaction was stirred 
over night. The precipitate that had formed overnight was filtered off and the solvent was 
evaporated. The crude mixture was dissolved in Et2O and washed with H2O. The organic 
phase was dried over MgSO4 and the solvent was evaporated to afford 16 g of a clear liquid 
crude mixture consisting of product and excess starting material. The crude product mixture 
was used without further purification in the subsequent step. 
Half the crude batch, 8 g, was used and it should consist of a given amount of 3-[tert-
butyl(diphenyl)silyl]oxybutyl 4-methylbenzenesulfonate (2.96 g, 6.14 mmol). This crude 
liquid was dissolved in dry DMF (50 ml) and NaN3 (2.73 g, 41.99 mmol) was added. The 
reaction was stirred at 70 °C over night. The solvent was evaporated, H2O/DCM (50/50) was 
added and the aqueous layer was extracted twice with DCM and once with EtOAc. The 
organic phases were dried over MgSO4 and the solvent was removed under reduced pressure. 
The obtained crude was a light yellow liquid amounting to 10 g and was purified using 
Et2O/Hexane (25/75) with the title compound having an r.f-value of 0.72. The title compound 
was isolated using flash chromatography as a light yellow liquid (1.89 g, 5.35 mmol) 






1H NMR (400 MHz, CDCl3) δ 7.72 (m, 1H), 7.44 (m, 1H), 4.01 (m, 1H), 3.38 (t, J = 7.2 Hz, 
1H), 1.75 (m, 1H), 1.11 (d, J = 6.2 Hz, 1H), 1.10 (s, 2H) 
13C NMR (101 MHz, CDCl3) δ 135.88 (Ph-H), 135.83 (Ph-H), 134.45 (Ph-Si), 133.93 (Ph-
Si), 129.74 (Ph-H), 129.61(Ph-H), 127.68 (Ph-H), 127.52 (Ph-H), 67.07 
(CHOSi(Ph)2(C(CH3)3)), 47.99 (CH2CH2N3), 38.16 (CH2CH2N3), 27.04 (C(CH3)3), 23.45 
(CH3CHOSi), 19.31 (C(CH3)3) 
 
3-[tert-butyl(diphenyl)silyl]oxybutan-1-amine 
(3-azido-1-methyl-propoxy)-tert-butyl-diphenyl-silane (1.81 g, 5.12 mmol) was reduced to 
the corresponding amine compound using the ThalesNano H-Cube continuous-flow 
hydrogenation reactor. The compound was dissolved in the EtOAc (50 ml) and a few drops of 
AcOH were added to the reaction mixture. This was used in order to protonate the amine upon 
formation in order to minimise adhesion to the palladium in the catalyst. The catalyst used in 
the hydrogenation was Pd/C (10% on carbon) packed in a cartridge. The reaction solution was 
pumped through the cartridge at 1 ml/min (recirculation) with a H2(g) pressure of 40 bar and a 
temperature of 40 °C. After 2.5 hours the solvent was evaporated and to afford the title 
compound in quantitative yield as a viscous yellow liquid. 
1H NMR (400 MHz, CDCl3) δ 7.69 (m, 4H, Ph-H), 7.42 (m, 6H, Ph-H), 7.08 (s, 2H, 
CH2NH2), 3.96 (m, 1H, CH3CHOSi), 2.90 (m, 2H, CH2CH2NH2), 1.80 (m, 2H, CH2CH2NH2), 
1.07 (d, J = 4.4 Hz, 2H, CH3CO), 1.06 (s, 9H,(CH3)3) 
13C NMR (101 MHz, CDCl3) δ 135.86 (Ph-H), 135.81 (Ph-H), 134.36 (Ph-Si), 133.72 (Ph-
Si), 129.77 (Ph-H), 129.62 (Ph-H), 127.72 (Ph-H), 127.52 (Ph-H), 67.67 
(CHOSi(Ph)2(C(CH3)3)), 38.76 (CH2CH2NH2), 36.74 (CH2CH2NH2), 27.01 ((CH3)3), 23.25 






2-(iodomethyl)-6-methyl-pyridine(2.68 g, 11.50 mmol) was dissolved in dry DMF (50 ml) 
and 3-[tert-butyl(diphenyl)silyl]oxybutan-1-amine (1.50 g, 4.60 mmol) was added. The 
reaction mixture was stirred, DIPEA (3.20 ml, 18.40 mmol) was added and the reaction was 
stirred at 70 °C over night. The DMF was evaporated and the crude reaction mixture was 
dissolved in CHCl3 and washed with 10 % Na2S2O3 and extracted twice with CHCl3 and once 
with EtOAc. The organic layer was dried over MgSO4 and the solvent was removed under 
reduced pressure to afford a dark liquid that was purified using flash chromatography. The 
product was obtained as a viscous yellow liquid (0.77 g, 1.43 mmol) in 31 % yield. 
1H NMR (400 MHz, MeOD) δ 7.61 (m, 6H, Py-H & Ph-H), 7.36 (m, 8H, Py-H & Ph-H), 
7.11 (d, J = 7.6 Hz, 2H, Py-H), 3.92 (m, 1H, CH3CHOSi), 3.63 (dd, J = 44.9, 14.6 Hz, 4H, 
Py-CH2), 2.55 (m, 2H, CH2CH2N), 2.49 (s, 6H, Py-CH3), 1.70 (m, 2H, CH2CH2N), 0.98 (d, J 
= 6.1 Hz, 3H, CH3CHOSi), 0.95 (s, 9H, (CH3)3) 
13C NMR (101 MHz, MeOD) δ 158.86 (Py-CH3), 157.15 (Py-CH2), 137.38 (Py-H), 135.56 
(Ph-Si), 135.54 (Ph-Si), 134.23 (Ph-H), 133.92 (Ph-H), 129.39 (Ph-H), 129.34 (Ph-H), 
127.27(Ph-H), 127.17 (Ph-H), 121.77 (Py-H), 120.09 (Py-H), 68.07 (CH3CHOSi), 59.67 (Py-
CH2), 50.67 (CH2CH2N), 36.40 (CH2CH2N), 26.09 ((CH3)3), 22.36 (Py-CH3), 22.24 
(CH3CHOSi), 18.56 (C(CH3)3) 














3-[tert-butyl(diphenyl)silyl]oxy-N,N-bis[(6-methyl-2-pyridyl)methyl]butan-1-amine (0.77 g, 
1.43 mmol) was dissolved in dry THF (20 ml) and stirred in an ice bath. Solid TBAF hydrate 
(3.74 g, 14.32 mmol) was added in 10 equivalent excess and stirred under N2(g) over night. 
The solvent was evaporated to afford a clear viscous liquid that was purified by flash 
chromatography. The product was obtained as a light yellow viscous liquid (0.37 g, 1.25 
mmol) in 87 % yield. 
1H NMR (400 MHz, MeOD) δ 7.67 (t, J = 7.7 Hz, 2H), 7.40 (d, J = 7.7 Hz, 2H), 7.14 (d, J = 
7.6 Hz, 2H), 3.79 (m, 1H), 3.77 (dd, J = 43.8, 14.5 Hz, 4H), 2.69 (m, 2H, CH2CH2N), 2.52 (s, 
3H, Py-CH3), 1.68 (m, 2H, CH2CH2N), 1.10 (d, J = 6.3 Hz, 3H, CH3CHOH) 
13C NMR (101 MHz, MeOD) δ 158.56 (Py-CH3), 157.36 (Py-CH2), 137.35 (Py-H), 121.78 
(Py-H), 120.23 (Py-H), 66.37 (CH3CHOH), 59.61 (Py-CH2), 51.68 (CH2CH2N), 35.52 
(CH2CH2N), 22.39 (Py-CH3), 22.09 (CH3CHOH) 
 
HRMS (ESI-TOF) m/z: Calculated for C18H24N3OZn: 326.1211  
Found: 362.1207 [M-+Zn2+]+  
All the following oximes were synthesised according to this general procedure: 
 
1-(2-pyridyl)ethanone oxime 
1-(2-pyridyl)ethanone (0.93 ml, 8.25 mmol) was dissolved in 50 ml of H2O/EtOH (50/50). 




an ice bath. 1 M NaOH (9.08 ml, 9.08 mmol) was added and the reaction was stirred over 
night. The EtOH was removed under reduced pressure and the remaining aqueous solution 
was extracted with THF followed by EtOAc and lastly CHCl3.The organic phases were 
pooled and the solvent was evaporated to remove the THF that might dissolve the drying 
agent (MgSO4). The extracted product was dissolved in EtOAc and dried over MgSO4. The 
solvent was evaporated and the product was isolated in 52% yield.  
1H NMR (400 MHz, CDCl3) δ 9.12 (s, 1H, NOH), 8.66 (dd, J = 4.8, 0.9 Hz, 1H, Py-H), 7.86 
(dd, J = 8.0 Hz, J = 0.8 Hz, 1H, Py-H), 7.72 (td, J = 7.8, 1.8 Hz, 1H, Py-H), 7.31 (m, 1H, Py-
H), 2.43 (s, 3H, CH3) 
13C NMR (101 MHz, CDCl3) δ 157.02 (Py-CNOH), 154.32 (Py-CNOH), 148.95 (Py-H), 
136.40 (Py-H), 123.73 (Py-H), 120.56(Py-H), 10.70 (CH3CNOH) 
HRMS (ESI-TOF) m/z: Calculated for C6H5N2O: 137.0709  
Found: 137.0705 [M+H]+  
 
(2E)-pyridine-2-carbaldehyde oxime 
Starting material pyridine-2-carbaldehyde  
50 % yield 
1H NMR (400 MHz, MeOD) δ 8.53 (dd, J = 4.9, 1.0 Hz, 1H, Py-H), 8.12 (s, 1H, CHNOH), 
7.87 (m, 2H, Py-H), 7.40 (td, J = 5.0, 1.7 Hz, 1H, Py-H). 
13C NMR (101 MHz, MeOD) δ 148.64 (Py-CNOH), 148.05 (Py-CNOH), 137.49 (Py-H), 
137.16 (Py-H), 123.91 (Py-H), 120.50 (Py-H) 
HRMS (ESI-TOF) m/z: Calculated for C6H5N2OZn: 184.9693  






Starting material 1-(6-acetyl-2-pyridyl)ethanone 
Quantitative yield 
1H NMR (400 MHz, MeOD) δ 7.85 (d, J = 7.9 Hz, 2H, Py-H), 7.70 (dd, J = 8.3, 7.3 Hz, 1H, 
Py-H), 2.34 (s, 6H, CH3) 
13C NMR (101 MHz, MeOD) δ 155.37 (Py-CNOH), 153.86 (Py-CNOH), 136.00 (Py-H), 
119.26 (Py-H), 8.93 (CH3) 
HRMS (ESI-TOF) m/z: Calculated for C9H12N3O2: 194.0930  
Found: 194.0936 [M+H]+  
 
bis(2-pyridyl)methanone oxime 


















7.6 - Miscellaneous synthesis 
 
tert-butyl N-tert-butoxycarbonyl-N-(6-methyl-2-pyridyl)carbamate 
Byproduct from the synthesis of tert-butyl N-(6-methyl-2-pyridyl)carbamate. 
1H NMR (400 MHz, CDCl3) δ 7.63 (t, J = 7.7 Hz, 1H, Py-H), 7.08 (d, J = 7.6 Hz, 1H, Py-H), 
7.05 (d, J = 7.9 Hz, 1H, Py-H), 2.54 (s, 3H, CH3), 1.46 (s, 18H, (CH3)3) 
13C NMR (101 MHz, CDCl3) δ 157.82 (Py-CH3), 151.58 (C=O), 151.40(Py-N(Boc)2), 138.04 






1-[tert-butyl(dimethyl)silyl]oxypropan-2-one (precursor for HPNPPi synthesis) 
Imidazole (27.57 g, 404.97 mmol) and tert-Butyldimethylsilyl chloride (30.52 g, 202.48mmol 
mmol) were dissolved in dry DMF (200 ml) and stirred in an ice bath. 1-hydroxypropan-2-one 
(9.26 ml, 134.99 mmol) was added slowly and the reaction mixture was stirred over night at 
room temperature. H2O was added to the reaction mixture followed by extraction with Et2O. 
The volatile solvent was removed under reduced pressure and the residual DMF was removed 
with an additional extraction with Et2O from H2O. The solvent was removed under reduced 
pressure to afford the title compound as a clear liquid in quantitative yield. 
1H NMR (400 MHz, CDCl3) δ 4.16 (s, 2H, CH3COCH2), 2.18 (s, 3H, CH3COCH2), 0.93 (s, 
9H, SiC(CH3)3), 0.10 (s, 6H, Si(CH3)2) 
13C NMR (101 MHz, CDCl3) δ 209.21 (CH3COCH2), 69.56 (CH3COCH2), 25.75 





































Chapter 8  - Appendix 
 
8.1 - Properties of 4-nitrophenol 
 
At any given pH (this effect is negligible at very high pH-values) some of the PNP will 
not be visible at 400 nm (ArOH has a maximum absorbance around 320 nm) and thus only the 
deprotonated species is monitored (ArO- has a maximum absorbance around 400 nm). This 
can be solved by multiplying the absorbance at 400 nm with the corresponding factor for the 
invisible species at any given pH. 
























The total amount of released 4-nitrophenol, [PNP]T, at a given pH can be determined by 
measuring the absorbance at 400 nm and correcting for the protonation state (pKa): 
[PNP] 	 ∝ 	Absjkl% 	× 	 1F(ArO5) 
 
The pKa for the 4-nitrophenol (PNP) was determined by measuring the absorbance at 
400 nm under the same conditions used for the kinetic experiments. The PNP was dissolved 
in an aqueous solution containing 50 mM HEPES or CHES buffer with an ionic strength of 
0.1 M (NaNO3) at 25 °C.  
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The absorbance for 50 µM PNP was measured at 400 nm at various pH and the 
following equation was fitted to the data in Figure 8.1: 






Figure 8.1. The absorbances at 400 nm versus pH plot for 50 µM PNP. 
The data for the plot in Figure 8.1 is summarised in Table 8.1. 










Table 8.1. The absorbances for 50 µM PNP at various pH. 
The pKa of PNP was determined to be 6.98 (± 0.05) which is in good agreement with 
literature (7.14).[211] 
The absorbance for 50 µM PNP at 400 nm can be estimated for any pH from 6.8 




















Abs	Q""R = 	0.94439	 ×	 (10
5o.pq"r)
(105o.pq"r 	+ 	105M) 
The absorbance at 400 nm versus the concentration of PNP (10, 20, 30, 40 and 50 µM) 
was measured at different pH and linear fitting yielded the extinction coefficient (ε) for each 
pH. A modified equation (Abs(ArO-) replaced by ε) was fitted to a plot of the extinction 
coefficients versus pH to yield the limiting extinction coefficient at 400 nm (18503), see data 














6.81 0.1044 0.1701 0.2591 0.3424 0.427 8175 
7.29 0.1341 0.2819 0.3723 0.5152 0.6006 11663 
7.67 0.1764 0.3388 0.4697 0.6294 0.7723 14824 
8.07 0.1625 0.3591 0.5142 0.6899 0.8383 16824 
8.66 0.2105 0.3904 0.5715 0.7665 0.9434 18419 
9.18 0.2136 0.3869 0.556 0.7773 0.9325 18282 
9.54 0.2109 0.3887 0.5855 0.7595 0.9471 18432 
10.04 0.2159 0.3848 0.5894 0.766 0.9724 18942 
 
Table 8.2. The absorbance at 400nm of PNP at various pH and concentrations yielded the pH dependent 
extinction coefficients.  
 
8.2 - Determining the purity and kinetic behavior of HPNPP  
 
The synthesis of HPNPP[29] (see Chapter 7) yielded the desired compound but 10 % of 
the purified phosphate was methyl (4-nitrophenyl) phosphate (MPNPP), see Figure 8.2, 
according to the ratio obtained from NMR integration. The source of the MPNPP is most 
likely the work-up procedure and purification where the use of MeOH might lead to the 
esterification of residual unreacted phosphorodichloridate. The MPNPP doesn’t contain an 
internal nucleophile and thus it hydrolyses at a slower rate (3200-fold slower in MeOH 




Figure 8.2. The HPNPP (left) and MPNPP (right) sodium salts. 
In order to check whether or not the HPNPP product behaves as expected i.e. check the 
prediction that the MPNPP won’t interfere, the transesterification was performed in NaOH 
(0.1 M) at 25 °C, see Figure 8.3. 
 
Figure 8.3. The absorbance (400 nm) versus time (left) was used to determine the pseudo-first-order rate 
and the concentration of released PNP versus time (right) was used to determine the initial rate for the 
transesterification of 50 µM HPNPP in 0.1 M NaOH.  
The apparent second-order rate constants were (first-order fit 0.045 M-1 s-1 and initial 
rate fit 0.040 M-1 s-1) determined and compared to the literature (0.065 M-1 s-1).[65] 
The initial rate for a reaction is followed within the time it takes for 10 % of the 
substrate to react. This initial phase is a linear relationship between time and amount of 
product formed. By following the complete reaction of a substrate one can obtain an accurate 
estimation of kobs but the initial rate can be obtained when following the full reaction is not an 
option. The method of initial rates is utilised for very slow reactions and for reactions where 
the progression of the reaction makes accurate monitoring difficult (too high concentration of 
product). In order for accurate estimations of the reaction rates to be obtained the substrate 












































8.3 - Equations for kinetic experiments 
 
Knowledge about the protonation state of a catalytic complex is of great importance for 
the determination of the optimal pH-range for a given reaction. The complexes that have been 
examined in previous chapters all display a pH-dependence with one or two deprotonations in 
the studied pH-range.  
The relationship between the activity and protonation state can be expressed as a series 
of equations where ligand-Zn(II) complex is C, the total complex complex concentration is 
[C]T, the first and second acid dissociation constants are Ka1 and Ka2, the second-order rate 
constant at a given pH is k2pH and the maxium second-order rate constant is k2max. 
Sinlge-ionisation equation 




The total complex concentration is: 
[s] 	= 	 [s(tW)] 	+	 [s(tW)]  
Which can be expressed as: 
[s] 	= 	 [s(tW)] 	×	(1	 +	 r[W]) 
Assuming that the monodeprotonated complex C(OH) is the active form, the percentage 




[s(tW)] 	× 	(1	 +	 r[W])




Which yields the equation for the single-ionisation complex: 












The total complex concentration is: 
[s] =	 [s(tW)] 	+	 [s(tWtW)] +	[s(tW)] 
Which can be expressed as: 
[s] 	= 	 [s(tW)] 	×	(1	 +	 r[W] +	
 	× 	r
[W] ) 
Assuming that the monodeprotonated complex C(OHOH2) is the active form, the 
percentage of the total amount of complex that is reactive can be expressed as: 
[s(tWtW)]
[s] 	= 	
[s(tW)] 	× 	 r[W]
[s(tW)] 	× 	(1	 +	 r[W] +	
 	× 	r[W] )
	 
Which yields the equation for the two-fold ionisation complex: 
 	= 	 M 	× 	
r 	× 	 [W]
[W] +	[W]r +	r 
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8.4 - Conditions for kinetic experiments  
 
The initial kinetic experiments surveying the reactivity of the complexes were 
performed on Varian UV spectrophotometers (Cary 1, Cary 3 or Cary 300 bio) using 
temperature controlled cell blocks. Quartz cuvettes (1 ml or 3 ml) were used for UV-scans 
and experiments carried out below 350 nm. For experiments at 400 nm, mainly plastic 
cuvettes (1 ml or 3 ml) were used. All experiments were carried out in 50 mM (HEPES or 
CHES) buffered aqueous solutions at 25 °C and the ionic strength was kept at 0.1 M (NaNO3) 
unless stated otherwise. The pH of the experiments in 1 ml and 3 ml cuvettes were measured 
after completion of the reaction. The substrate HPNPP was synthesised according to the 
procedure in Chapter 7.2.1 and bis-(4-nitrophenyl) phosphate (BNPP) was purchased from 
Sigma-Aldrich and used without further purification. 
The indicator displacement assays were performed using the Varian Cary 50 UV-Vis 
spectrophotometer with a fiber optic probe in a 5 ml solution containing 50 mM HEPES at  
pH 7.4 and 0.1 M ionic strength (NaNO3). Each complex was used in 50 µM concentration 
and incubated with 50 µM pyrocatechol Violet (PV) prior to addition of phosphate. The 
substrate disodium hydrogenphosphate was added to the solution in 0.2 equivalent portions 
and stirred after each addition followed by a UV-scan (200-800 nm).  
The main body of the DMP inhibition experiments was performed using a BMG 
Polarstar plate reader using Greiner flat bottom 96 well plates under the same conditions used 
for the previous kinetic experiments unless otherwise stated. 
 
8.5 - Plate reader experiments 
 
The plate reader experiments were performed on BMG Polarstar plate reader using 
Greiner Bio One 96-well black µClear flat bottom plates. The plate reader was set to 20 
flashes per well at 25 °C and the standard volume used for each experiment was 200 µL. The 




The absorbance of the solutions in the wells needs to be adjusted for the solution since 
the detector reading is vertical therefore the path length varies with the volume of the solution 
although this cancels out since the concentration increases accordingly. Based on the 
dimensions of the wells reported by the manufacturer, the theoretical volume of each well is 
392 µL. The depth of each well is 10.9 mm and a 10 mm path length equals approximately 
360 µL. The experiments were performed in 200 µL volume which equals a path length of 
approximately 5.6 mm. A series of experiments were performed using the Greiner plates with 
200 µL of 50 µM 4-nitrophenol at pH 13, see Table 8.3. 
Well Abs 400nm Well Abs400nm 
1 0.5280 9 0.5266 
2 0.5098 10 0.5308 
3 0.5292 11 0.5327 
4 0.5214 12 0.5252 
5 0.5139 13 0.5332 
6 0.5148 14 0.5232 
7 0.5150 15 0.4887 
8 0.5202 16 0.5273 
        
Average 0.5213 
 
Table 8.3. The absorbance at 400 nm for 50 µM 4-nitrophenol with 0.1 M NaOH in 200 µL. The 
measurements were performed in 16 different wells and the absorbances were averaged to yield a 
representative value. 
The expected absorbance for 50 µM 4-nitrophenol at pH 13 for a 10 mm path length is 
0.944, see Figure 8.1, which equates to a factor of 1.8-fold lower absorption for the plate 
reader experiments. The data obtained from the plate reader experiments were corrected for 
the discrepancy in path length. 
It is worth keeping in mind that the wells of the plate are small which can affect the path 
length since the meniscus intrinsically displaces some of the liquid from the path of the beam. 
Additionally, the path length can be reduced by negligent deposition of the liquid leading to 






8.6 - The lability of the tBDMS protecting group  
 
The synthesis of HPNPP highlighted some issues regarding the stability of the 
tertButyldimethylsilane protecting (tBDMS) group. The tBDMS protecting group was stable 
in the synthesis leading up to the attachment to the phosphate and showed no indication of 
being prone to spontaneous deprotection.  
 
Figure 8.4. The 1H-NMR spectrum (δ ppm) for the tBDMS protected HPNPP in MeOD-d4. 
 
 
Figure 8.5. The partial 1H-NMR spectra (δ ppm) showing the tBDMS group detaching over time             
(60 hours) in MeOD-d4. Since the mechanism is not know, the functionality attached to the silicone of the 









The instability was discovered after NMR analysis where the protected diester seemed 
to lose the tBDMS group in MeOD-d4 over time with no external addition of reagent. The 1H-
NMR spectra for tBDMS protected HPNPP, see Figure 8.4, indicated spontaneous loss of the 
protecting group over time, see Figure 8.5.The relative 1H-NMR integrals plotted over time 
yielded an apparent zeroth order reaction rate for the deprotection of tBDMS, see Figure 8.6. 
 
 
Figure 8.6. The percentage of free tBDMS versus time. The table represents the data points obtained from 
1H-NMR integration 
Interestingly, the equivalent non-phosphorylated diol, see Figure 8.7, did not display 
similar tBDMS lability.  
 



































Time (sec) % free tBDMS 
0 5 
81240 42 
2.78 × 105 83 
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8.7 - Appendix for Chapter 2 
 
8.7.1 - Compound structures 
 

























































































































8.7.2 - Data for Chapter 2 
 
2-1 2-2 
pH kobs (× 10-4) (s-1) log kobs kobs (× 10-5) (s-1) log kobs 
6.81 1.13 (± 0.001) -3.95 2.10 (± 0.004) -4.68 
7.27 1.61 (± 0.001) -3.79 2.84 (± 0.003) -4.55 
7.66 1.93 (± 0.001) -3.71 3.73 (± 0.003) -4.43 
8.04 2.19 (± 0.002) -3.66 5.14 (± 0.005) -4.29 
8.40 2.45 (± 0.002) -3.61 4.13 (± 0.002) -4.38 
8.95 2.23 (± 0.002) -3.65 3.99 (± 0.003) -4.40 
9.36 2.03 (± 0.001) -3.69 3.93 (± 0.003) -4.41 
9.77 2.09 (± 0.001) -3.68 4.00 (± 0.002) -4.40 
2-3 2-4 
pH kobs (× 10-3) (s-1) log kobs kobs (× 10-2) (s-1) log kobs 
6.81 4.01 (± 0.04) -2.40 1.26 (± 0.005) -1.90 
7.27 4.23 (± 0.05) -2.37 - - 
7.66 5.28 (± 0.02) -2.28 - - 
8.04 4.19 (± 0.08) -2.38 - - 
8.40 - - - - 
8.95 - - - - 
9.36 - - - - 
9.77 - - - - 
 
Table 8.4. The pseudo-first-order rate constants for 2 mM 2-1, 2 mM 2-2, 0.2 mM 2-3 and 0.2 mM 2-4 
with 50 µM HPNPP and 50 mM HEPES or CHES with 0.1 M ionic strength (NaNO3). 
 
2-1 2-2 
pH k2 (M-1 s-1) (× 10-2) log k2 k2 (M-1 s-1) (× 10-2) log k2 
6.83 2.7144 (± 0.06) -1.57 0.53128 (± 0.06) -2.27 
7.28  4.1778 (± 0.04) -1.38 0.87866 (± 0.09) -2.06 
7.67 5.1226 (± 0.03) -1.29 1.31424 (± 0.14) -1.88 
8.11 5.9836 (± 0.08) -1.22 1.70868 (± 0.20) -1.77 
8.7 5.6176 (± 0.10) -1.25 1.32304 (± 0.41) -1.88 
9.14 6.0886 (± 0.36) -1.22 0.9052 (± 0.51) -2.04 
9.5 4.5962 (± 0.39) -1.34 1.87872 (± 0.36) -1.73 
9.95 5.3368 (± 1.04) -1.27 1.85596 (± 0.90) -1.73 
 
Table 8.5. The second-order rate constants for 2-1 and 2-2 in 50 mM HEPES or CHES at 0.1 M ionic 
strength (NaNO3) at various pH.  
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pH 6.9 pH 6.9 pH 7.4 pH 7.4 

















0 1 0 1 0 1 0 1 
2 0.70683 5 0.83836 8 0.54429 5 0.91369 
4 0.53721 10 0.71018 15 0.39939 10 0.80043 
6 0.44439 20 0.65625 20 0.32796 15 0.79699 
8 0.36755 30 0.50907 20 0.75309 
12 0.30365 40 0.42751 30 0.70349 
15 0.26647 50 0.37704 40 0.62864 





Table 8.6. The normalised rate k/k0 for the inhibition studies with DMP for 1 mM 2-1 and 2-2 with 0.5 mM 















Table 8.7. The normalised rate k/k0 for the inhibition studies with DMP for 0.2 mM 2-3 with 50 µM 









pH 6.9 pH 6.9 pH 6.9 pH 6.9 

















0 1 0 1 0 1 0 1 
2 0.88741 5 0.87474 5 0.11903 5 0.11228 
4 0.81601 10 0.7405 10 0.048574 10 0.054833 
6 0.73002 20 0.60575 20 0.022369 20 0.024802 
8 0.68555 30 0.52433 30 0.010513 30 0.011846 
12 0.58365 40 0.45124 40 0.006831 40 0.006872 
15 0.52859 50 0.40606 50 0.004032 50 0.003776 





Table 8.8. The normalised rate k/k0 for the inhibition studies with DMP for 1 mM 2-1 and 2-2 with 0.5 mM 
HPNPP as well as 0.2 mM 2-3 and 2-4 with 50 µM HPNPP using DMP at pH 6.9. The experimental 













2-1 20.01736 8.728752 2.440496 72 28 
2-2 20.24175 8.504359 2.028539 76 24 
2-3 15.84049 12.90563 4.393468 66 34 
2-4 15.15542 13.59069 4.403421 68 32 
HPNPPuncat 28.74611 - - - - 
 
Table 8.9. The contribution of interactions in the ground state versus the transition state are estimated 
using the kinetic data obtained for the complexes at pH 6.9 for 1 mM 2-1 and 2-2 with 0.5 mM HPNPP 
















0 1 1 
1 0.61279 0.91653 
2 0.35043 0.80025 
5 0.13719 0.66053 
10 0.084117 0.56847 
 
Table 8.10. The normalised rate k/k0 for the inhibition studies with DMP for 1 mM 2-1 and 2-2 with        
0.5 mM HPNPP at pH 6.9 in 50 mM HEPES and 0.1 M ionic strength (NaNO3). 
 
2-5  2-6 
pH kobs (× 10-5) (s-1) log kobs kobs (× 10-4) (s-1) log kobs 
6.87 0.20 (± 0.01) -5.6914 1.60 (± 0.05) -3.7947 
7.33 0.97 (± 0.006) -5.0121 1.61 (± 0.02) -3.7919 
7.74 1.68 (± 0.003) -4.7734 - - 
8.14 2.20 (± 0.01) -4.6566 - - 
8.65 - - - - 
9.15 - - - - 
9.54 - - - - 
9.91 - - - - 
2-7 L2-6-Co(II) 
pH kobs (× 10-5) (s-1) log kobs kobs (× 10-4) (s-1) log kobs 
6.87 0.62 (± 0.004) -5.2067 0.76 (± 0.0004) -4.1167 
7.33 1.30 (± 0.001) -4.8868 1.10 (± 0.001) -3.9592 
7.74 2.07 (± 0.001) -4.6843 1.22 (± 0.002) -3.9121 
8.14 2.82 (± 0.002) -4.5494 1.29 (± 0.002) -3.8898 
8.65 4.56 (± 0.05) -4.3410 - - 
9.15 4.35 (± 0.05) -4.3619 - - 
9.54 6.02 (± 0.06) -4.2202 - - 
9.91 7.61 (± 0.08) -4.1186 - - 
 
Table 8.11. The observed rate constants for 0.4 mM oxazole-bridged complex in 50 mM HEPES or CHES 






8.8 - Appendix for Chapter 3 
 
8.8.1 - Compound structures 
 
 
Figure 8.9. The structures of the mononuclear complexes studied in Chapter 3. 
 
8.8.2 - Data for Chapter 3 
 
Complex 3-1 Complex 3-2 
pH k2 (M-1 s-1) log k2 k2 (M-1 s-1) log k2 
6.83 0.9648 (± 0.02) -0.0156 0.0232 (± 0.0004) -1.6342 
7.28 1.7007 (± 0.08) 0.2306 0.0425 (± 0.0003) -1.3718 
7.67 2.4632 (± 0.17) 0.3915 0.0668 (± 0.0002) -1.1752 
8.11 3.6224 (± 0.16) 0.5590 0.1028 (± 0.0003) -0.9881 
8.7 - - 0.1572 (± 0.0007) -0.8035 
9.14 - - 0.1908 (± 0.003) -0.7194 
9.5 - - 0.1550 (± 0.001) -0.8096 
9.95 - - 0.1404 (± 0.002) -0.8528 
 
Table 8.12. The second-order rate constants for 3-1 and 3-2 at 1 mM with 100 µM HPNPP at various pH 
in 50 mM HEPES and 25 °C. The highest observed k2 is highlighted (green) for each complex. 
The apparent second-order rate constants, see Table 8.12, for 3-1 and 3-2 show the 
highest k2 is at pH 8.11 (3.38 ± 0.16 M-1 s-1) and pH 9.14 (0.19 ± 0.003 M-1 s-1), respectively. 
The listed second-order rate constants in Table 8.12 indicate that there is approximately 
an order of magnitude difference in reactivity in favor of 3-1. The data seem to indicate a 
decrease in activity for 3-1 at pH 8.7 but this can be misleading given the unreliability of 






Figure 8.10. The absorbance at 400 nm versus time for Na2CO3 treated 1 mM 3-2 and 50 µM HPNPPi in 
50 mM HEPES at pH 7.4 in 0.1 M ionic strength (NaNO3). 
 
[Na2CO3] mM kobs (× 10-3) (s-1) k/k0 
0 1.065 (± 0.0005) 1 
0.5 0.614 (± 0.0014) 0.575958 
1 0.45 (± 0.0007) 0.422634 
1.5 0.34 (± 0.0013) 0.318729 
2 0.255 (± 0.0014) 0.239579 
 
Table 8.13. The observed rates and normalised rate for Na2CO3 with 1 mM 3-2 and 50 µM HPNPPi in 50 






























8.9 - Appendix for Chapter 4 
 
8.9.1 - SPPS chemistry 
 
The standard mechanism for activation of carboxyl groups in organic using N,N’-
dicyclohexylcarbodiimide (DCC). The byproduct of the reaction with DCC is 
dicyclohexylurea that precipitates out of most organic solution and is therefore not 
appropriate for use in solid phase peptide synthesis. 
 
Figure 8.11. The activation and coupling of an amino acid using DCC. 
For SPPS purposes N,N’-diisopropylcarbodiimide (DIC) is a better alternative since it 
follows the same mechanism but the by-product diisopropylurea is more soluble in organic 
solvent and thus doesn’t interfere with the solid support. Unfortunately the usage of DCC and 
DIC lead to significant racemisation of the amino acid which could be attributed to the fact 





DIC were usually employed together with HOBt (1-hydroxybenzotriazol) which formed a less 
reactive activated ester and reduced the risk of racemisation.[213] For Fmoc peptide synthesis 
the standard activating agent is HBTU which incorporates a carbodiimide and benzotriazole 
in one molecular entity. 
 














































































8.9.2 - SPPS protocol 
 
The following protocol has been devised for 2-chlorotrityl chloride (2-CTC) functionalised 
resins although most of the steps are applicable for any general Fmoc peptide synthesis. The 
added advantage of 2-CTC, apart from allowing for mild cleavage, is that it is reusable and 
can be activated with relative ease.[214] 
i) Put the unloaded resins in the reaction vessel with the sintered filter bottom of 
appropriate porosity for the polymer beads and allow them to swell without agitation 
in 5 ml DCM, enough to cover the resin, for approximately 15 min. Wash out the 
DCM and add 5 ml DMF and allow the resins to swell for approximately 30 min 
without agitation. 
ii) Wash out the DMF and add the first reaction mixture by first dissolving the 
amino acid in DMF and then adding DIPEA. Agitate the mixture together with the 
resins for 4 hours preferably over night since the addition of the first amino acid is one 
of the most critical steps in solid phase peptide synthesis. The first amino acid is used 
in a 6-fold excess and DIPEA is used in a 6.6-fold excess compared to the unloaded 
resin. 
iii)  Wash the resins (agitate) with approximately 5 ml of each solvent in the 
following order: 
 DMF:  5 times (approx. 1 min each) 
 MeOH:  2 times (approx. 1 min each)  
 DCM: 5 times (approx. 1 min each) 
The linkers that have not attached the amino acid must be capped This can be achieved by 
washing the resins with MeOH for a longer period of time. 
 MeOH:  2 times (approx. 10 min each) 
*OPTIONAL* In this step it is possible to get an estimation of the actual loading for the 
attachment of the first the amino acid (see subappendix below).  
iv) Wash resins with 5 ml each time: 
DCM: 5 times (approx. 1 min each) 
DMF: 3 times (approx. 1 min each) 
v) In order to attach the subsequent amino acid in the peptide the N-terminal must 
be deprotected i.e. the Fmoc group must be cleaved off. The mixture used to cleave off 
Fmoc is a solution of 20 percent piperidine in DMF (30 percent piperidine in DMF is 
preferred). Store the piperidine solution in dark colored glassware. 
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Wash with approximately 5 ml of: 
Piperidine/DMF:  1 time (approx. 20 min) 
Piperidine/DMF:  2 times (approx. 10 min each) 
vi) Wash the resins with approximately 5 ml of: 
 DMF:  5 times (approx. 1 min each) 
 MeOH:  2 times (approx. 1 min each)  
 DCM: 5 times (approx. 1 min each) 
DMF: 3 times (approx. 1 min each) 
vii) Add the reaction mixture 2 by first dissolving the amino acid and coupling 
reagent in DMF and then adding DIPEA. Agitate the mixture together with the resins 
for 1.5 to 2 hours or longer if there are no time constraints. The second amino acid like 
the other remaining amino acids are used in a 4-fold excess and DIPEA is used in a 
4.4-fold excess compared to the unloaded resins. 
viii) Wash as described in step vi. 
ix) Deprotect as described in v. 
x) Wash as described in step vi. 
Repeat step vii through x until all amino acids are coupled to the peptide. 
xi) Skip this step if acetylation is not required. Use a 50-fold excess of acetic 
anhydride and a 50-fold excess of DIPEA dissolved in DMF. Add the mixture to the 
resin and agitate for 1 hour. Wash the resin according to step vi and proceed.  
xii) Before cleaving off the peptide from the beads they must be washed in order to 
remove all DMF because DMF can cleave the peptide in the presence of TFA. 
Wash resins with approximately 5ml of: 
MeOH:  2 times (approx. 1 min each)  
 DCM: 5 times (approx. 1 min each) 
It is essential that DMF is thoroughly removed from the resins and reaction vessel prior to 
addition of cleavage mixture. Dry the resins by blowing nitrogen at them and place them in a 
vacuum desiccator over night. If the fully protected peptide is desired, use 1% TFA in DCM, 
otherwise follow the procedure below. 
Add the cleavage mixture containing TFA /TIS/H2O in the ratio 90/5/5. 
Cleave with 3 times the volume of the resin each time: 
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TFA/TIS/H2O:  3 times (approx. 60 min each) 
Collect the fractions and evaporate the solvent in the rotary evaporator. 
Subappendix 
Wash the resins with approximately 5ml of: 
DCM:  5 times (approx. 1 min each)  
Et2O: 3 times (approx. 1 min each) 
Dry the resins by gently blowing nitrogen at the resins. Place the resins in a vacuum 
desiccator over night. Weigh approximately 1 mg of the resins and place them in a 1 ml UV-
cuvette and add 1 ml of 20 or 30 percent piperidine in DMF. Leave the resins together with 
the piperidine solution (with occasional agitation) for 2-3 h. Set the UV detection to 290 nm 
and don’t forget to zero with the piperidine solution. The loading can then be estimated using 
the following equation: 
Loading = Abs290nm / (mg resin * 1.75)  [in the unit mmol/g] 
 











8.9.4 - Data for Chapter 4 
 









Table 8.14. The spectrophotometric concentration calibration measurements for L4-2 and the interpolated 
measurement for L4-1 (green). 
 
 
Figure 8.14. The absorbance was monitored at 400 nm for the transesterification of 50 µM HPNPP using 
0.4 mM 4-1 at pH 7.4 in 50 mM HEPES and 0.1 M ionic strength (NaNO3). No activity was seen during 
the initial 7 minutes of the experiment therefore 6 equivalents of Zn(OTf)2 were added at 450 seconds (*). 

























The reactivity observed after the addition of excess Zn(II) hints that potential allosteric 
binding of Zn(II) could be the cause, see Figure 8.14 The addition of excess Zn(OTf)2 can be 
seen in light of the x-ray crystallographic data of the trihelical structure studied by Pecoraro et 
al. (PDB code: 3PBJ), see Figure 8.15, that show multiple Zn(II) ions coordinated to other 
residues (glutamic acid) than histidine in the peptide sequence.[161] 
 
 
Figure 8.15. Additional Zn(II) coordination by glutamic acid in the trihelical structure studied by 
Pecoraro et al. (PDB code: 3PBJ). [45] 
 
pH kobs ( × 10-5) (s-1) log kobs 
6.87 3.12 (± 0.003)  -4.5059 
7.32 6.8 (± 0.004) -4.1677 
7.36 7.56 (± 0.003) -4.1214 
7.68 11.70 (± 0.005) -3.9296 
8.11 19.51 (± 0.009) -3.7097 
8.73 30.05 (± 0.008) -3.4808 
9.18 34.54 (± 0.02) -3.4617 
9.52 30.95 (± 0.006) -3.4617 
9.93 34.54 (± 0.008) -3.5093 
 
Table 8.15.The observed rates for 1 mM 4-2 and 4-1 (green) with 50 µM HPNPP and 50 mM HEPES or 




Addition  pH Addition  pH Addition  pH 
0 3.25 17 7.00 34 10.82 
1 3.33 18 7.27 35 10.86 
2 3.43 19 7.47 36 10.90 
3 3.57 20 7.66 37 10.94 
4 3.76 21 7.83 38 10.97 
5 4.04 22 8.06 39 11.01 
6 4.38 23 8.29 40 11.04 
7 4.71 24 8.65 41 11.06 
8 4.98 25 9.23 42 11.08 
9 5.20 26 9.80 43 11.11 
10 5.38 27 10.13 44 11.14 
11 5.57 28 10.45 45 11.16 
12 5.74 29 10.45 46 11.18 
13 5.95 30 10.56 47 11.20 
14 6.17 31 10.64 48 11.22 
15 6.43 32 10.71 49 11.23 
16 6.72 33 10.77 50 11.25 
 
Table 8.16. The titration of L4-2 using 50 mM NaOH added in 0.1 equivalents per addition (10 µL).  
 
Addition  pH Addition  pH Addition  pH 
0 3.12 17 5.06 34 8.53 
1 3.19 18 5.14 35 8.71 
2 3.27 19 5.23 36 8.96 
3 3.36 20 5.32 37 9.23 
4 3.48 21 5.43 38 9.57 
5 3.64 22 5.56 39 9.79 
6 3.86 23 5.73 40 9.96 
7 4.09 24 5.97 41 10.09 
8 4.27 25 6.28 42 10.2 
9 4.4 26 6.71 43 10.3 
10 4.51 27 7.09 44 10.38 
11 4.6 28 7.41 45 10.45 
12 4.68 29 7.67 46 10.52 
13 4.76 30 7.88 47 10.58 
14 4.83 31 8.06 48 10.64 
15 4.91 32 8.21 49 10.69 
16 4.97 33 8.37 50 10.74 
 




The Zn(OH) and Zn(OH)2 formation constants were obtained from literature.[215] 
 
pH kobs ( ×10-4) (s-1) log kobs 
6.88 2.46 (± 0.004) -3.6084 
7.31 3.47 (± 0.007) -3.4603 
7.33 6.31 (± 0.004) -3.1999 
7.71 11.96 (± 0.006) -2.9223 
8.15 21.08 (± 0.008) -2.6762 
8.77 31.28 (± 0.022) -2.4571 
9.23 35.60 (± 0.027) -2.4205 
9.58 37.97 (± 0.029) -2.4485 
9.97 34.91 (± 0.020) -2.5047 
 
Table 8.18. The observed pseudo-first-order rate constants for 0.4 mM 4-4 and for comparison 0.4 mM   
3-2 (green) towards the transesterification of 50 µM HPNPPi in 50 mM HEPES/CHES at various pH with 















8.10 - Appendix for Chapter 5 
 
8.10.1 - Compound structures 
 
 














8.10.2 - Data for Chapter 5 
 
 
Figure 8.17. The observed reaction rates for 1 mM of the nucleophilic complexes in 50 mM HEPES       











































































































































































Figure 8.18. The observed reaction rates for 1 mM of the nucleophilic complexes in 50 mM HEPES       
(pH 7.4) with 0.1 M ionic strength (NaNO3) and 50 µM BNPP. Complex 5-6 was used with 2 mM Zn(NO3)2 














































































































































































































 [5-1] mM pH 6.82 pH 7.28 pH 7.65 pH 7.92 pH 8.10 
0.2 2.39 × 10-13 1.04 × 10-11 2.62 × 10-11 5.59 × 10-11 1.88 × 10-12 
0.4 8.15 × 10-12 2.88 × 10-11 6.36 × 10-11 1.36 × 10-10 5.93 × 10-12 
0.6 1.53 × 10-11 4.97 × 10-11 1.09 × 10-10 2.30 × 10-10 9.61 × 10-12 
0.8 2.36 × 10-11 7.24 × 10-11 1.58 × 10-10 3.30 × 10-10 1.38 × 10-11 
1 3.42 × 10-11 9.75 × 10-11 2.03 × 10-10 4.12 × 10-10 1.84 × 10-11 
 
Table 8.19. Initial rate (M s-1) for the hydrolysis 1 mM BNPP (50 µM BNPP at pH 8.1) at various 5-1 
concentrations and pH in 50 mM HEPES (pH 8.1 in EPPS) with 0.1 M ionic strength (NaNO3). 
 
At higher pH the data became unreliable due to precipitation. This was initially 
observed using CHES at pH 8.59 which further deteriorated with increasing pH. The initial 
rates were measured up to pH 8.1 in 50 mM EPPS and 0.1 M ionic strength (NaNO3). 
 
pH kobs ( × 10-8) (s-1) k2 (× 10-5) (M-1 s-1) log k2 
6.82 4.17 (± 0.18) 4.17 (± 0.18) -4.38 
7.28 10.89 (± 0.37) 10.89 (± 0.37) -3.96 
7.65 22.40 (± 0.58) 22.40 (± 0.58) -3.65 
7.92 45.31 (± 0.97) 45.31 (± 0.97) -3.34 
8.10 2.05 (± 0.05) 40.91 (± 0.05) -3.39 
 
Table 8.20. The linear fit of initial rate versus complex concentration yielded observed rate constants (s-1) 
and apparent second-order rate constants (M-1 s-1) for 5-1 with 1 mM BNPP (50 µM BNPP at pH 8.1). 
 
[5-3] mM pH 6.72 pH 7.21 pH 7.58 pH 8.00 
0.2 1.32 × 10-8 3.06 × 10-8 4.17 × 10-8 5.24 × 10-8 
0.4 3.87 × 10-8 7.21 × 10-8 9.50 × 10-8 1.09 × 10-7 
0.6 6.53 × 10-8 1.2 × 10-7 1.49 × 10-7 1.65 × 10-7 
0.8 9.93 × 10-8 1.61 × 10-7 2.20 × 10-7 2.25 × 10-7 
1 1.23 × 10-7 2.1 × 10-7 2.44 × 10-7 2.72 × 10-7 
 
Table 8.21. Initial rate (M s-1) for the hydrolysis 1 mM BNPP at various 5-3 concentrations and pH in      





 [5-3] mM pH 8.54 pH 9.10 pH 9.45 pH 9.86 
0.2 5.45 × 10-8 4.34 × 10-8 3.46 × 10-8 1.91 × 10-8 
0.4 1.16 × 10-7 9.24 × 10-8 7.22 × 10-8 4.36 × 10-8 
0.6 1.60 × 10-7 1.37 × 10-7 1.11 × 10-7 6.78 × 10-8 
0.8 2.67 × 10-7 1.85 × 10-7 1.47 × 10-7 9.20 × 10-8 
1 2.14 × 10-7 2.32 × 10-7 1.86 × 10-7 1.21 × 10-7 
 
Figure 8.19. Initial rate (M s-1) for the hydrolysis 1 mM BNPP at various 5-3 concentrations and pH in    
50 mM HEPES with 0.1 M ionic strength (NaNO3). 
 
pH kobs (× 10-4) (s-1) k2 (M-1 s-1) log k2 
6.72 1.40 (± 0.04) 0.14(± 0.04) -0.85 
7.21 2.24 (± 0.04) 0.22 (± 0.04) -0.64 
7.58 2.65 (± 0.19) 0.26 (± 0.19) -0.58 
8.00 2.78 (± 0.06) 0.28 (± 0.06) -0.56 
8.54 2.62 (± 0.06) 0.26 (± 0.06) -0.58 
9.10 2.34 (± 0.01) 0.23 (± 0.01) -0.63 
9.45 1.89 (± 0.01) 0.19 (± 0.01) -0.72 
9.86 1.26 (± 0.02) 0.13(± 0.02) -0.90 
 
Figure 8.20. The linear fit of initial rate versus complex concentration yielded observed rate constants     
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